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The Gram-negative bacterium, Serratia marcescens, is an important opportunistic 
human pathogen capable of causing serious infections, particularly in immunocompromised 
patients. S. marcescens Db10 is an insect pathogen that is closely related to S. marcescens 
strains which cause disease in humans. The genome sequence of S. marcescens Db10 is 
available and tools exist which allow the genetic manipulation of this bacterium, making it 
an ideal model organism. In this work, contact dependent and independent antibacterial 
strategies employed by S. marcescens Db10 are investigated at the molecular level. 
Non-ribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) are 
widespread in bacteria and fungi and are responsible for the biosynthesis of many 
metabolites with medically relevant properties, including antibiotics. The activity of NRPS 
and PKS enzymes is dependent on their modification by a phosphopantetheinyl transferase 
(PPTase) enzyme. In this work we identify the biosynthetic genes, alb2-6, which are 
required for the production of the NRPS-PKS antibiotic, althiomycin, in S. marcescens 
Db10. The role of the Major Facilitator Superfamily protein, Alb1, in the export of and 
resistance to althiomycin is also defined. Using a combination of bioinformatic, 
biochemical and genetic approaches we demonstrate that a PPTase  enzyme, PswP, is 
essential for althiomycin production. We further show that PswP is required for the 
biosynthesis of the surfactant, serrawettin W2, and an enterobactin-like siderophore. These 
PswP dependent metabolites are all shown to possess antimicrobial activity against the 
Gram-positive bacterium, Staphylococcus aureus. 
The Type VI Secretion System (T6SS) is the most recently identified Gram-
negative bacterial secretion system and has been demonstrated to play important roles in 
mediating contact dependent interactions with neighbouring bacterial and eukaryotic cells. 
S. marcescens Db10 is known to encode an anti-bacterial T6SS. In this study, S. marcescens 
Db10 strains are constructed which harbour fusions of T6SS components to fluorescent 
proteins. The functionality of these fusion proteins and their localisation profiles are 
analysed by fluorescence microscopy. We demonstrate that different sub-complexes of the 
T6SS show distinct patterns of localisation. We additionally show that the T6SS assembles 
within many cells within a population of S. marcescens Db10 and that assembly is not 
dependent on the presence of neighbouring cells. Strains constructed in this study will 
comprise a toolbox for further investigations into the mechanisms of assembly and 












1.1 Serratia marcescens 
The genus Serratia belongs to the Enterobacteriaceae family and comprises 14 
different species and two subspecies. This Gram-negative bacterium is found 
ubiquitously in the environment and has been isolated from insects, plants, water, 
animals, nematodes and soil (Mahlen, 2011). The earliest reports of the existence of 
Serratia date back to 1819, when a pigmented species of Serratia was isolated from 
polenta in Italy. Initially believed to be a fungus, the red micro-organism was named 
Serratia marcescens (Bizio, 1823). Several species of Serratia are pigmented due to the 
production of the red metabolite, prodigiosin (Williams, 1973). This attribute, as well as 
the belief that Serratia species were non-pathogenic, led to the widespread use of 
Serratia as a tracer organism to study the transmission and spread of bacteria in the 
environment, during the latter half of the 20
th
 century (Mahlen, 2011). However, certain 
species of Serratia, notably S. marcescens, are now recognised as important 
opportunistic human pathogens and many reports exist which implicate this bacterium 
in disease, especially in neonates and immunocompromised patients (Haddy et al., 
1996; Hejazi & Falkiner, 1997; Mahlen, 2011; Manfredi et al., 2000; Voelz et al., 
2010). S. marcescens infections are not limited to these groups of patients and reports 
exist which implicate Serratia in almost every type of infection, including: urinary tract 
infections (Su et al., 2003), blood stream infections (Blossom et al., 2009), surgical site 
infections (Chiang et al., 2013), conjunctivitis (Dias et al., 2013) and endocarditis 
(Korner et al., 1994). The treatment of S. marcescens infections is complicated by the 
fact that many isolates are resistant to a range of antibiotics. Resistance to antibiotics 
was first described thoroughly in the early 1980s and, whilst recognised as a potential 
issue, it was noted that S. marcescens remained sensitive to aminoglycosides and 
cephalosporins (Sleigh, 1983). More recently, reports of resistance to these antibiotics 
have also been described (Coria-Jimenez & Ortiz-Torres, 1994; Hejazi & Falkiner, 
Chapter 1: Introduction 
3 
 
1997).  S. marcescens is therefore an important nosocomial pathogen and, since this 
species is by far the most frequent species of Serratia isolated from affected patients, it 
is the most well studied member of the genus. 
S. marcescens isolate Db10, used in this work, is an insect pathogen and a non-
pigmented strain of Serratia which was originally isolated from Drosophila flies (Flyg 
et al., 1980). The genome of S. marcescens Db11, which is a streptomycin resistant 
derivative of the parental Db10 strain, has been sequenced (Sanger Institute, United 
Kingdom). This isolate of S. marcescens is also genetically tractable, with tools and 
methods to manipulate its genome being available, making it an ideal model organism 
for molecular investigation. 
 
1.2 Competitive inter-bacterial interactions 
 Bacteria must constantly sense and respond to their environment in order to 
survive. In most instances, the environment in which a bacterium lives will harbour 
many bacteria, often of multiple species. Within a confined environment, different 
species of bacteria may interact directly, for example, through the use of contact 
dependent secretion systems (Fronzes et al., 2009), or they may influence neighbouring 
bacteria indirectly by altering the immediate environment, for example, through the 
release of antibiotics (Alanis, 2005). Interactions between competing bacteria may be 
co-operative or competitive. Co-operative interactions include examples such as quorum 
sensing (where bacteria are able to produce and sense extracellular chemicals in order to 
monitor population density (Ng & Bassler, 2009)) and biofilm formation (whereby a 
community of cells adhere to a surface or interface and encase themselves in a self-
produced extracellular matrix (Flemming & Wingender, 2010)).  In this work, two 
examples of competitive inter-bacterial interactions mediated by S. marcescens Db10 
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were investigated, namely antibiotic production and Type VI secretion system-
dependent bacterial killing. 
1.2.1 Antibiotics 
1.2.1.1 Biological role of antibiotics 
Antibiotics are defined as chemicals that are capable of killing or inhibiting the 
growth of micro-organisms. Antibiotics are produced by a wide variety of bacteria, 
particularly soil dwelling micro-organisms. At high concentrations, antibiotics kill or 
inhibit growth of bacteria by a variety of mechanisms which include inhibition of cell 
wall synthesis, inhibition of protein synthesis, inhibition of DNA or RNA synthesis and 
disruption of the cell membrane (Figure 1.1) (Alanis, 2005).  
 
Figure 1.1. Potential targets of antibiotics in the bacterial cell. Antibiotics may target cell 
wall biosynthesis (e.g. -lactams), protein synthesis (e.g. tetracyclines), DNA synthesis (e.g. 
fluoroquinolones), RNA synthesis (e.g. rifampin) or the cell membrane (e.g. polymyxins)  
 
The advantages of such drugs have certainly been exploited in the medical profession, 
so much so that resistance to antibiotics is now a pressing issue, as discussed further 
below. In a polymicrobial environment, antibiotic producing organisms have better 
access to physical space and nutrients by eliminating neighbouring competing bacteria. 
In this case, the advantages of antibiotic biosynthesis to the producing organism seem 
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apparent and this type of bacterial interaction would be detrimental to the susceptible 
bacterium. However, it has also been suggested that, in the natural environment, 
antibiotics may never reach concentrations high enough to inhibit growth of 
surrounding bacteria and that antibiotics rather serve as signalling molecules (Davies, 
2006; Fajardo & Martinez, 2008; Yap, 2013). Demonstrably, transcriptomic responses 
to the presence of antibiotics at a low concentration have been shown to be extensive 
with around 5% of the genome of Salmonella typhimurium and Escherichia coli 
responding to the antibiotics rifampicin and erythromycin (Goh et al., 2002). Also in 
support of this theory, bacteria appear to respond differently to closely related 
antibiotics that have a similar mode of action (Goh et al., 2002). In this instance, 
antibiotics mediate a very different type of bacterial interaction. 
 
1.2.1.2 Therapeutic role of antibiotics and the need for discovery of novel agents 
As described in section 1.2.1.1, the antibacterial properties of antibiotics have 
been harnessed by the medical profession for the treatment of bacterial infections, so 
much so that it is estimated that well over one million tonnes of antibiotics have been 
produced since their discovery in the 1940s (Andersson & Hughes, 2010). Antibiotics 
remain essential medicines for the treatment of infectious disease, which remains the 
second leading cause of death worldwide (WHO, 2011). Not only are antibiotics used 
for the treatment of disease in humans, they are also used extensively in agriculture and 
aquaculture to increase growth rates of livestock. It is estimated that 80% of antibiotics 
consumed in the United States are used in agriculture (Hollis & Ahmed, 2013). These 
vast quantities of drugs constitute an enormous selection pressure for the evolution of 
resistant organisms. Infection with antibiotic resistant organisms is becoming more and 
more prevalent and these infections are becoming increasingly difficult to treat. For 
Chapter 1: Introduction 
6 
 
example, seven countries have now reported cases of treatment failure with third 
generation cephalosporins against Neisseria gonorrhoeae, which is the causative agent 
of gonorrhoea (WHO, 2014). Antibiotic resistance is recognised as a serious threat to 
human health, and infections caused by antibiotic resistant bacteria have twice the 
mortality rate of those caused by the same non-resistant bacteria (WHO, 2014).  
Although there has been an increase in the number of infections caused by multidrug 
resistant pathogens, the number of new antibiotics coming into use follows an inverse 
trend and has dramatically declined over the past 20 years, with the most recent distinct 
class of antimicrobial being discovered in 1987 (Figure 1.2) (Silver, 2011). The 
decrease in the discovery of novel agents is partly due to the huge cost and the large 
amount of time associated with development; it has been estimated to cost $800 million 
and take 8-15 years to develop such a drug (Gwynn et al., 2010). Further, once a drug 
has been developed, the nature of the treatment course with antimicrobials means that 
antibiotics should eliminate the need for their own use. Antibiotics are therefore usually 
used over a short time period, by comparison with drugs which are taken for long term 
illnesses. These factors do not make antibiotics the most attractive drugs to develop. 
However, it should not be assumed that the lack of development of novel drugs is 
entirely due to a lack of research by pharmaceutical companies. The screening of 
fermentation products to identify novel agents, which proved so fruitful in the early 
days of antibiotic discovery, is no longer a viable means of discovery due to saturation 
(Silver, 2011). The difficulties associated with the development of novel antibiotics are 
recognised, yet the pressing need for the discovery of novel antibiotics remains. Our 
understanding of antibiotic biosynthesis pathways in bacteria is essential if we are to 
harness the potential application of these biosynthetic pathways in the synthetic 
production of novel drugs. 




Figure 1.2. Timeline illustrating the discovery of novel classes of antibiotics.  The shaded area represents the most recent time period, during which no new 
classes of anti-bacterials have been discovered. Adapted from (Silver, 2011). 
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1.2.2 Interactions mediated by bacterial secretion systems 
Not only are Gram-negative bacteria capable of interacting with surrounding 
bacteria by the production of antibiotics, they can also mediate interactions with 
neighbouring bacteria (as well as eukaryotic cells or their abiotic environment) via the 
assembly of secretion systems. These protein secretion machines transport proteins from 
the cytoplasm of the producing cell to the extracellular environment, where the proteins 
may remain associated with the outside of the bacterial cell, released into the 
extracellular milieu or be directly transported into a target cell (Chagnot et al., 2013; 
Fronzes et al., 2009). Protein secretion machines therefore may alter the extracellular 
environment or they may alter the intracellular environment of a target cell. To date, six 
different bacterial secretion systems have been described in Gram-negative bacteria, 
namely the Type I to Type VI Secretion Systems. The Gram-negative cell envelope 
consists of the inner membrane (IM), the periplasm (which contains a layer of 
peptidoglycan) and the outer membrane (OM). The nature of the Gram-negative cell 
envelope therefore allows secretion to occur as a one-step or a two-step event (Figure 
1.3).  
 
1.2.2.1 One-step secretion systems 
In one-step secretion systems (Type I, III, IV and VI), substrates are transported 
directly from the bacterial cytoplasm into the extracellular environment and are never 
free in the periplasm. The Type I Secretion System (T1SS) transports proteins that vary 
greatly in size and function, although many play an essential role in pathogenesis or in 
nutrient degradation and acquisition. The machinery itself is relatively simple and 
consists of three membrane proteins: an ABC transporter to transport substrates across 
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the inner membrane, a membrane fusion protein which spans the periplasm and an OM 
factor which shapes a pore in the OM (Figure 1.3) (Kanonenberg et al., 2013). 
 Type III Secretion Systems (T3SSs) comprise more than 20 different proteins 
that assemble as three distinct “parts”. The basal body spans the IM, periplasm and the 
OM. Substrates are then thought to be transported through an extracellular needle like 
structure, which together with the basal body, comprises the “needle complex”. The 
third component of the T3SS is the translocon at the distal end of the needle, which 
inserts into the membrane of the eukaryotic target cell (Figure 1.3). Many plant and 
animal pathogens employ the T3SS to inject virulence proteins directly into target cells.  
Of note, several components of the T3SS show homology at the sequence or structural 
level to components of the bacterial flagellum (Izore et al., 2011). 
Type IV Secretion Systems (T4SSs) are unusual in that they mediate transport of 
both DNA and proteins. Three subgroups of T4SSs can be distinguished based on 
function. The first and most widespread sub-group comprises conjugation systems. 
These systems mediate the transfer of single stranded DNA and one or more proteins 
from the donor cell directly into a target bacterial or eukaryotic cell through a 
transenvelope channel (Bhatty et al., 2013). Conjugation represents an important 
mechanism of horizontal gene transfer and the spread of genes within a population 
facilitates bacterial adaption to the environment. The second subgroup of T4SSs are the 
effector translocation systems. These systems deliver proteins into eukaryotic cells and 
play an important role in virulence in many medically relevant pathogens. Substrate 
release or uptake systems comprise the third subgroup of T4SSs and in this case the 
Type IV apparatus functions independently of cell-cell contact. They mediate the export 
of DNA or the uptake of DNA and proteins (Bhatty et al., 2013). It should be noted that 
T4SS are not exclusively involved in secretion, and the T4SS can also be involved in 
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the synthesis of extracellular pili (Trokter et al., 2014).  T4SSs are usually composed of 
12 proteins that are organised as four “parts”, these are: three cytoplasmic ATPases, the 
inner membrane channel and the periplasmic complex and the extracellular pilus 
(Figure 1.3) (Fronzes et al., 2009).  
The Type VI Secretion System (T6SS) represents the most recently discovered 
Gram-negative bacterial secretion system. This secretion system comprises a minimum 
of 13 core components and mediates the transfer of proteins directly into target cells 
which may be bacterial or eukaryotic (Filloux, 2013). The T6SS is therefore an 
important mediator of bacterial-bacterial interactions and will be discussed in more 
detail in section 1.4. 
 
1.2.2.2 Two-step secretion systems 
In two-step secretion systems (Type II and V), substrates are firstly targeted to 
the export systems, Sec or Tat, for transport across the IM. Type II Secretion Systems 
(T2SSs) are employed by many bacteria for the transport of exoenzymes into the 
environment, where they are essential for the breakdown of extracellular nutrients. This 
system is composed of 12-16 proteins which exist in the cytoplasm, inner membrane, 
periplasm and outer membrane (Figure 1.3) (Nivaskumar & Francetic, 2014).  
Type V secretion systems (T5SSs) are relatively simple secretion systems which 
can be divided into five different sub groups; Va-e. All members of T5SS subgroups 
traverse the IM via the Sec transport system and are dependent on a -barrel transporter 
domain that inserts into the OM for translocation of the passenger domain (Figure 1.3). 
The passenger domain refers to the domain that is being translocated into the 
extracellular milieu (Leo et al., 2012). Subgroup Va substrates are termed 
autotransporters; the information required to traverse the IM and the OM is contained 
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within a single polypeptide chain and translocation does not require the aid of additional 
proteins. Subgroup Vb describes two partner secretion whereby a passenger protein 
interacts with a separate transporter protein via two POTRA (polypeptide transport-
associated) domains. Subgroup Vc substrates are trimeric autotransporters, which 
mediate the export of three passenger domains. Subgroup Vd substrates are also 
contained within a single polypeptide chain, however, in this case, the passenger 
domain is fused to a single POTRA domain within the transporter. Finally, subgroup Ve 
substrates are thought to resemble Va substrates, except that the orientation of the N- 
and C-terminus of the -barrel transporter domain is reversed. Substrates of the T5SS 
function as adhesins, toxins or enzymes (Gawarzewski et al., 2013; Leo et al., 2012). Of 
particular relevance, Type V secretion systems also include contact dependent growth 
inhibition (CDI) systems. CDI systems were discovered in E. coli, where they were 
found to include the two partner secretion system, CdiAB (Aoki et al., 2005). CdiB is a 
-barrel transporter that mediates the translocation of CdiA across the producing cell 
envelope and its attachment to the target cell. CdiA then appears to be cleaved, allowing 
its C-terminal toxin domain to be translocated into the target cell. The C-terminal 
domain of CdiA likely exerts its toxic effects through perturbation of the proton motive 
force. These toxic effects are neutralised in cells of the producing organism by the 
immunity protein, CdiI. Genes encoding Cdi systems have since been discovered in 
many -, - and - proteobacteria and the diverse C-termini of different CdiA proteins 
represent various different toxins, each associated with a specific cognate CdiI protein 
(Ruhe et al., 2013). 
 
  




Figure 1.3. Schematic representation of secretion systems in Gram-negative bacteria. Adapted from (Fronzes et al., 2009; Gerlach & Hensel, 2007; Zoued et al., 2014). 
Secretion systems may be divided into one-step systems or two step systems. In one-step systems, secreted substrates traverse the envelope of the host cell in a single step and 
intermediates are not released into the periplasm. In T3SS, T4SS and T6SS, substrates are additionally transported across the membrane of a target cell. In two-step systems, 
substrates are first transported across the inner membrane by the Sec or Tat transport pathways and then subsequently transported across the outer membrane by separate 
machineries. Components of the secretion systems presented are named as indicated in the organism below the corresponding secretion system. See section 1.2.2 for details of each 
secretion system.  
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1.2.3 Other mechanisms of competitive bacterial-bacterial interactions 
Antibiotic production and the secretion of substrates via secretion systems 
represent two mechanisms by which bacteria may affect the behaviour of neighbouring 
cells. Additional mechanisms of competitive bacterial-bacterial interactions include the 
synthesis of bacteriocins and cannibalism. 
Bacteriocins are ribosomally synthesised peptides of bacterial origin that possess 
antimicrobial properties. Bacteriocins can be divided into two classes, Class I 
bacteriocins are post-translationally modified, whereas class II bacteriocins are 
unmodified (Cotter et al., 2013). Bacteriocins are released into the extracellular 
environment and interact with specific molecules on the target cell surface that act as 
receptors (Hammami et al., 2013). Bacteriocins are diverse in terms of their mode of 
action. Several class I, as well as some class II, bacteriocins target the bacterial cell 
envelope. This can either be through the formation of pores in the membrane or through 
binding to lipid II, which is required for the biosynthesis of peptidoglycan. Additional 
targets of bacteriocins include DNA, RNA and protein synthesis. Bacteriocin producing 
bacteria must produce immunity proteins in order to protect themselves from the toxic 
effects of the bacteriocin. These immunity proteins may bind the bacteriocin itself, or 
they may compete for binding to the target of the bacteriocin (Nishie et al., 2012). It has 
been suggested that bacteriocin production by invading bacteria may allow these 
bacteria to become established in a stable microbial community. Alternatively, 
bacteriocin production may prevent invasion by foreign species of bacteria which are 
susceptible to the antimicrobial effects of the peptide (Riley & Wertz, 2002). 
Cannibalism in bacteria is distinct from the above mechanisms of antibacterial 
interactions in that bacteria kill genetically identical siblings rather than bacteria of a 
different strain or species. In Bacillus subtilis, cannibalism occurs upon the early stages 
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of sporulation of a sub-population of cells within a biofilm. In this example, cells 
sporulate in response to nutrient deprivation. The killing of non-sporulating cells within 
the population releases nutrients to delay the onset of sporulation, thus ensuring the 
energetically expensive process of sporulation only proceeds if absolutely necessary 
(Gonzalez-Pastor et al., 2003). In Streptococcus pneumoniae, cannibalism is referred to 
as fratricide and is induced upon entry into the “competent state”. In this instance, 
competent cells kill non-competent siblings. The reasoning behind the co-incidence of 
competence and fratricide is not as obvious as in B. subtilis, but it has been suggested 
that the induction of competence is a general stress response and fratricide is therefore 
also a stress response (Claverys & Havarstein, 2007). 
 
1.3 Non-ribosomal peptide synthetases and polyketide synthase enzymes 
Non-ribosomal peptide synthetases (NRPS) and polyketide synthases (PKS) 
enzymes synthesise a variety of medically important small molecules in bacteria and 
fungi, including many antibiotics, such as erythromycin (Donadio et al., 1991), 
tetracycline (Binnie et al., 1989), penicillin, cephalosporin (Aharonowitz et al., 1992) 
and vancomycin (Bischoff et al., 2005). The potential utilisation of these enzymes for 
the synthesis of novel products depends on our understanding of their mechanism of 
function. NRPS and PKS systems are large enzymes (they may be megadaltons in size) 
which are comprised of multiple units called modules. These modules each incorporate 
several essential domains and may include auxiliary domains. Linker regions between 
adjacent domains allow domains to interact whilst keeping them apart (Weissman & 
Muller, 2008). NRPS and PKS systems function in a very similar manner where each 
module within a system is responsible for the incorporation of a specific building block, 
or monomer, into the final product. Essential modules within an NRPS system differ 
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from those in a PKS system, and these differences result in two different classes of 
monomer being incorporated (Keating & Walsh, 1999). NRPS systems incorporate 
amino acids and catalyze peptide bond formation between monomers. PKS systems 
incorporate carboxylic acids and catalyze C-C bond formation between monomers.  
In the majority of systems discovered to date, the number and order of modules 
in the NRPS or PKS enzyme is equivalent to the number and order of monomers in the 
final product; these enzymes are therefore described as linear  (Fischbach & Walsh, 
2006). The correlation between the sequence of modules in the enzyme and the 
sequential incorporation of monomers has led to these enzymes being termed “assembly 
lines”. However, several examples of NRPS and PKS enzymes which do not act in a 
linear manner have been described. In these cases, the enzymes are described as 
iterative or nonlinear (Mootz et al., 2002). In iteratively acting enzymes, a single 
module or modules act more than once to incorporate the same monomer into the final 
product. For example, during the biosynthesis of the siderophore enterobactin, the 
NRPS module, EntF, incorporates three molecules of 2,3-dihydroxybenzoate into the 
final product (Gehring et al., 1998). In enzymes that act in a non-linear manner, 
modules may not be comprised of the standard domains.  “Essential” domains within 
modules may appear to be missing but are in fact supplied in trans from a separate 
module. For example, the PKS antibiotic, mupirocin, is synthesised non-linearly 
whereby essential domains exist separately from other biosynthetic modules (El-Sayed 
et al., 2003). Alternatively, entire modules may be skipped during biosynthesis (Mootz 
et al., 2002). It should be noted that many NRPS and PKS enzymes cannot be neatly 
categorized into one of the three assembly pathways described above and in many cases 
fusions of different types of assembly pathways exist.  
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In bacteria, individual modules are normally spread over several proteins, 
whereas in fungi these enzymes are often formed from a single polypeptide chain 
(Schwarzer & Marahiel, 2001). Docking domains seem to mediate interactions between 
modules that act consecutively but are found on separate polypeptides. The specificity 
of these docking domains for their corresponding NRPS or PKS enzyme has been 
shown to be important for efficiency of catalysis as these interactions may prevent non-
productive module pairing  (Wu et al., 2002). Individual modules are an average of 
145kDa in size, however, entire NRPS/PKS enzymes can be much larger. For example, 
the phytotoxin syringopeptin (which itself is composed of only 22 amino acids) is 
synthesized by an NRPS enzyme that totals 2.7MDa in size (Fischbach & Walsh, 2006; 
Scholz-Schroeder et al., 2003).  Despite the enormous energy cost involved in the 
synthesis of these enzymes, they do offer an advantage over the ribosomal system; they 
can incorporate hundreds of different building blocks into the final product and are not 
limited to the 20 proteinogenic amino acids (Finking & Marahiel, 2004). 
Enzymatic domains involved in modification of the NRP or PK product during 
biosynthesis are described below. Additionally, however, NRP or PK modifying 
enzymes may also act in trans during synthesis, or after release. For example, the 
synthesis of the PKS antibiotic, erythromycin, is dependent on the action of post 
assembly line, trans acting tailoring enzymes which include hydroxylases, glycosyl 
transferases and methyltransferases (Staunton & Wilkinson, 1997). Thus, NRPS/PKS 
systems can incorporate different monomers, and intermediates can be enzymatically 
modified in cis or in trans during synthesis or after synthesis. Therefore the structural 
diversity of NRPS/PKS products is huge. 
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1.3.1 NRPS enzymes 
NRPS systems may incorporate proteinogenic, non-proteinogenic or modified 
amino acids, as well as other aryl acids, into the final product. To date, more than 500 
different NRPS monomers have been described (Walsh & Fischbach, 2010). Essential 
domains in an NRPS module are the adenylation (A) domain, the peptidyl carrier 
protein (PCP) domain and the condensation (C) domain. However, the initiation and 
termination modules frequently deviate from this paradigm; the C domain is often 
absent from the initiation module and the termination module often includes an 
additional domain for release or cyclisation of the product, as described below (Figure 
1.4) (Conti et al., 1997; Stachelhaus et al., 1996; Stachelhaus et al., 1998). The A 
domain acts as a gatekeeper and is responsible for monomer selection and activation as 
an acyl adenylate. This process is ATP dependent (Conti et al., 1997). Numerous 
mutagenesis studies revealed specificity conferring residues within core motifs of the A 
domain. This knowledge can be applied to predict A domain specificity and thus the 
NRPS product from analysis of the protein sequence of the A domain (Challis et al., 
2000; Eppelmann et al., 2002; Stachelhaus et al., 1999). The activated monomer is then 
covalently tethered to a thiol group on a 4’-phosphopantetheine (P-pant) arm belonging 
to the PCP domain (Stachelhaus et al., 1996). This P-pant arm is post-translationally 
added to the PCP domain and this process is termed priming. Priming of the PCP 
domain is catalysed by a phosphopantetheinyl transferase (PPTase) enzyme, which uses 
acyl coenzyme A as the source of the P-pant group (Lambalot et al., 1996). PPTase 
enzymes will be discussed in more detail in section 1.3.5. The sequestration of 
intermediates by covalent attachment to the PCP domain allows 
microcompartmentalisation of the reaction (which is particularly relevant in bacteria) 
and prevents reaction of the intermediates with cytoplasmic constituents (Weissman & 
Muller, 2008). Lastly, the C domain catalyzes peptide bond formation between two 
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monomers tethered to adjacent PCP domains. Since peptide bond formation cannot 
occur on the first module of the NRPS enzyme, this domain is often absent from the 
initiation module.  (Stachelhaus et al., 1998). A fourth essential domain, the thioesterase 
(TE) domain, is found as part of the terminal module and catalyses NRP release from 
the enzyme via hydrolysis or cyclization (Tseng et al., 2002). In addition to the 
thioesterase enzyme which catalyses release of the NRP product, many NRPS systems 
include a type II TE enzyme. The majority of co-enzyme A present within the cell exists 
as acetyl-CoA and so PCP domains are often mis-primed, resulting in the P-pant arm 
terminating in an acetyl group rather than an sulfhydryl group. Type II TE enzymes 
hydrolyze these non-functional acetyl groups, freeing the P-pant arm (Mootz et al., 
2002).  
Enzymes responsible for modification of the intermediates may also be found 
along the assembly line in the form of additional domains within the NRPS modules. 
Examples of these domains include epimerization, oxidase and cyclization domains. 
These domains allow further modification of the NRP to increase the diversity of the 
products synthesised (Fischbach & Walsh, 2006). 
  





Figure 1.4 .  Representation of a typical non-ribosomal peptide synthetase (NRPS) 
assembly line. Each module is responsible for the incorporation of a specific amino acid into 
the non-ribosomal peptide. Modules can be further divided into domains. Essential elongation 
domains are the condensation (C), adenylation (A) and peptidyl carrier protein (PCP). The 
termination module may also comprise a thioesterase (TE) domain. The C domain (which 
catalyzes bond formation between peptides) is usually absent in the initiation module. 
Additional domains, such as the epimerisation (E) domain, or alternative domains, such as the 
cyclization (Cy) domain, may be found along the assembly line and these function to modify the 
growing polypeptide chain during synthesis.   
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1.3.2 PKS enzymes 
PKS systems incorporate short carboxylic acids activated as coenzyme A (CoA) 
linked thioesters. The first monomer to be incorporated into the product is termed the 
starter unit whereas subsequent monomers are termed extender units. Starter units 
include a plethora of carboxylic acids. By comparison with NRPS enzymes which 
incorporate a diverse range of monomers, the majority of extender units for PKS 
enzymes are either malonyl-CoA or methylmalonyl-CoA (Chan et al., 2006; Chan et 
al., 2009). Core domains in PKS systems are the acyltransferase (AT) domain, the acyl 
carrier protein (ACP) domain and the ketosynthase (KS) domain (Figure 1.5) (Bibb et 
al., 1989). These domains have functions similar to the A, PCP and C domains, 
respectively, of NRPS systems. Similar to the PCP domain of NRPS enzymes, the ACP 
domain must be post-translationally modified by the addition of a P-pant group. The AT 
domain selects the monomer to be incorporated and catalyses transfer of the acyl group 
of the monomer to the P-pant arm of the ACP domain. This step does not require any 
energy input as monomers are selected as activated acyl-CoA thioesters (Schwarzer & 
Marahiel, 2001).  The KS domain catalyzes C-C bond formation via a decarboxylative 
condensation reaction between acyl thioesters attached by adjacent ACP domains 
(Fischbach & Walsh, 2006). The initiation module of the PKS enzyme may lack the KS 
domain entirely, in which case acyl CoA starter units are incorporated. Alternatively, 
the initiation module may contain a KS domain, which does not catalyse a condensation 
reaction, but rather decarboxylates the ACP bound malonyl or methylmalonyl groups to 
yield ACP bound acetyl or propionyl groups (Moore & Hertweck, 2002). Similar to 
NRPS biosynthesis, the termination module of PKS enzymes frequently contains a TE 
domain, which effects release of the PK product by hydrolysis or cyclization (Fischbach 
& Walsh, 2006). 
  




Figure 1.5. Representation of a typical polyketide synthase (PKS) assembly line. Each 
module is responsible for the incorporation of a specific acyl unit into the polyketide. Similar to 
non-ribosomal peptide synthetases, modules can be subdivided into domains. Typically 
essential domains in the PKS elongation module are the acyl transferase (AT), ketosynthase 
(KS), acyl carrier protein (ACP), although many PKS enzymes deviate from this paradigm (see 
text for more information). A thioesterase (TE) domain is frequently found on the termination 
module. Additional ketoreductase (KR), dehydratase (DH) and enoylreductase (ER) domains 
may also be found along the assembly line. These accessory domains alter the oxidation state of 
the -keto moiety on the growing ketide (see figure 1.6). The KS domain (which catalyzes bond 
formation between ketides) is usually absent in the initiation module. 
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PKS enzymes can be classed as type I, type II or type III. In type I PKS systems, 
modules are arranged linearly and catalytic domains are fused in cis. Type I enzymes 
may be modular, whereby each module incorporates a single starter or extender unit, or 
they may be iterative, where one module functions more than once. Type I modular 
enzymes are found in bacteria, whereas type I iterative enzymes are mainly found in 
fungi. In type II PKS systems, domains exist as discrete entities that come together as a 
complex during PK biosynthesis. Type II systems act iteratively and contain the 
essential PKS domains, but possess an additional KS domain which controls the length 
of the PK product. Type II systems have thus far only been described in bacteria (Chan 
et al., 2009; Hertweck, 2009). Type III PKS systems often lack essential catalytic 
domains and substrates are incorporated in an ACP domain independent manner. In 
these systems, a single enzyme is responsible for monomer selection and extension. 
Type III PKS enzymes are most frequently found in plants, but examples of type III 
systems have recently been described in bacteria and fungi (Yu et al., 2012). 
Up to three additional domains - the ketoreductase (KR), dehydratase (DH) and 
enoylreductase (ER) domain can be found in each PKS module. They function in this 
order and they alter the oxidation state of the -keto moiety on the growing PK. The-
keto group is initially reduced by the KR domain to -hydroxyacyl. The DH domain 
catalyzes dehydration of the -hydroxyacyl to ,-enoyl. Lastly, the ER domain 
catalyzes reduction to the methyl group (Figure 1.6) (Katz, 1997). 




Figure 1.6.  Representation of the optional -carbon reducing steps in polyketide 
assembly. The ketoreductase (KR), dehydratase (DH) and enoylreductase (ER) domain function 
to alter the oxidation state of the -keto moiety of the ketide. The reactions these domains 
catalyze are illustrated above. The carbonyl group of the -carbon may be reduced to a hydroxyl 
group (top panel), an alkene group (middle panel) or a saturated methylene (bottom panel).  
 
1.3.3 NRPS-PKS hybrid enzymes 
The modular nature of NRP and PK synthases has allowed nature to form 
functional fusions of these enzymes, called hybrids. A variety of medically important 
small molecules are synthesized by hybrid enzymes, including the immunosuppressant, 
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rapamycin (Schwecke et al., 1995) and the anti-tumour drug, bleomycin (Du et al., 
2000). The similarities in the organisation of these enzymes mean that the same 
underlying principles of NRP and PK biosynthesis can be applied when trying to 
understand hybrid enzymes. In hybrid NRPS-PKS enzymes, domains are generally 
thought to be less specific for their usual substrates, since they must accept both peptide 
and ketide intermediates (Walsh & Fischbach, 2010). By combining NRPS and PKS 
enzymes, the potential diversity of the resulting products is greatly increased. 
 
1.3.4 Manipulation of NRPS and PKS enzymes 
Breakthroughs in our understanding of NRPS and PKS systems led to the 
realisation that NRPS and PKS enzymes may be utilised in the biosynthesis of 
“unnatural” natural products. However, technical difficulties associated with 
modification of these enzymes were perhaps not fully appreciated in the early days of 
research into this field. Indeed it was proposed that it would be possible to modify the 
product of these enzymes as precisely as we are able to modify the amino acid sequence 
by alteration of the encoding gene (Cane et al., 1998). Nevertheless, progress has been 
made in engineering NRPS and PKS enzymes. 
Modification of NRPS and PKS enzymes to alter the resulting product may 
involve swapping of entire domains or modules or it may involve mutagenesis of 
specific residues within domains. Several attempts to engineer NRPS and PKS enzymes 
have been described, specific examples and limitations with this approach are detailed 
below. The principle of increasing natural product diversity by substitution of domains 
was proven by engineering of the 6-deoxyerythronolide B synthase (DEBS), which is 
the PKS responsible for the production of the macrolide antibiotic erythromycin. In this 
example, AT domains or -keto processing domains from the rapamycin PKS were 
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used to substitute the natural DEBS PKS domains. Single, double and triple domain 
substitutions were incorporated to create a library of more than 50 variants (McDaniel et 
al., 1999). Modules from different systems can also, like building blocks, be taken apart 
and recombined to create a novel protein. In an attempt to bioengineer the daptomycin 
antibiotic NRPS, single and multiple homologous and heterologous modules were 
introduced. The resulting products were no more potent than daptomycin, but the results 
demonstrated the possibility of swapping modules to synthesise new proteins (Giessen 
& Marahiel, 2012). Another mechanism by which the NRP or PK product can be 
modified is by altering the specificity of the AT domain (PKSs) or A domain (NRPSs). 
Since these domains control selection of the incorporated monomer, mutagenesis of 
specific residues involved in this process can result in the incorporation of alternative 
monomers. This is particularly relevant in engineering NRPS directed biosynthesis, 
since the diversity of NRPS monomers is much larger than PKS monomers. In the A 
domain of NRPS enzymes, elucidation of the specificity conferring code has been 
pivotal in allowing rational design of these domains. This code consists of specific 
residues within the A domain binding pocket that determine specificity (Stachelhaus et 
al., 1999). Recently, the A domain within module 10 of the calcium dependent 
antibiotic, CdaPS3, NRPS was altered by site directed mutagenesis. Mutagenesis of a 
single residue was sufficient to alter the specificity of the module from glutamic acid 
and methyl glutamic acid, to glutamine and methyl glutamine (Thirlway et al., 2012). A 
significant issue when engineering NRPS and PKS enzymes is the reduction in yield of 
the novel product by comparison with wildtype levels. It is likely that NRPS and PKS 
domains are specific not only for their incorporated monomer, but also for the product 
of the upstream modules. More conservative mutations, such as alteration of the A 
domain specificity rather than module substitution, may make these enzymes more 
tolerant to manipulation (Williams, 2013). 
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1.3.5 Phosphopantetheinyl transferase (PPTase) enzymes 
As described above, PKSs and NRPSs are dependent upon the catalytic action of 
PPTase enzymes to function. PPTase enzymes catalyse the transfer of a P-pant 
prosthetic group from coenzyme A to a conserved serine residue in the carrier protein 
domain of PKSs and NRPSs (Beld et al., 2014; Lambalot et al., 1996). The P-pant 
prosthetic group of the carrier protein domain fulfils two main functions: the thiol 
terminated P-pant arm serves as the point of attachment for the PKS or NRPS 
intermediate to the biosynthetic machinery and the flexibility of this arm allows the 
biosynthetic intermediate access to the catalytic reaction centres within the PKS or 
NRPS module (Figure 1.7) (Beld et al., 2014). 
  





Figure 1.7. Representation of the reaction catalysed by phosphopantetheinyl transferase 
(PPTase) enzymes. PPTase enzymes are essential for the modification of the peptidyl carrier 
domain (PCP) or the acyl carrier domain (ACP) of non-ribosomal peptide synthetases or 
polyketide synthases. They catalyse the transfer of a 4’-phosphopantetheine group from co-
enzyme A to the PCP or ACP domain. 
 
 PPTase enzymes can be divided into three families: the Sfp family whose prototype is 
Sfp of B. subtilis (Lambalot et al., 1996; Reuter et al., 1999); the AcpS family whose 
prototype is AcpS of Escherichia coli (Elovson & Vagelos, 1968; Lambalot & Walsh, 
1995); and a third family whose members are integrated as domains within the FAS or 
PKS enzyme that they modify (Beld et al., 2014; Copp & Neilan, 2006; Lambalot et al., 
1996; Walsh et al., 1997). The Sfp family of PPTases have broad substrate specificity 
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and are generally required for the activation of PKS and NRPS enzymes of secondary 
metabolism (Mootz et al., 2001; Quadri et al., 1998); these enzymes are approximately 
230 residues in length and exist as monomers (Reuter et al., 1999). Based on sequence 
comparisons, members of the Sfp family were further divided into the F/KES or 
W/KEA subfamily (Copp & Neilan, 2006; Lambalot et al., 1996). F/KES family 
members were shown to largely be associated with NRPS enzymes whereas W/KEA 
family members are more often associated with PKS enzymes (Copp & Neilan, 2006). 
Members of the AcpS family of PPTases are generally around 120 residues in length 
and are thought to exist as trimers (Chirgadze et al., 2000; Parris et al., 2000). AcpS 
family PPTases show a higher degree of specificity towards the carrier protein domain 
that they modify and are generally required for the modification of FAS enzymes of 
primary metabolism (Lambalot et al., 1996; Mootz et al., 2001; Parris et al., 2000). 
Despite limited overall sequence similarity between AcpS and Sfp family members, 
these enzymes share homology at the structural level: an AcpS dimer resembles one Sfp 
monomer (Lambalot et al., 1996; Reuter et al., 1999). As previously described, there 
exists a third family of PPTases which are translationally fused to the FAS or PKS 
enzyme that they modify (Copp & Neilan, 2006; Fichtlscherer et al., 2000; Lambalot et 
al., 1996). Examples of these integrated PPTases are few and, to date, only two bacterial 
integrated PPTases have been experimentally validated (Murugan & Liang, 2008; 
Weissman et al., 2004). 
1.4 The Type VI Secretion System (T6SS) 
1.4.1 Identification of the T6SS 
The T6SS is the most recently described secretion system in Gram-negative 
bacteria. The genetic locus encoding this secretion system was first identified in 1997 in 
Rhizobium leguminosarum bv. trifolii. In this bacterium, it was noted that mutation of 
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this locus extended the spectrum of plants that R. leguminosarum bv. trifolii was able to 
nodulate. However, at the time, the genetic locus showed no homology to characterised 
genes and so the significance of the identified genes was not appreciated (Roest et al., 
1997). Hints at the function of this locus came in 2003 when it was shown that mutation 
of the identified genetic locus impaired secretion of a number of proteins in a 
temperature dependent manner. The authors also noted that many open reading frames 
(ORFs) within this gene cluster showed homology to ORFs in Vibrio cholerae and 
Pseudomonas aeruginosa (Bladergroen et al., 2003). In the intervening and following 
years, several studies implicated this secretion system in virulence in Salmonella 
(Folkesson et al., 2002), Francisella (Nano et al., 2004) and Edwardsiella (Rao et al., 
2004). However, it was not until 2006 that seminal work conducted in the Mekalanos 
laboratory revealed that these genes encoded a novel secretion system, termed the T6SS, 
in V. cholerae and P. aerunginosa (Mougous et al., 2006; Pukatzki et al., 2006). In V. 
cholerae, the T6SS was implicated in cell-cell contact dependent virulence towards 
Dictostelium amoebae and towards macrophages (Pukatzki et al., 2006). In P. 
aeruginosa, the T6SS was identified as being required for the secretion of a component 
of the secretion system, Hcp1 (a TssD family protein). Further, Hcp1 was detected in 
the lungs of cystic fibrosis patients infected with P. aeruginosa (Mougous et al., 2006). 
Together, these studies demonstrated the potential importance of the T6SS in the 
survival and virulence of medically relevant pathogens. 
 
1.4.2 Identification of conserved components of the T6SS and predicted function 
T6SS-encoding gene clusters are large, variable and have been identified in at 
least 25% of all sequenced Gram-negative bacterial species. One third of T6SS 
encoding bacterial genomes contain more than one system and some organisms contain 
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many systems, for example six T6SSs were identified in the genome of Burkholderia 
pseudomallei (Boyer et al., 2009). Systematic mutation of components of the T6SS 
combined with bioinformatics analysis revealed the system is comprised of a minimum 
of 13 conserved core components (Boyer et al., 2009; Zheng & Leung, 2007). These 
components will be referred to by their Tss (Type Six Secretion) name throughout 
(TssA-M), although it should be noted that TssD, TssI and TssH are also widely known 
by their common names, Hcp, VgrG and ClpV, respectively (Shalom et al., 2007). 
These essential components form a secretion system which extends from the cytoplasm 
of the producing cell, across its cell envelope and then across the cell membrane of a 
target cell (Figure 1.3). T6SS components may be cytoplasmic, anchored within the 
inner or outer membrane, or part of an extracellular puncturing device (Figure 1.8). 
Effectors are translocated in a single step, either through, or in association with, the 
extracellular puncturing structure. Additional components are likely to be involved in 
regulation of the system or tailoring of the system to suit the lifestyle of the particular 
bacterium (Zoued et al., 2014). 
  




Figure 1.8. Schematic representation of the bacterial Type VI Secretion System (T6SS). 
The essential, conserved components are indicated by their Tss name. The proposed localisation 
of each of the components is indicated. Briefly, TssD (Hcp) is thought to form a tube through 
which certain substrates are transported. The TssD tube is capped by the TssI (VgrG) protein, 
which is predicted to puncture the membrane of target cells. Contraction of the TssBC sheath, 
which surrounds the TssD tube, is thought to propel the TssDI needle out of the host cell and 
into the target cell. TssH (ClpV) is required for disassembly and recycling of the TssBC sheath 
following contraction. TssLMJ have been hypothesised to anchor the T6SS to the cell envelope. 
The role of TssAEFGK remains speculative, although these proteins may form part of a 
baseplate-like structure. See section 1.5.2 for details. 
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1.4.2.1 Bacteriophage-like components of the T6SS 
Several components of the T6SS “needle-like” structure share structural 
homology with the bacteriophage tail (Figure 1.9). TssD forms hexameric rings that 
stack together head to tail to form a 40 Å channel through which many T6SS substrates 
are thought to be transported (Ballister et al., 2008; Brunet et al., 2014; Mougous et al., 
2006). TssD is structurally similar to the gpV protein of the non-contractile phage,  
(Pell et al., 2009).  Trimers of TssI are thought to sit at the top of this TssD tube. TssI is 
structurally very similar to the gp5-gp27 cell puncturing device of bacteriophage T4; the 
C-terminus of TssI shares homology with gp5 whereas the N-terminus shares homology 
with gp27. These similarities have led to the hypothesis that TssI is involved in piercing 
the target cell membrane. More recently, a protein of unknown function known to bind 
to the tip of the central spike protein, gp5, was used as bait to identify so-called PAAR 
domain containing proteins encoded within T6SS gene clusters. It was proposed that the 
PAAR domain of these proteins binds to the tip of TssI and therefore ‘sharpens’ the 
needle, and that these PAAR domain containing proteins are involved in the assembly 
of TssI trimers or translocation of TssI across the host cell envelope. Additionally, 
PAAR domain containing proteins may harbour additional toxin domains that are 
delivered into target cells in a T6SS dependent manner (Shneider et al., 2013). In 
bacteriophage T4, a sheath composed of gp18 surrounds the gp19 tail tube and 
contraction of this sheath propels the gp19 tube forwards and into the bacterial target 
cell (Figure 1.9) (Filloux, 2013). An analogous mechanism of contraction has been 
proposed for the T6SS. In the case of the T6SS, two proteins (TssB and TssC) have 
been shown to form a stable complex and are believed to assemble to form a contractile 
sheath-like structure. Tubules of TssBC have been visualised by electron microscopy 
and, further, fluorescent labelling of TssB has allowed visualisation of cycles of 
extended and contracted conformations (Basler & Mekalanos, 2012; Basler et al., 2012; 
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Lossi et al., 2013). The internal diameter of the TssBC sheaths has been shown to be 
~100 Å, which would be sufficient to accommodate the TssD tube (Lossi et al., 2013). 
Indirect evidence for the presence of the TssD tube within the TssBC sheath was 
provided by electron microscopic analysis of extended and contracted versions of the 
TssBC sheath; the contracted sheath appears hollow whilst the extended sheath contains 
electron dense material (Kapitein et al., 2013). Again, in support of this theory, the C-
termini of TssBC show homology to tail sheath proteins of various bacteriophages 
(Lossi et al., 2013). Additionally, the cytoplasmic T6SS protein, TssE, shares homology 
with gp25, one of the components of the bacteriophage T4 baseplate (Figure 1.9) (Lossi 
et al., 2011). However, to date, the function of TssE remains elusive. All the above data 
suggest that the contractile bacteriophage tail and the T6SS are evolutionarily related, 
however, a lack of sequence identity between structurally homologous proteins suggests 
these systems diverged a long time ago (Lossi et al., 2013). Based on the similarities 
between these two systems, the T6SS has been proposed to function like an inverted 
bacteriophage, whereby the T6SS fires from the inside of the bacterial cell (Figure 1.9 
and Figure 1.10) (Records, 2011). 




Figure 1.9. Comparison of the bacteriophage T4 cell puncturing machinery with the Type 
VI Secretion System (T6SS) cell puncturing machinery. Structurally homologous proteins 
are indicated by the same colour. Adapted from (Ho et al., 2014).  
 
1.4.2.2 The membrane anchored components of the T6SS 
Additional components of the T6SS do not share homology with bacteriophage 
proteins. These include the components comprising the so-called “membrane 
anchoring” complex. This complex is composed of TssJ, TssL and TssM. TssJ is a 
lipoprotein that is anchored in the OM and protrudes into the periplasm, where it may 
self-interact (Aschtgen et al., 2008). TssJ has also been shown to interact with the 
periplasmic domain of TssM (Felisberto-Rodrigues et al., 2011). TssM is an integral 
inner membrane protein that possesses three transmembrane domains, a cytoplasmic N-
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terminus and a periplasmic facing C-terminus (Ma et al., 2009b). In certain systems, the 
ATPase activity of TssM has been shown be required for the formation of the 
membrane anchoring complex and for recruitment of TssD to the membrane (Ma et al., 
2009b). Lastly, TssL is anchored in the inner membrane via a single transmembrane 
spanning domain in its C-terminus, however the majority of the protein is cytoplasmic 
(Aschtgen et al., 2012). TssL has been shown to interact with, and stabilize, TssM (Ma 
et al., 2009b). In some systems there exists an additional inner membrane protein called 
TagL. TagL encodes a peptidoglycan binding domain that has been suggested to anchor 
the T6SS to the cell wall. In the absence of TagL, a C-terminal extension of TssL fulfils 
this anchoring role by interacting with peptidoglycan. It is likely that, in some systems, 
TssL and TagL have fused at some point to form a single protein (Aschtgen et al., 
2010).  
 
1.4.2.3 Additional, cytoplasmic components of the T6SS 
Additional essential components of the T6SS include TssA, F, G, H and K, 
however, very little data exists for TssA, F and G. In the absence of secretion signals or 
domains which would hint at the localisation of these components, they have been 
predicted to be cytoplasmic. TssK is an intrinsically cytoplasmic protein that has been 
shown by bacterial two-hybrid (BTH) studies and immunoprecipitation experiments to 
interact with TssA, D, C and L of entero-aggregative E. coli (EAEC) (Zoued et al., 
2013). In S. marcescens Db10, experiments in the native organism have shown that 
TssK interacts with TssF and TssG (English et al., 2014). Rather more information is 
available for TssH. TssH was one of the initial proteins identified as playing an essential 
role in Type VI dependent secretion (Mougous et al., 2006). TssH belongs to the AAA+ 
family ATPases and is responsible for disassembly of the TssBC sheath following 
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contraction (Bonemann et al., 2009). TssH has been shown to specifically co-localise 
with the contracted form of the T6SS sheath and its deletion prevents recycling of the 
sheath components (Basler & Mekalanos, 2012; Kapitein et al., 2013). TssH may also 
play an important role in removal of aberrantly polymerised TssBC which is not 
associated with the secretion system (Kapitein et al., 2013). 
  





Figure 1.10. Schematic representation of the mechanism of action of the Type VI secretion 
system (T6SS). The different stages of assembly, contraction and disassembly are depicted. 
Assembly of the system involves elongation of the TssBC sheath, which surrounds the TssD 
tube. Effectors of the T6SS may associate with the TssD tube or with the TssI/PAAR protein 
structure. Contraction of the TssBC sheath is thought to propel the TssD tube forwards, out of 
the secreting cell and into the target cell. TssD, TssI and effector proteins can therefore be 
detected in the extracellular environment. Following contraction, the TssBC sheath is 
disassembled by the action of the ATPase, TssH, presumably allowing recycling of these 
components. In Vibrio cholerae, the T6SS has been shown to fire from the same site, suggesting 
that the membrane associated complex or the baseplate structure remain intact between T6SS 
cycles. Conversely, in P. aeruginosa, assembly and  re-assembly occur at different sites (Basler 
& Mekalanos, 2012). 
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1.4.3 Secreted effectors of the T6SS 
The T6SS functions as either an anti-bacterial or an anti-eukaryotic system. The 
distinction between the target cell profile is at least partially dependent upon the type of 
effector proteins secreted by the system (Figure 1.11). In addition to this distinction, 
effector proteins of the T6SS may be divided into two different categories. A subset of 
effector proteins are fused to components of the T6SS, such as the effector domains of 
evolved VgrG (TssI) proteins and PAAR domain containing proteins. Alternatively, 
non-fused effectors are thought to be delivered by the T6SS via the interior of the TssB 
tube or non-covalent interactions with TssI proteins (Ho et al., 2014). 
 
Figure 1.11. Schematic representation of Type VI Secretion System (T6SS) effector 
protein secretion into eukaryotic or bacterial target cells. The T6SS of the producing 
bacteria may target effector proteins to eukaryotic or bacterial cells. In order to protect against 
self-intoxication, the T6SS producing bacteria must also biosynthesise cognate immunity 
proteins (adapted from S. Coulthurst).  
 
1.4.3.1 Anti-bacterial effector proteins of the T6SS 
Many T6SSs, including the T6SS of S. marcescens Db10, target bacteria and 
several anti-bacterial effector proteins have been identified. The first identified and best 
characterised of these are the non-fused Tse1-3 proteins of P. aeruginosa (Hood et al., 
2010; Russell et al., 2011). Comparison of the secretome of P. aeruginosa between 
Chapter 1: Introduction 
39 
 
strains with an activated T6SS versus an inactive T6SS identified proteins that were 
present in the secretome only in the activated sample. Three of these proteins, Tse1-3, 
were shown to be dispensable for function of the Type VI system (Hood et al., 2010; 
Russell et al., 2011). Tse1 and Tse3 were subsequently shown to be peptidoglycan 
hydrolases that target distinct bonds within peptidoglycan (Russell et al., 2011). Tse2 is 
known to exert its effects in the cytoplasm, however, the target of Tse2 remains elusive 
(Hood et al., 2010). In addition to the identification of effector proteins, so called Tsi 
immunity proteins were also identified. The genes encoding cognate pairs of Tse and 
Tsi effector and immunity proteins are arranged in bicistronic operons, and are therefore 
expressed together (Hood et al., 2010; Russell et al., 2011). In E. coli, expression of the 
Tsi1 and Tsi3 immunity proteins negates the toxic effects of the cognate effector 
proteins Tse1 and Tse3, respectively. These toxic effects are alleviated through direct 
physical interaction between the cognate immunity and effector proteins (Russell et al., 
2011). Resolution of the crystal structure of the Tse1-Tsi1 complex revealed the 
mechanism of this inhibition; binding of Tsi1 occludes the active site of Tse1 (Benz et 
al., 2012). Immunity proteins have therefore been proposed to protect against self or 
sibling cell intoxication.  
Despite a lack of primary sequence homology, various T6SS secreted 
antibacterial effector proteins have been since been discovered in other bacteria. These 
bacteria include V. cholerae (Pukatzki et al., 2009), Pseudomonas protegens (Whitney 
et al., 2013), Burkholderia thailandensis (Russell et al., 2012) and S. marcescens 
(English et al., 2012). The repertoire of antibacterial effectors encoded within the 
bacterial genome is potentially extensive; in B. thailandensis, analysis of the secretome 
unveiled 13 putative effector proteins. On closer inspection, two effector proteins were 
found to resemble bacteriocins and one was shown to possess peptidoglycan hydrolase 
activity (Russell et al., 2012). Subsequently, another putative effector protein was 
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demonstrated to possess phospholipase activity, which would result in perturbation of 
the bacterial membrane (Russell et al., 2013). In S. marcescens Db10, Ssp1 and Ssp2 
(secreted small protein 1 and 2), which are encoded within the T6SS gene cluster, were 
identified as non-fused T6SS dependent effectors that exert their toxic effect in the 
periplasm through the hydrolysis of peptidoglycan (Figure 1.12) (English et al., 2012; 
Srikannathasan et al., 2013). The cognate immunity proteins of Ssp1 and Ssp2 are 
Rap1a and Rap2a (resistance associated protein 1a and 2a). In S. marcescens Db10, the 
Rap resistance proteins appear to be highly specific to their immunity proteins and no 
cross interactions between non-cognate pairs of proteins are observed (English et al., 
2012). In addition to Ssp1 and Ssp2, the Ssp3, Ssp4, Ssp5 and Ssp6 proteins were 
subsequently identified as non-fused antibacterial effectors of the T6SS in this 
organism. Ssp3-6 are encoded outwith the T6SS and were identified by comparing the 
secretome of wildtype S. marcescens Db10 with that of a T6SS mutant (Figure 1.12). 
Ssp4 likely exerts its toxic effects in the periplasm of target cells whereas Ssp3, Ssp5 
and Ssp6 are likely cytoplasmic toxins, although the target of these toxins remains to be 
identified (Fritsch et al., 2013). 
 
1.4.3.2 Anti-eukaryotic effector proteins of the T6SS 
Not only can the T6SS target effectors to bacterial cells, but it can also secrete 
eukaryotic specific effectors. The first of these to be identified was the VgrG-1 protein 
(a TssI family protein) of V. cholerae. In this case, an extra C-terminal extension of the 
core protein was identified as possessing actin crosslinking activity (Pukatzki et al., 
2007). In phagocytes, the actin crosslinking domain is only translocated into the target 
upon internalization of the bacteria. This results in impairment of phagocytosis and 
phagocytic cell death (Ma et al., 2009a). Since bacteria must be internalized for 
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activation of the actin crosslinking activity, it has been suggested that this behaviour is 
altruistic, and functions to protect remaining external bacteria from phagocytosis 
(Coulthurst, 2013). In addition to the VgrG-1 protein of V. cholera, only two other 
experimentally verified anti-eukaryotic TssI proteins have been identified. These are 
VgrG-1 of Aeromonas hydrophila  and VgrG-5 of Burkholderia pseudomallei (Suarez 
et al., 2010; Toesca et al., 2014). In A. hydrophila, VgrG-1 induces ADP ribosylation of 
target cell actin in a T6SS dependent manner, leading to cell rounding and eventual 
death. Since A. hydrophila causes gastroenteritis, these effects have been proposed to 
play a role in disruption of the host’s intestinal epithelial barrier (Suarez et al., 2010). In 
B. pseudomallei, VgrG-5 is required for the fusion of mammalian cells to generate 
mononucleated giant cells (MNGCs). These MNGCs aid in the intracellular spread of 
Burkholderia (Toesca et al., 2014). In the above examples, the effector domain is fused 
to part of the TssI protein, and so these proteins have been named “evolved VgrGs”. To 
date, non-fused anti-eukaryotic effector proteins have only been described in two 
organisms. In P. aeruginosa, the effector proteins PldA and PldB were shown to be 
phospholipases required for internalization of bacteria into HeLa and epithelial cells 
(Jiang et al., 2014). In V. cholerae, the effector proteins TseL (also a phospholipase) 
and VasX were shown to be required for killing of Dictyostelium discoideum (Dong et 
al., 2013; Miyata et al., 2011). 
 
1.4.3.3 Selection of secreted effectors of the T6SS 
In the case of the evolved VgrG proteins, specific mechanisms for targeting the 
effector to the secretion apparatus is are unnecessary. However, non-fused effector 
proteins must be targeted to the secretion apparatus for translocation. T6SS effector 
proteins do not possess a recognisable secretion signal, partly contributing to the 
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difficulties associated with identifying novel effectors. The mechanism of effector 
export is not yet fully understood, however, some progress has been made recently in 
trying to elucidate this process. The Tse1-3 effector proteins of P. aeruginosa have been 
shown to interact with the inner surface of the TssD1 tube and this interaction was 
demonstrated to be essential for secretion of the effectors (Silverman et al., 2013). 
Alternatively, effector proteins may associate with TssI. Many PAAR repeat proteins, 
which were demonstrated to bind to the tip of the TssI needle, are predicted to possess 
extra domains with toxic enzymatic activities. Interaction with TssI proteins through the 
effector protein PAAR repeat domain was proposed to mediate export (Shneider et al., 
2013). Additionally, several Rhs family proteins, which are examples of evolved PAAR 
proteins, are genetically closely associated with TssI genes. These Rhs family proteins 
were shown to exert toxic effects on bacterial target cells only in the presence of their 
cognate TssI protein (Hachani et al., 2014). It therefore seems that in certain instances 
association with TssD mediates export, whilst in other cases binding to TssI facilitates 
export of effectors. 
 
1.4.4 Regulation of the T6SS 
As might be expected, regulation of the T6SS varies in different organisms and 
likely reflects the different lifestyles inhabited by different bacteria. The T6SS is 
regulated at the transcriptional, post-transcriptional and post-translational level. At the 
transcriptional level, the T6SS can be regulated by quorum sensing, temperature, 
biofilm formation, iron depletion, salinity or in response to general stress conditions 
(Ho et al., 2014). Several transcriptional regulators have been identified as playing a 
role in T6SS regulation under variations of the conditions described above (Ho et al., 
2014). Notably, organisms that possess more than one T6SS may display differential 
Chapter 1: Introduction 
43 
 
regulation of the systems (Salomon et al., 2013). At the post-transcriptional level, the 
RNA binding protein, Hfq, has been implicated in the regulation of the T6SS in certain 
organisms, including S. marcescens Db10 (S. Murdoch, unpublished). 
At the post-translational level, a protein called Fha has been implicated in the 
regulation of the T6SS via the threonine phosphorylation pathway (TPP). Fha has been 
identified in around 40% of T6SSs, including that of S. marcescens Db10 (Figure 1.12) 
(Boyer et al., 2009; Fritsch et al., 2013). In S. marcescens Db10 and in P. aeruginosa 
Fha dependent activation of the T6SS is reliant on its phosphorylation status, this is 
controlled by a threonine kinase (PpkA) and a phosphatase (PppA) (Fritsch et al., 2013; 
Mougous et al., 2007). Post-translational regulation through Fha has been best 
described in P. aeruginosa. In this organism, activation of PpkA results in 
autophosphorylation of PpkA and subsequent phosphorylation of Fha (Mougous et al., 
2007). Since PpkA is required for activation of the system, deletion of the kinase 
abolishes T6 dependent secretion. Conversely, deletion of PppA results in an up-
regulation of T6SS dynamics (Mougous et al., 2007). Additional Tag (Type VI 
secretion associated gene) proteins (TagQRST) control the activation of PpkA. TagS 
and TagT are hypothesised to form an inner membrane bound complex in P. 
aeruginosa, although their specific role in regulation of PpkA activation remains 
unclear. TagQ is an outer membrane lipoprotein that is required for the correct 
localisation of the periplasmic protein, TagR, to the outer membrane. It is thought that 
TagQRST may form a trans-membrane signalling complex that functions to transduce 
the T6SS activating signal through the TPP (Casabona et al., 2013). It has been 
suggested that the TPP in P. aeruginosa is activated upon sensing of membrane 
pertubations, which may be induced by the T6SS, or some other secretory system, of an 
adjacent cell. This allows the T6SS to become assembled at the point of an exogenous 
attack (Basler et al., 2013; Ho et al., 2013). This phenomenon has been termed duelling. 
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Since the T6SS of P. aeruginosa only fires upon sensing of incoming Type VI attacks 
from neighbouring cells, it has been described as defensive. In other systems, the T6SS 
is described as offensive, as bacteria do not need to sense an incoming attack to deploy 
the T6SS. This appears to be the case in S. marcescens Db10, where the system is 
constitutively active even when there is no cell-cell contact (Fritsch et al., 2013; 
Murdoch et al., 2011). Phosphorylation of Fha by PpkA is also required for activation 
of the T6SS in S. marcescens Db10. PppA also has an important modulatory role, as 
seen by a reduction in T6-dependent bacterial killing in its absence. For example, PppA 
may be required to facilitate disassembly and reassembly of the system at new spatial 
locations, as suggested for P. aeruginosa (Basler 2013). However, activation of the TPP 
in S. marcescens Db10 does not depend on cell-cell contact and is seen under all 
conditions tested. The TagQRST genes are also absent in S. marcescens Db10, implying 
that the signal which activates secretion in this organism is sensed via a different 
mechanism (Figure 1.12) (Fritsch et al., 2013).    





Figure 1.12. Schematic representation of the Type VI Secretion System (T6SS) of Serratia marcescens Db10. Core T6SS components, phosphorylation 
components, effector proteins and resistance associated proteins are indicated. Arrows represent open reading frames and are drawn approximately to scale. The 
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2.1 Bacterial strains and plasmids 
Bacterial strains and plasmids used in this study are provided in Table 2.1. 
Table 2.1. Bacterial strains and plasmids used in this study 
Bacterial Strain / Plasmid Description 
a




Bacillus subtilis    
NCIB3610 Wild type NCIB3610 prototroph B.G.S.C. 
NRS1473 NCIB3610 sacA-P hy-spac-gfp (Kan) (Verhamme et al., 
2009) 
   
Micrococcus luteus ATCC4698  M. Bibb 
   
Staphylococcus aureus 113  ATCC35556 T. Palmer 
   
Escherichia coli    
MC1061 F'lacIQ lacZM15 Tn10 (Tet) Cloning host (Perego & Hoch, 
1988) 
CC118pir Cloning host and donor strain for pKNG101-derived marker exchange plasmids (λpir) (Herrero et al., 
1990) 
HH26 pNJ5000 Mobilizing strain for conjugal transfer (Tet) (Grinter, 1983) 
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Bacterial Strain / Plasmid Description 
a




Serratia marcescens    
Db10 Wild type strain (Flyg et al., 1980) 
ATCC274 Wild type A.T.C.C. 
NRS2992 S. marcescens Db10 SMA2290::Tn5 This Study 
SJC13 S. marcescens Db10 SMA2290::Tn5 This Study 
SAN2 S. marcescens Db10 (alb1) in-frame This study 
SAN89 S. marcescens Db10 (alb15-105) in-frame This study 
SAN177 S. marcescens Db10 (alb1300-400) in-frame This study 
SAN3 S. marcescens Db10 (alb2) in-frame This study 
SAN4 S. marcescens Db10 (alb3) in-frame This study 
SAN88 S. marcescens Db10 (alb351-262) in-frame This study 
SAN5 S. marcescens Db10 (alb4-5) in-frame This study 
SAN60 S. marcescens Db10 (alb6) in-frame This study 
SAN100 S. marcescens Db10 PT5-alb1-6 (T5 promoter replacing native promoter upstream of alb1) This study 
SAN96 S. marcescens Db10 (SMA4147) in-frame This study 
SAN112 S. marcescens Db10 (SMA2452::Cml) This study 
JESM267 S. marcescens Db10 swrA::Tn5 (Pradel et al., 
2007) 
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Bacterial Strain / Plasmid Description 
a




SAN124 S. marcescens Db10 swrA::Tn5 (alb4-5) in-frame This study 
SAN176 S. marcescens Db10 (SMA4415/entB) in-frame This study 
SAN180 S. marcescens Db10 (SMA4415/entB) in-frame, (alb4-5) in-frame This study 
SAN181 S. marcescens Db10 (SMA4415/entB) in-frame, (alb4-5) in-frame, swrA::Tn5 This study 
SAN157 S. marcescens Db10 tssJ-mCherry (translational fusion) This study 
SAN158 S. marcescens Db10 tssK-mCherry (translational fusion) This study 
SAN159 S. marcescens Db10 tssH-mCherry (translational fusion) This study 
SAN162 S. marcescens Db10 tssL-mCherry (translational fusion) This study 
SAN163 S. marcescens Db10 tssB-mCherry (translational fusion) This study 
SAN164 S. marcescens Db10 fha-mCherry (translational fusion) This study 
SAN166 S. marcescens Db10 tssE-mCherry (translational fusion) This study 
SAN186 S. marcescens Db10 vgrG2-mCherry (translational fusion) This study 
SAN195 S. marcescens Db10 lacZ::PT5-gfpmut2-kan This study 
SAN199 S. marcescens Db10 lacZ::PT5-gfpmut2-kan, tssB-mCherry (translational fusion) This study 
SAN207 S. marcescens Db10 tssB-gfpmut2 This study 
SAN208 S. marcescens Db10 tssB-gfpmut2 tssJ-mCherry This study 
SAN209 S. marcescens Db10 tssB-gfpmut2 tssH-mCherry This study 
SAN210 S. marcescens Db10 tssB-gfpmut2 tssL-mCherry This study 
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a




   
Plasmids   
pSUPROM Vector for constitutive expression of cloned genes under the control of the E. coli tat promoter (Kan) (Jack et al., 2004) 
pBluescript KS+ High copy cloning vector (Amp) Stratagene 
pKNG101 Suicide vector for marker exchange (Sm, sacBR, mobRK2, ori R6K) (Kaniga et al., 
1991) 
pQE-80L Protein overexpression vector; source of T5 promoter Qiagen 
pmCherry-N1 Source of mCherry for generation of translational fusion strains C. Rickman 
pBL165 Source of gfpmut2 for generation of translational fusion strains and for generation of constitutively 
expressing gfp strain 
(Stanley et al., 
2003) 
pNW573 pKNG101-derived marker exchange plasmid for the generation of chromosomal alb1 This study 
pSAN25 pKNG101-derived marker exchange plasmid for the generation of chromosomal alb15-105 This study 
pSAN66 pKNG101-derived marker exchange plasmid for the generation of chromosomal alb1300-400 This study 
pNW577 pKNG101-derived marker exchange plasmid for the generation of chromosomal alb2 This study 
pNW579 pKNG101-derived marker exchange plasmid for the generation of chromosomal alb3 This study 
pSAN24 pKNG101-derived marker exchange plasmid for the generation of chromosomal alb351-262 This study 
pNW572 pKNG101-derived marker exchange plasmid for the generation of chromosomal alb4-5 This study 
pSAN8 pKNG101-derived marker exchange plasmid for the generation of chromosomal alb6 This study 
pSAN31 pKNG101-derived marker exchange plasmid for the generation of chromosomal SMA4147 This study 
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Bacterial Strain / Plasmid Description 
a




pSAN40 pKNG101-derived marker exchange plasmid for the generation of chromosomal 
SMA2452(pswP)::Cml 
This study 
pSAN1 alb1 coding sequence in pSUPROM This study 
pSAN2 alb2 coding sequence in pSUPROM This study 
pSAN3 alb3 coding sequence in pSUPROM This study 
pSAN32 alb6 coding sequence in pSUPROM This study 
pSAN81 SMA2452 (pswP) coding sequence in pSUPROM This study 
pSAN51 pKNG101-derived marker exchange plasmid for the generation of tssJ-mCherry translational fusion This study 
pSAN52 pKNG101-derived marker exchange plasmid for the generation of tssK-mCherry translational fusion This study 
pSAN53 pKNG101-derived marker exchange plasmid for the generation of tssH-mCherry translational fusion This study 
pSAN57 pKNG101-derived marker exchange plasmid for the generation of tssE-mCherry translational fusion This study 
pSAN58 pKNG101-derived marker exchange plasmid for the generation of fha-mCherry translational fusion This study 
pSAN60 pKNG101-derived marker exchange plasmid for the generation of tssL-mCherry translational fusion This study 
pSAN61 pKNG101-derived marker exchange plasmid for the generation of tssB-mCherry translational fusion This study 
pSAN70 pKNG101-derived marker exchange plasmid for the generation of vgrG2-mCherry translational 
fusion 
This study 
pSAN72 pKNG101-derived marker exchange plasmid for the generation of chromosomal lacZ::PT5-gfpmut2-
kan 
This study 
pSAN79 pKNG101-derived marker exchange plasmid for the generation of tssB-gfpmut2 translational fusion This study 
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a. The antibiotic resistances are represented as follows: Amp, ampicillin; Cml, chloramphenicol; Kan, kanamycin; Tet, tetracycline; Sm, 
streptomycin. 
b. B.G.S.C. is the Bacillus genetic stock centre. 
 
2.2 Primers 





 Amplified Region 
NSW755 GACTAGGAAGTTGAGTCG 3’ end of the Tn5 cassette 
NSW756 TAGTGCGTAGAAGGGCTG 3’ end of the Tn5 cassette 
NSW686 CGATAAAGACGTAGCTGGCCAT internal alb1 
NSW688 CGTGGCGTCATTTTCAATCC internal alb1 
NSW681 CATCAGGCGTCACTTCAAAA internal alb2 
NSW682 TCGCCAGACATATGATCAATC internal alb2 
NSW1105 GCATCCCGCTGGAAAACCC internal alb3 
NSW1107 GGTGGCGTGAGGAAACTGA internal alb3 
NSW689 GGCGCTACGTAATGCGCTTT internal alb4 
NSW674 GGCCAAGGAAGAACAACAGGCGTT internal alb4 
NSW695 CCAGAACTTGCTTTGATTTTCAGG internal alb5 
NSW697 CATCTTGAGCGAGGCGAATG internal alb5 
NSW692 GCACAACGCCTCTGAAAAG internal alb6 
NSW693 CGGATAGCGTCATATTCTTGC internal alb6 
NSW1101 TAACGGAGAGCGTATACCCTGC internal sma2294 
NSW1102 CTTCGTCGAATATCAAAATGCGGAA internal sma2294 







 Amplified Region 
NSW699 GTCAAAGCTTGAAAAAACGCAC junction alb1 to sma2294 
NSW1100 GCAGGGTATACGCTCTCCGTTA junction alb1 to sma2294 
NSW685 GCGCTGTTCCCATTTATCAG junction alb1 to alb2 
NSW687 ATGGCCAGCTACGTCTTTATCG junction alb1 to alb2 
NSW696 CCTGAAAATCAAAGCAAGTTCTGG junction alb5 to alb6 
NSW694 GCAAGAATATGACGCTATCCG junction alb5 to alb6 
DEN5 TCACGRCACGAGCTGACGAC internal 16S rRNA 
DEN7 ACTCCTACGGGAGGCAGC internal 16S rRNA 
SC2127 TATATCTAGACAAGGCGCAGGACAAAGC 
 
Forward primer for the upstream flanking region of 




Reverse primer for the upstream flanking region of 




Forward primer for the downstream flanking region 




Reverse primer for the downstream flanking region 
of alb1; encodes ApaI site. For generation of alb1 
strain. 
AG41 TATATCTAGATGCGCGGGTATTGGGC Forward primer for the upstream flanking region of 
the 5’ end of alb1; encodes XbaI site. For generation 
of alb15-105 strain. 







 Amplified Region 
AG42 TATAAAGCTTCCAACAGAACATTAATCCG Reverse primer for the upstream flanking region of 
the 5’ end of alb1; encodes HindIII site. For 
generation of alb15-105 strain. 
AG43 TATAAAGCTTACTTCAATCGATCTTTTGATGTTG Forward primer for the downstream flanking region 
of the 5’ end of alb1; encodes HindIII site. For 
generation of alb15-105 strain. 
AG44 TATAGGGCCCTAGAGCGAGAATGCTG Reverse primer for the downstream flanking region 
of the 5’ end of alb1; encodes ApaI site. For 
generation of alb15-105 strain. 
AG147 TATAAAGCTTAAAGCTGAAGAATAAATAATCGTTTTC Reverse primer for the downstream flanking region 
of the 3’ end of alb1; encodes HindIII site. For 
generation of alb1300-400 strain. 
AG148 TATATCTAGACAGGTAACCGTTTCATCACC Forward primer for the downstream flanking region 
of the 3’ end of alb1; encodes XbaI site. For 
generation of alb1300-400 strain. 
AG149 TATAAAGCTTGCTGACGATGGCTAACG Forward primer for the upstream flanking region of 
the 3’ end of alb1; encodes HindIII site. For 
generation of alb1300-400 strain. 
AG150 TATAGGGCCCGGATGTACCTACGCCACTTC Reverse primer for the upstream flanking region of 
the 3’ end of alb1; encodes ApaI site. For generation 
of alb1300-400 strain. 
SC2155 TGTGTCTAGAATTCATGCGATTATCGTTGATTCC 
 
Forward primer for the upstream flanking region of 
alb2; encodes XbaI site 
SC2156 TGTGAAGCTTATTTTCCATAGATATTCTCCAGATGAAGG 
 
Reverse primer for the upstream flanking region of 
alb2; encodes HindIII site 







 Amplified Region 
SC2157 TATAAAGCTTCCCGGGCAGGGATTCGAAAATATTGGTTGG 
 
Forward primer for the downstream flanking region 
of alb2; encodes HindIII site 
SC2158 TATAGGGCCCGACGATACAAAGCCACC 
 
Reverse primer for the downstream flanking region 
of alb2; encodes ApaI site 
SC2151 TATATCTAGACAGATTAAATTGAATGCCTATACCGTC 
 
Forward primer for the upstream flanking region of 




Reverse primer for the upstream flanking region of 




Forward primer for the downstream flanking region 




Reverse primer for the downstream flanking region 
of alb3; encodes ApaI site. For generation of alb3 
strain. 
AG037 TATATCTAGACATTGCGGTGTGCATTTTC Forward primer for the upstream flanking region of 
alb3; encodes XbaI site. For generation of alb351-
262. 
AG038 TATAAAGCTTCAGTTCAAGATTTCTCTCTAATGG Reverse primer for the upstream flanking region of 
alb3; encodes HindIII site. For generation of 
alb351-262. 
AG039 TATAAAGCTTATCTTTGGCGACATTATTC Forward primer for the downstream flanking region 
of alb3; encodes HindIII site. For generation of 
alb351-262. 







 Amplified Region 
AG040 TATAGGGCCCAATATCCAGATCTTTC Reverse primer for the downstream flanking region 




Forward primer for the upstream flanking region of 
alb4; encodes XbaI site 
SC2124 TGTGAAGCTTAATCTTCATGGATATTACTCTTTTGGG 
 
Reverse primer for the upstream flanking region of 
alb4; encodes HindIII site 
SC2125 TATAAAGCTTCCCGGGTGGACGCTGGCTTGATGG 
 
Forward primer for the downstream flanking region 
of alb5; encodes HindIII site 
SC2126 TATAGGGCCCGCTTCTGAAATCAACGTCATCC 
 
Reverse primer for the downstream flanking region 
of alb5; encodes ApaI site 
AG011 TATAAAGCTTCTCAAACCACATACGG 
CTTCC 
Forward primer for the upstream flanking region of 
alb6; encodes HindIII site 
AG012 TATATCTAGAAGGACAGGGAAATCT 
GCC 
Reverse primer for the upstream flanking region of 
alb6; encodes XbaI site 
AG013 TATAAAGCTTCAGCAGCTGGCGTAAA 
GCG 
Forward primer for the downstream flanking region 
of alb6; encodes HindIII site 
AG014 TATAGGGCCCACCTTTCTGGCGGCGG 
AATAC 
Reverse primer for the downstream flanking region 
of alb6; encodes ApaI site 
AG049 TATAGGGCCCGAATATGAAAATGCG Forward primer for the upstream flanking region of 
the alb promoter; encodes ApaI site 
AG050 TATAAAGCTTCCCTCTTCTGTCATGAGC 
 
Reverse primer for the upstream flanking region of 
the alb promoter; encodes HindIII site 
AG051 TATAAAGCTTAAATCATAAAAAATTTATTTGCTTTG 
 
Forward primer to amplify the T5 promoter from 
pQE80; encodes HindIII site 







 Amplified Region 
AG052 TATAGGATCCTGTGTGAAATTGTTATCCG 
 
Reverse primer to amplify the T5 promoter from 
pQE80; encodes BamHI site 
AG053 TATAGGATCCTTAACATTCGGATTAATGTTCTG 
 
Forward primer for the downstream flanking region 
of the alb promoter; encodes BamHI site 
AG054 TATATCTAGATTTCTTCGTTTCCGGCAG 
 
Reverse primer for the downstream flanking region 
of the alb promoter; encodes XbaI site 
AG001 GCATGGATCCATGTTCTGTTGGAG Forward primer for the alb1 coding region; encodes 
BamHI site for cloning into pSUPROM 
AG002 GCATCTCGAGTTATTCTTCAGCTTTGC Reverse primer for the alb1 coding region; encodes 
XhoI site for cloning into pSUPROM 
AG003 GCATGGATCCATGGAAAATGAAACC 
 
Forward primer for the alb2 coding region; encodes 
BamHI site for cloning into pSUPROM 
AG004 GCATCTCGAGTTAAATTATCCAACC 
 
Reverse primer for the alb2 coding region; encodes 
XhoI site for cloning into pSUPROM 
AG007 GCATGGATCCATGGATAGTTTCGCCT 
CGCAT 
Forward primer for the alb3 coding region; encodes 
BamHI site for cloning into pSUPROM 
AG008 GCATCTCGAGTCAGGGTTTTACCGCC 
ACGAG 
Reverse primer for the alb3 coding region; encodes 
XhoI site for cloning into pSUPROM 
AG035 TATAGGATCCTTGATTACGCCGCTCCCG 
 
Forward primer for the alb6 coding region; encodes 
BamHI site for cloning into pSUPROM 
AG036 GATACTCGAGTTACGCCAGCTGCTGATTC 
 
Reverse primer for the alb6 coding region; encodes 
XhoI site for cloning into pSUPROM 
AG024 TTCGTCAAATTTGACAGCGAGATCG Gene specific primer 1 (GSP1) internal to alb2; for ’ 
Rapid amplification of cDNA ends (5’RACE) 
AG025 ACAACATCAAAAGATCGATTGAAGTGG GSP1 internal to alb1; for 5’RACE 
NSW697a CTTCCTCTCATTGTCCATGCC GSP2 internal to alb2; for 5’RACE 







 Amplified Region 
NSW698 CAACGCGCCAAACACAAAT GSP2 internal to alb1; for 5’RACE 
SM044 GACCACGCGTATCGATGTCGACTTTTTTTTTTTTTTTT Anchor primer complimentary to poly(A) tail of 
cDNA; for 5’RACE 
NSW685 GCGCTGTTCCCATTTATCAG GSP3 internal to alb2; for 5’RACE 
NSW699 GGACATCTCCACTTCAATACACCCAG GSP3 internal to alb1; for 5’RACE 
SM045 GACCACGCGTATCGATGTCGAC Second anchor primer; for 5’ RACE 
AG063 TATATCTAGAGCGAACCTTGTACCGTGAG 
 
Forward primer for the upstream flanking region of 
SMA4147; encodes XbaI site 
AG064 TATAAAGCTTAAAATGACACGCCATTG 
 
Reverse primer for the upstream flanking region of 
SMA4147; encodes HindIII site 
AG065 TATAAAGCTTAAGACGCCCGGTTAAC 
 
Forward primer for the downstream flanking region 
of SMA4147; encodes HindIII site 
AG066 TATAGGGCCCCAGGCTTGTTCATTAC 
 
Reverse primer for the downstream flanking region 
of SMA4147 (pswP); encodes ApaI site 
AG067 TATATCTAGACTATCAGGATTCGCTGTTCAC 
 
Forward primer for the upstream flanking region of 
SMA2452 (pswP); encodes XbaI site 
AG068 TATAAAGCTTGATAAAAGTGGGCAACG 
 
Reverse primer for the upstream flanking region of 
SMA2452 (pswP); encodes HindIII site 
AG071 TATAGGGCCCTTGTTTAAAGCGGCTGAC 
 
Reverse primer for the downstream flanking region 
of SMA2452 (pswP); encodes ApaI site 
AG072 TATAAAGCTTGAAGGTGACGATGTCACG 
 
Forward primer for the downstream flanking region 
of SMA2452 (pswP); encodes HindIII site 
AG092 TATAGGATCCTTGCCCACTTTTATCCG Forward primer for the SMA2452 (pswP) coding 
region; encodes BamHI site for cloning into 
pSUPROM 







 Amplified Region 
AG093 TATACTCGAGTTAGCAAAAAATAAAAGTCGTGACAT Forward primer for the SMA2452 (pswP) coding 
region; encodes XhoI site for cloning into 
pSUPROM 
AG157 TATAAAGCTTTTTTGGAATGGCCATCGA Reverse primer for the upstream flanking region of 
SMA4415 (entD); encodes HindIII site 
AG158 TATAGGGCCCACATCCTGACGACGCAAG Forward primer for the upstream flanking region of 
SMA4415 (entD); encodes ApaI site 
AG159 TATAAAGCTTGAAGAGAAAGCCTGATTTTAATAATG Forward primer for the downstream flanking region 
of SMA4415 (entD); encodes HindIII site 
AG160 TATATCTAGATATTTGCCGGTGTCGGTC Reverse primer for the downstream flanking region 
of SMA4415 (entD); encodes XbaI site 
AG097 CGCAAGGAACCGGAAAGGGAGCAGGAGCACCGGTCGCCACCATGG Forward primer for amplification of mCherry from 
pmCherry-N1; overlaps with reverse primer for the 
upstream flanking region of the 3’ end of SMA2254 
(tssL) 
AG098 CCATGGTGGCGACCGGTGCTCCTGCTCCCTTTCCGGTTCCTTGCG Reverse primer for the upstream flanking region of 
the 3’ end of SMA2254 (tssL); overlaps with forward 
primer for amplification of mCherry from 
pmCherry-N1 
AG099 TATATCTAGACTTCCTGGCTTCGCTGC Forward primer for the upstream flanking region of 
the 3’ end of SMA2254 (tssL); encodes XbaI site 
AG100 CCTTGCGGCAAGCCGTTCTTGTACAGCTCGTCCATGCC Reverse primer for amplification of mCherry from 
pmCherry-N1; overlaps with forward primer for the 
downstream flanking region of the 3’ end of 
SMA2254 (tssL) 







 Amplified Region 
AG101 GGCATGGACGAGCTGTACAAGAACGGCTTGCCGCAAGG Forward primer for the downstream flanking region 
of the 3’ end of SMA2254 (tssL); overlaps with 
reverse primer for amplification of mCherry from 
pmCherry-N1 
AG102 TATAGGGCCCGTGTCGAGCAGCA Reverse primer for the downstream flanking region 
of the 3’ end of SMA2254 (tssL); encodes ApaI site 
AG103 GCCCCGTAAAAAAGGTCGACGGAGCAGGAGCACCGGTCGCCACCATGG Forward primer for amplification of mCherry from 
pmCherry-N1; overlaps with reverse primer for the 
upstream flanking region of the 3’ end of SMA2252 
(tssJ) 
AG104 CCATGGTGGCGACCGGTGCTCCTGCTCCGTCGACCTTTTTTACGGGGC Reverse primer for the upstream flanking region of 
the 3’ end of SMA2252 (tssJ); overlaps with forward 
primer for amplification of mCherry from 
pmCherry-N1 
AG105 TATATCTAGAAACAGGACTGCGTCAAAGTC Forward primer for the upstream flanking region of 
the 3’ end of SMA2252 (tssJ); encodes XbaI site 
AG106 CAGCGCAGCGGTAGGTCACTTGTACAGCTCGTCCATGCC Reverse primer for amplification of mCherry from 
pmCherry-N1; overlaps with forward primer for the 
downstream flanking region of the 3’ end of 
SMA2252 (tssJ) 
AG107 GGCATGGACGAGCTGTACAAGTGACCTACCGCTGCGCTG Forward primer for the downstream flanking region 
of the 3’ end of SMA2252 (tssJ); overlaps with 
reverse primer for amplification of mCherry from 
pmCherry-N1 
AG108 TATAGGGCCCCCTGGCAGTTCAGCATCG Reverse primer for the downstream flanking region 
of the 3’ end of SMA2254 (tssJ); encodes ApaI site 







 Amplified Region 
AG109 CAGCCATACGGACCGGGGAGCAGGAGCACCGGTCGCCACCATGG Forward primer for amplification of mCherry from 
pmCherry-N1; overlaps with reverse primer for the 
upstream flanking region of the 3’ end of SMA2253 
(tssK) 
AG110 CCATGGTGGCGACCGGTGCTCCTGCTCCCCGGTCCGTATGGCTG Reverse primer for the upstream flanking region of 
the 3’ end of SMA2253 (tssK); overlaps with forward 
primer for amplification of mCherry from 
pmCherry-N1 
AG111 TATATCTAGACCACCTCGATCATCTGCAC Forward primer for the upstream flanking region of 
the 3’ end of SMA2253 (tssK); encodes XbaI site 
AG112 GCTATTTTCCTGAGTCATAGGTTACTTGTACAGCTCGTCCATGCC Reverse primer for amplification of mCherry from 
pmCherry-N1; overlaps with forward primer for the 
downstream flanking region of the 3’ end of 
SMA2253 (tssK) 
AG113 GGCATGGACGAGCTGTACAAGTAACCTATGACTCAGGAAAATAGC Forward primer for the downstream flanking region 
of the 3’ end of SMA2253 (tssK); overlaps with 
reverse primer for amplification of mCherry from 
pmCherry-N1 
AG114 TATAGGGCCCGGCCGCCACAGCTTCT Reverse primer for the downstream flanking region 
of the 3’ end of SMA2253 (tssK); encodes ApaI site 
AG115 ATTCATTTGTCAATTTCAGGCAGGAGCAGGAGCACCGGTCGCCACCATGG Forward primer for amplification of mCherry from 
pmCherry-N1; overlaps with reverse primer for the 
upstream flanking region of the 3’ end of SMA2274 
(tssH) 







 Amplified Region 
AG116 CCATGGTGGCGACCGGTGCTCCTGCTCCTGCCTGAAATTGACAAATGAAT Reverse primer for the upstream flanking region of 
the 3’ end of SMA2274 (tssH); overlaps with 
forward primer for amplification of mCherry from 
pmCherry-N1 
AG117 TATATCTAGACTATGTCGGCTACGGCG Forward primer for the upstream flanking region of 
the 3’ end of SMA2274 (tssH); encodes XbaI site 
AG118 CTCGGCGGCCGCGGCGTTACTTGTACAGCTCGTCCATGCC Reverse primer for amplification of mCherry from 
pmCherry-N1; overlaps with forward primer for the 
downstream flanking region of the 3’ end of 
SMA2274 (tssH) 
AG119 GGCATGGACGAGCTGTACAAGTAACGCCGCGGCCGCCGAG Forward primer for the downstream flanking region 
of the 3’ end of SMA2274 (tssH); overlaps with 
reverse primer for amplification of mCherry from 
pmCherry-N1 
AG120 TATAGGGCCCGCGCCGATCCGAAGTC Reverse primer for the downstream flanking region 
of the 3’ end of SMA2254 (tssH); encodes ApaI site 
AG121 CAACAACGAGCGTGAGGATGGAGCAGGAGCACCGGTCGCCACCATGG Forward primer for amplification of mCherry from 
pmCherry-N1; overlaps with reverse primer for the 
upstream flanking region of the 3’ end of SMA2258 
(tssB) 
AG122 CCATGGTGGCGACCGGTGCTCCTGCTCCATCCTCACGCTCGTTGTTG Reverse primer for the upstream flanking region of 
the 3’ end of SMA2258 (tssB); overlaps with forward 
primer for amplification of mCherry from 
pmCherry-N1 
AG123 TATATCTAGATGTTCTCTTGACGCATCCG Forward primer for the upstream flanking region of 
the 3’ end of SMA2258 (tssB); encodes XbaI site 







 Amplified Region 
AG124 GCTCGTTGTTGTCGTCGTTCTTGTACAGCTCGTCCATGCC Reverse primer for amplification of mCherry from 
pmCherry-N1; overlaps with forward primer for the 
downstream flanking region of the 3’ end of 
SMA2258 (tssB) 
AG125 GGCATGGACGAGCTGTACAAGAACGACGACAACAACGAGC Forward primer for the downstream flanking region 
of the 3’ end of SMA2258 (tssB); overlaps with 
reverse primer for amplification of mCherry from 
pmCherry-N1 
AG126 TATAGGGCCCTCCATCTGCATCACGCTC Reverse primer for the downstream flanking region 
of the 3’ end of SMA2258 (tssB); encodes ApaI site 
AG127 CTTCGATCTGAAAGACATAGGGGGAGCAGGAGCACCGGTCGCCACCATGG Forward primer for amplification of mCherry from 
pmCherry-N1; overlaps with reverse primer for the 
upstream flanking region of the 3’ end of SMA2271 
(tssE) 
AG128 CCATGGTGGCGACCGGTGCTCCTGCTCCCCCTATGTCTTTCAGATCGAAG Reverse primer for the upstream flanking region of 
the 3’ end of SMA2271 (tssE); overlaps with forward 
primer for amplification of mCherry from 
pmCherry-N1 
AG129 TATATCTAGAGAATTCCCACTGCACAGC Forward primer for the upstream flanking region of 
the 3’ end of SMA2271 (tssE); encodes XbaI site 
AG130 CCTATGTCTTTCAGATCGAAGTGCTTGTACAGCTCGTCCATGCC Reverse primer for amplification of mCherry from 
pmCherry-N1; overlaps with forward primer for the 
downstream flanking region of the 3’ end of 
SMA2271 (tssE) 







 Amplified Region 
AG131 GGCATGGACGAGCTGTACAAGCACTTCGATCTGAAAGACATAGG Forward primer for the downstream flanking region 
of the 3’ end of SMA2271 (tssE); overlaps with 
reverse primer for amplification of mCherry from 
pmCherry-N1 
AG132 TATAGGGCCCGGCCAGGTAAAACATCAATTG Reverse primer for the downstream flanking region 
of the 3’ end of SMA2271 (tssE); encodes ApaI site 
AG139 GACCAAACCGGACGCGGGAGCAGGAGCACCGGTCGCCACCATGG Forward primer for amplification of mCherry from 
pmCherry-N1; overlaps with reverse primer for the 
upstream flanking region of the 3’ end of SMA2267 
(fha) 
AG140 CCATGGTGGCGACCGGTGCTCCTGCTCCCGCGTCCGGTTTGGTC Reverse primer for the upstream flanking region of 
the 3’ end of SMA2267 (fha); overlaps with forward 
primer for amplification of mCherry from 
pmCherry-N1 
AG141 TATATCTAGAAAGTGGCGACGCATTGG Forward primer for the upstream flanking region of 
the 3’ end of SMA2267 (fha); encodes XbaI site 
AG142 CGGTTTGGTCTGTGAGTCTTTCTTGTACAGCTCGTCCATGCC Reverse primer for amplification of mCherry from 
pmCherry-N1; overlaps with forward primer for the 
downstream flanking region of the 3’ end of 
SMA2267 (fha) 
AG143 GGCATGGACGAGCTGTACAAGAAAGACTCACAGACCAAACCG Forward primer for the downstream flanking region 
of the 3’ end of SMA2267 (fha); overlaps with 
reverse primer for amplification of mCherry from 
pmCherry-N1 
AG144 TATAGGGCCCGCAGCGACTGTTCCAGTTC Reverse primer for the downstream flanking region 
of the 3’ end of SMA2267 (fha); encodes ApaI site 




 Primer engineered DNA restriction sites are underlined. 




2.3.1 Growth media and growth conditions 
Growth media used in this study are provided in Table 2.3 and Table 2.4. E. coli 
and B. subtilis were routinely cultured in LB medium overnight at 37 
o
C and with 
shaking at 200 rpm. S. marcescens and Micrococcus luteus were routinely cultured in 
low salt LB medium overnight at 30 
o
C and with shaking at 200 rpm, unless otherwise 
stated. S. aureus was routinely grown in TSB overnight at 37 
o
C and with shaking at 
200 rpm, unless otherwise stated. Growth media were solidified through addition of 
agar to 1.5% (w/v). 
When appropriate, antibiotics and supplements were added as described in Table 2.5.  
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Table 2.3. Growth media used in this study 






1 % (w/v) 
0.5 % (w/v) 
1 % (w/v) 
Low salt LB medium Tryptone 
Yeast extract 
NaCl 
1 % (w/v) 
0.5 % (w/v) 
0.5 % (w/v) 
Tryptic Soya Broth (TSB) Tryptone 
Soyatone 
NaCl 
1.5 % (w/v) 
0.5 % (w/v) 
0.5 % (w/v) 






1 % (w/v) 
0.1 % (w/v) 
0.41 mM 
0.2 % (w/v) 






1 % (w/v) 
0.1 % (w/v) 
0.41 mM 
0.2 % (w/v) 
 
Table 2.4. Composition of Chrome azurol S indicator plates 




100 ml 10x MM9 (pH7) 22.04 mM KH2PO4 
  
   85.55 mM NaCl 
   186.94 mM NH4Cl 
 100 ml CAS-HDTMA 1 mM CAS 
   1mM FeCl3•6 H20 in 10 mM 
HCl 
   2 mM 
Hexadecyltrimethylammonium 
bromide (HDTMA) 
 30 ml Deferrated 
Casamino Acids 
10 % Casamino acids (w/v) 
 750 ml CAS agar (pH 7) 112.5 mM NaOH 
   75 mM Piperazine-N,N′-bis 
(2-ethanesulfonic acid) 
(PIPES) 
 10 ml 20 % glycerol  
 1 ml 1 M MgCl2  
 1 ml 1 M CaCl2  
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Table 2.5. Antibiotics or supplements used in this study 
 
Antibiotic or supplement Final concentration 
Ampicillin or carbenicillin (Amp) 





Kanamycin (Kan) 100 g ml
-1
 
Tetracycline (Tet) 10 g ml
-1
 
Streptomycin (Strep) 100 g ml
-1
 
Isopropyl β-D-1-thiogalactopyranoside 50 M 
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Table 2.6. Buffers and Solutions 
Buffer / Solution Component Final concentration 



















0.1 % (v/v) 









0.1 % (w/v) 






2 %  (v/v) 
15 % (v/v) 
25 % (v/v) 
0.01% (w/v) 





0.1 % (w/v) 
Coomassie stain Methanol 
Acetic acid 
Coomassie blue 
10 % (v/v) 
20 % (v/v) 
Few grains per litre 





10 % (v/v) 
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Table 2.7. Antibodies used in this study 
Antibody Dilution Raised in Supplier 
Polyclonal Hcp 
antiserum 
1 : 6,000 Rabbit Eurogentec 
Polyclonal Ssp2 
antiserum 
1 : 1,000 Rabbit Eurogentec 
mCherry 1 : 1,000 Rabbit Eurogentec 
Gfp 1 : 1,000 Mouse Roche 
Anti-Rabbit IgG – 
HRP conjugate 
1 : 20,000 Goat Thermo  
 
2.4 Molecular biology techniques 
2.4.1 DNA methods 
2.4.1.3 Agarose gel electrophoresis 
Separation of DNA fragments ranging from 100 bp – 10 kb in size was achieved 
by running the sample through 1 – 2 % (w/v) horizontal agarose gels containing 1x 
GelRed nucleic acid stain (Biotium). Agarose powder was dissolved in 1x TAE buffer 
by heating (Table 2.6). 1x TAE buffer was also used as a running buffer. DNA samples 
were mixed with 5x DNA loading dye (Bioline) prior to being loaded into the wells. 
DNA fragments were separated through application of a constant voltage of 80 – 120 V. 
DNA fragments were visualised by exposure to UV light and were photographed using 
a Bio-Rad Gel Doc XR. The approximate size of DNA fragments was estimated 
according to a DNA standard (100 bp ladder (Bioline) or 1kb ladder (NEB)), which was 
run alongside the DNA samples. 
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2.4.1.2 Plasmid purification 
To purify plasmids from E. coli, the QIAprep Miniprep Kit (Qiagen) was used 
and manufacturer’s instructions were followed. This technique is based on the alkaline 
lysis method originally described by Birnboim and Doly (Birnboim & Doly, 1979).  
Briefly, cells from an overnight culture were harvested by centrifugation at 13,000 rpm 
for 1 min. Cells were then re-suspended 250 l buffer P1, containing RNase to degrade 
any RNA present. Cells were lysed by the addition of buffer P2, which contains SDS 
and NaOH to destroy the cell membrane and denature DNA. The addition of buffer N3 
neutralised the cell lysate and allowed re-naturation of plasmid DNA. Cell debris, 
including chromosomal DNA, was removed by centrifugation at 13,000 rpm for 10 min. 
Cleared lysate was then loaded onto the binding column, which selectively binds DNA 
under high salt and low pH conditions. RNA, proteins and other metabolites were 
washed from the column by the addition of buffer PE. Since MC1061 is endA+, when 
purifying plasmids from this strain, an additional wash step with buffer PB was required 
to remove this endonuclease from the silica membrane. Plasmid DNA was then eluted 
from the binding column by the addition of 50 l H2O. 
 
2.4.1.3 Genomic DNA (gDNA) purification 
To extract gDNA for PCR purposes, the DNeasy Blood and Tissue Kit (Qiagen) 
was used. Manufacturer’s instructions for extraction of gDNA from Gram-negative 
bacteria were followed. Briefly, cells from a 0.5 ml overnight culture were harvested by 
centrifugation at 13,000 rpm for 1 min. Cells were re-suspended in 180 l Buffer ATL 
and were lysed by the addition of 20 l proteinase K and then incubation at 56 
o
C for 25 
min. Samples were vortexed thoroughly following the incubation step. 400 l of a 1:1 
ratio of Buffer AL : ethanol were then added to the sample and the sample mixed well 
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by vortexing. Cell lysate was then loaded onto the spin column which selectively binds 
DNA at the appropriate pH. The column was then washed by the addition of 500 l 
Buffer AW1 and centrifugation at 13,000 rpm for 1 min. Buffer AL and Buffer AW1 
contain guanidine hydrochloride for the denaturation of proteins. A second wash step 
was then performed by the addition of 500 l Buffer AW2 and centrifugation at 13,000 
rpm for 1 min. DNA was then eluted by the addition of 200 l elution buffer to the 
column, incubation for 1 min at room temp and centrifugation at 8,000 rpm for 1 min. 
 
2.4.1.4 Amplification of DNA by polymerase chain reaction 
DNA fragments were amplified by the polymerase chain reaction (PCR) using 
the oligonucleotide primers described in Table 2.2. Qiagen Taq DNA polymerase was 
predominantly used for screening of potential clones whereas PCR fragments required 
for construction of new stains and plasmids were amplified using Phusion (NEB). 
Reaction mixes and cycling conditions for standard PCR reactions are detailed in Table 
2.8, Table 2.9, Table 2.10 and Table 2.11 
 
Table 2.8. Reaction mix for Taq polymerase (Qiagen) PCR reaction 
Component Volume 
DNA template 1 l 
10x PCR buffer 5 l 
25 mM MgCl2 5 l 
Q buffer 10 l 
10 mM dNTPs 1 l 
25 mM Forward primer 1 l 
25 mM Reverse primer 1 l 
Taq DNA polymerase 1 l 
H2O 25 l 
Final volume 50 l 
 





Table 2.9 Reaction mix for Phusion (NEB) polymerase PCR reaction 
Component Volume 
DNA template 1 l 
5x Phusion buffer 10 l 
10 mM dNTPs 1 l 
25 ml Forward primer 1 l 
25 ml Reverse primer 1 l 
Phusion DNA polymerase 0.5 l 
H2O 35.5 l 
Final volume  50 l 
 
Table 2.10. Cycling conditions for Taq (Qiagen) polymerase 
Step Temperature Time (Min:Sec) Cycles 
Denaturation 94 
o



















Final elongation 72 
o
C 10:00 1 
 
Table 2.11. Cycling conditions for Phusion (NEB) DNA polymerase 
Step Temperature Time (Min:Sec) Cycles 
Denaturation 98 
o



















Final elongation 72 
o
C 5:00 1 
 
2.4.1.5 Restriction endonuclease digests 
Purified DNA was digested by restriction endonuclease enzymes (NEB). Digests 
were performed using the supplied endonuclease buffer and were incubated at the 
recommended temperature for a minimum of 3 hours. Digests typically contained 1.5 l 
of enzyme and 1 g DNA in a 50 l reaction. 
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2.4.1.6 Phosphatase treatment of digested plasmids 
As required, digested vector DNA was dephosphorylated with 200 U of Calf 
Intestinal Phosphatase (CIP) (NEB) in the recommended buffer and in a total volume of 
60 l. The reaction was incubated at 37 
o
C for 30 min followed by a 5 min incubation at 
65 
o
C to inactivate the enzyme. 
 
2.4.1.7 Extraction of DNA from agarose gels 
DNA fragments were excised from agarose gels and purified using QIAquick 
Gel Extraction kit (Qiagen) following the manufacturer’s instructions. 
 
2.4.1.8 DNA ligation 
DNA fragments were inserted into linearised vectors using T4 DNA ligase 
(NEB). Reactions totalling 20 l contained 1x T4 DNA ligase buffer, 400 U of T4 
ligase, 2 l purified vector DNA and 2, 4 or 6 l insert DNA. Reactions were incubated 
at room temperature for a minimum of 1 hour. Following the ligation reaction, 10 l 
ligation reaction was to transform 100 l competent E. coli MC1061 cells. 
 
2.4.1.9 DNA sequencing 
Sequencing of DNA was performed by the DNA Sequencing Service at the 
College of Life Sciences, University of Dundee. Resulting sequences were analysed 
using the BLAST tool (Altschul et al., 1997). 
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2.4.2 Generation of chemically competent Escherichia coli and transformation with 
plasmid DNA 
Chemically competent E. coli cells were generated using the CaCl2 method. An 
overnight culture of E. coli cells was diluted 10-fold into LB media. This culture was 
grown at 37
o 
C with shaking at 200 rpm until the OD600 was approximately 0.3. The 
cells were then chilled on ice for 30 min prior to centrifugation at 4,200 rpm for 10 min. 
Recovered cells were then re-suspended in 0.1 volume ice cold 0.1 M CaCl2 and then 
pelleted as before. Cell pellets were again re-suspended in 0.04 volumes ice cold 0.1 M 
CaCl2. The cells were then incubated overnight on ice. Glycerol was added to a final 
concentration of 10% and cells were stored at -80 
o
C. 
Prior to transformation, E. coli cells were thawed on ice. Following the addition 
of plasmid DNA to the cells, cells were incubated on ice for 30 min. The cells were then 
heat shocked at 42 
o
C for 90 sec. The cells were then chilled on ice for 3 min prior to 
the addition of 1 ml LB. Finally, cells were allowed to recover at 37 
o
C for 1 hour prior 
to plating on selective media. 
 
2.4.3 Generation of electro-competent Serratia and transformation with plasmid 
DNA 
For preparation of electro competent cells, an overnight culture of S. marcescens 
was diluted 10-fold into low salt LB.media. The culture was grown at 30 
o
C with 
shaking at 200 rpm until the OD600 reached 0.4 – 0.6. The culture was then chilled on 
ice for a minimum for 1 hour prior to centrifugation at 4,200 rpm for 10 min. The cell 
pellets were re-suspended in 10 ml ice cold sterile H2O and pelleted as before. The 
above wash step was repeated and cell pellets were then re-suspended in 10 ml ice cold 
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sterile 10 % (v/v) glycerol and pelleted as before. Finally, cell pellets were re-suspended 
in 1ml ice cold sterile 10 % (v/v) glycerol. 
To transform electro competent cells, 100 μl cells were incubated 1 μl of DNA 
on ice for 10 min. Cells were transferred to an electro cuvette, then pulsed using Bio-
Rad GenePulser with following settings: E. coli, 2 mm cuvette, 2.5 kV. 1 ml of LB 
medium was immediately added to the transformed cells and the cultures were 
incubated at 30 
o
C for 1 hour with shaking at 200 rpm. Cells were pelleted by 
centrifugation at 13,000 rpm for 1 min and then re-suspended in 100 μl of LB medium. 
Finally, cells were plated onto selective media. 
 
2.4.4 Allelic marker exchange 
S. marcescens Db10 chromosomal mutants with in-frame deletions in selected 
genes were constructed by allelic marker exchange using the suicide vector pKNG101. 
Upstream and downstream flanking regions (600-700 bp in length) of the target gene 
were cloned into pBluescript to generate a nonpolar, in-frame deletion of the gene 
(Table 2.1). This deletion allele was then cloned into pKNG101, and the resulting 
marker exchange plasmid was used to transform E. coli CC118λpir to generate a donor 
strain for introduction of the plasmid into S. marcescens Db10 by conjugation. A tri-
parental mating was performed by mixing equal volumes of overnight cultures of the 
donor strain, recipient S. marcescens Db10 strain and a helper strain HH26 (pNJ5000) 
and then spotting 30 μl onto an LB plate which was incubated overnight at 30ºC.  
Co-integrants were selected by streaking cells from the mating onto Minimal 
Medium glucose (MM) agar supplemented with streptomycin (100 μg ml
-1
) and 
incubating overnight, at 30 ºC. Three single colonies were then purified on MM glucose 
agar supplemented with streptomycin (100 μg ml
-1
) three times. To isolate resolvants, 
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overnight cultures of co-integrants were grown in LB medium with no selection, diluted 
to 10
-6
 in phosphate buffer and 100 μl plated on to MM high sucrose agar. A second 
round of growth on MM high sucrose was then performed.  
Colonies on the MM high sucrose agar were replica patched onto LB agar and 
LB agar supplemented with streptomycin. Streptomycin sensitive candidates were 
chosen for further analysis. Candidates could be wild-type or mutant depending on the 
direction of the resolution event; therefore PCR was performed on gDNA using suitable 
primers to identify candidates with the correct allele. Candidates with the correct allele 
were struck through single colonies twice on LB agar. gDNA of final candidates was 
prepared and the mutation confirmed by PCR of the region surrounding mutation 
followed by sequencing of PCR products.  
To construct the mCherry and gfpmut2 translational reporter fusions, mCherry or 
gfpmut2 coding regions were amplified from the relevant plasmid (Table 2.1) and 
cloned into pBluescriptKS+ containing the appropriate upstream and downstream 
flanking regions of the target gene. To construct the T5alb1-6 strain (SAN100) expressing 
elevated levels of althiomycin, the T5 promoter was amplified from the relevant 
plasmid (Table 2.1) and cloned into pBluescriptKS+ containing the appropriate 
upstream and downstream flanking regions of the 5’ start of alb1. The relevant fusions 
were then cloned into pKNG101 for introduction into the chromosome as described 
above. 
 
2.4.5 Phage preparation and transduction 
To prepare phage lysate, the required S. marcescens Db10 strain was grown 




 in phage buffer (Table 2.6) 
and each dilution then mixed with 200 l S. marcescens Db10 overnight culture. Phage 
were incubated with the culture for 5 min prior to the addition of 4 ml molten low salt 
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LB 0.35 % agar. The mixture was then poured onto an LB plate and the plate incubated 
overnight at 30 
o
C. The following day, phage were harvested from the plate by 
collection of the top agar and addition of 3 ml phage buffer. 0.5 ml chloroform saturated 
with NaHCO3 was added and the phage mixture then vortexed for 3 min. Agar was 
separated from the phage lysate by centrifugation of the phage mixture at 4,000 rpm at 4 
o
C for 20 min. The phage lysate was collected and stored with 20 l chloroform and at 4 
o
C. 
To transduce the allele of interest into the required strain, an overnight culture of 
the recipient strain was grown. 10 l and 100 l phage lysate were mixed with 2 ml of 
the overnight culture and the samples then incubated for 30 min statically at 22 
o
C. 10 
ml low salt LB was then added and the samples mixed well. Cells were harvested by 
centrifugation at 4,000 rpm for 10 min at 22 
o
C. Cells were then re-suspended in 10 ml 
LB and harvested by centrifugation as before. Cells were re-suspended in 5 ml LB and 
incubated at 30
 o
C for 20 min. Finally, cells were again harvested by centrifugation as 
above and re-suspended in 30 l LB. These cells were then plated onto LB containing 
the appropriate antibiotic to select for the required allele. At the same time, a cell only 
and phage only control were plated onto selective media to monitor background 
resistance. Plates were incubated overnight at 30 
o
C and candidate transductants were 
re-streaked twice on selective media to restrict phage carryover. The presence of the 
required allele was confirmed by PCR. 
 
2.5 Transposon mutagenesis 
2.5.1 Generation of transposon mutants 
Random transposon mutagenesis was performed by a bi-parental conjugation 
with the donor strain (E. coli S17-1Pir harbouring plasmid pUT-mini-Tn5lacZ1 – 





 transposon) and S. marcescens Db10 as the recipient strain. Donor and 
recipient strains were grown overnight at the required temperature and in the 
appropriate media; LB Amp for the donor strain and low salt LB for the recipient strain. 
The following day, the OD600 of the overnight cultures was adjusted to 1 and the donor 
and recipient strains were mixed at a ratio of 2:1 donor : recipient in a total volume of 
40 l. The cells were then recovered by centrifugation at 13,000 rpm for 1 min and re-
suspended in 40 l LB. 40 l of the mixed culture, along with 40 l of the donor and 40 
l of the recipient were then spotted onto an LB agar plate and incubated for 16 hours at 
30 
o
C. The following day, the bacterial spots were harvested and re-suspended in 1ml 
LB. These cultures were then diluted 10 fold and 100 fold in LB. 100 l of each of the 
diluted cultures were plated onto LB agar supplemented with 10 g ml
-1
 Tet (to kill the 
donor strain) and 100 g ml
-1
 Kan (to kill the recipient strain), 100 μl of the undiluted 
donor and recipient strains were also plated on the same medium to check for any 
background growth. Plates were then incubated at 30 
o
C for 24 hours. 
To select for S. marcescens Db10 mutants affected positively or negatively in 
their ability to kill B. subtilis, individual S. marcescens Db10 Tn5 mutant colonies were 
streaked onto an LB agar plate and an LB agar plate + B subtilis lawn. 2,800 S. 
marcescens Db10 Tn5 mutants were screened. Mutants that showed an increased or 
decreased ability to kill B. subtilis were isolated from the LB agar plate and re-streaked 
to single colonies. From these single colonies, the mutant isolates were stocked. 
 
2.5.2 Mapping of transposon insertion 
Candidate mutants identified in the transposon mutagenesis screen were 
analysed to map the location of the transposon insertion. gDNA was isolated from each 
mutant, as described above, and diluted 1 in 2. This gDNA was digested with the 
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restriction enzyme Taq1, as previously described. The restriction digest reaction was 
cleaned and 1 l of the digested products were self-ligated in a total volume of 50 l, as 
described above. The ligated DNA products were then amplified by PCR using 
outwardly directed primers (Table 2.2) that were designed to be specific for the terminal 
3’ fragment of Tn5. PCR products were visualised by gel electrophoresis and purified 
from the agarose gel as detailed above. Purified PCR products were then sequenced. 
2.6 RNA techniques 
 
2.6.1 Preparation of RNA 
To isolate RNA from S. marcescens Db10, strains were grown in low salt LB for 
6 hours and 10 l of culture was then spotted onto an LB agar plate. For each strain, 3 
culture spots were grown. These plates were then incubated for 16 hours at 30 
o
C. The 
following day, culture spots were harvested and 3 spots re-suspended in a total of 750 l 
RNAwiz (Ambion). RNA was harvested using the RiboPure Bacteria RNA extraction 
kit (Ambion) according to the manufacturer’s instructions. RNA was checked for 
quality and quantified using a Nanodrop. 
 
2.6.2 Preparation of cDNA 
RNA samples were reverse transcribed to cDNA for use in PCR. 1 μg of RNA 
was incubated with 2.1 M random hexamers, 0.83 mM dNTPs and H2O to a total of 12 
l. Samples were heated at 65 
o
C for 5 min then chilled to 4 
o
C before the addition of 
the following components: 4 mM dithiothreitol (DTT), 40 U RNaseOUT (Invitrogen), 
1x First strand buffer (Invitrogen) and either 200 U Superscript III reverse transcriptase 
or RNase free H2O as a negative control. Samples were then incubated at 25 
o
C for 5 





C for 1 hour and 70 
o
C for 15 min. Samples were made to a final volume of 
100 μl with RNase free H2O for use in further applications. 
2.6.3 5’ Rapid amplification of cDNA ends (5’RACE) 
The transcriptional start site for the alb operon was determined using 5’RACE 
conducted using DNase treated RNA harvested from S. marcescens Db10, as described 
above. To identify potential transcriptional start sites upstream of alb1 or alb2 we 
attempted to synthesise cDNA corresponding to the potential promoter regions for both 
genes. 5’RACE involves the generation of cDNA using a Gene Specific antisense 
Primer (GSP) which permits cDNA conversion of the mRNA of interest to the 5’ end of 
the message. cDNA was synthesised using 250 ng RNA and the Gene Specific Primers 
(GSPs) AG024  and AG025, which were internal to alb2 and alb1, respectively. RNA 
was mixed with 1 mM dNTPs, 5 mol of either primer and H2O to a total of 10l. The 
reaction was then incubated at 65 
o
C for 10 minutes. The reaction mixture was then 
made up to a total volume of 20 l with the addition of 1x first strand buffer, 5 mM 
MgCl2, 10  mM DDT, 40 U RNase OUT (Invitrogen) and either 200 U Superscript III 
reverse transcriptase or RNase free H2O as a control. The mixture was then incubated at 
25 
o
C for 10 min, 50 
o
C for 50 min and 85 
o
C for 5 min (to inactivate the reverse 
transcriptase). The reaction was then cooled on ice. To remove any remaining RNA 
template, 5 U RNase H (NEB) was added to the reaction and the reaction incubated for 
a further 20 min at 37 
o
C. Finally the cDNA was purified using the Gel Extraction Kit 
(Qiagen) according to manufacturer’s instructions. 
Following cDNA synthesis, it is necessary to polyA tail the cDNA product. This 
allows amplification of the cDNA from GSP1 to the unknown 5’ end of the cDNA. A 
polyT- anchor primer complementary to the polyA tail of the cDNA and a GSP2, which 
anneals upstream of GSP1, are required to amplify this product. To polyA tail the 
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cDNA, 12.5 l cDNA was added to 1x Terminal Deoxynucleotidyl Transferase (TDT) 
buffer, 0.5 mM CoCl2, 0.5 mM dATP and 25 U Terminal Transferase (NEB). The 
reaction was incubated at 37 oC for 15 min and then 70 oC for 10 min to inactivate the 
terminal transferase. To amplify the resulting product, the anchor primer SM044 and 
the GSP2 primers NSW 697a (alb2) and NSW698 (alb1) were used. 5 l polyA tailed 
cDNA was added to 0.63 M SM044, 0.63 M GSP2, 0.1 mM dNTPs, 1x PCR buffer 
(Roche), 1.18 U Taq polymerase (Roche) and H2O to a total of 50 l. Reactions were 
then incubated as described in Table 2.12. 
Table 2.12 Cycling conditions for PCR amplification of polyA tailed cDNA for 
5’RACE 
Step Temperature Time (Min:Sec) Cycles 
Denaturation 95 
o



































Final elongation 72 
o
C 7:00 1 
 
The presence of a PCR product was confirmed by agarose gel electrophoresis. It 
was determined that a second round of PCR was necessary to increase the quantity of 
product. This PCR was performed using the anchor primer SM045 and the GSP3 
primers NSW685 (alb2) and NSW699 (alb1). 1 l of PCR product from the previous 
reaction was added to 0.63 M SM045, 0.63 M GSP3, 0.1 mM dNTPs, 1x PCR buffer 
(Roche), 1.18 U Taq polymerase (Roche) and H2O to a total of 50 l. Reactions were 
then incubated as described in Table 2.13. 
. 





Table 2.13. Cycling conditions for second PCR amplification of polyA tailed cDNA 
for 5’RACE 
 Step Temperature Time (Min:Sec) Cycles 
Denaturation 95 
o

















C 5:00 1 
 
The final PCR products were run on an agarose gel and the major bands purified 
by gel extraction (2.4.1.7). It should be noted that 3 major bands could be observed 
from the alb2 PCR. All three bands were excised. The purified products were then 
cloned into pGEM-T Easy Vector (Promega) according to manufacturer’s instructions. 
10 plasmids from two independent rounds of 5’RACE were sequenced and the 
transcriptional start site was defined as the point at which the sequence of interest was 
no longer homologous to the upstream region of the relevant gene and instead became 
the polyA tail.  
2.7 Protein methods 
 
2.7.1 SDS polyacrylamide gel electrophoresis 
The Bio-Rad mini-PROTEAN II System was used to separate proteins under 
denaturing conditions by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
(Laemmli, 1970). The 15 % resolving gel for SDS-PAGE contained the following: 15 % 
(v/v) Acrylamide; 375 mM Tris-HCl pH 8.8; 0.1 % (v/v) SDS; 0.1 % (v/v) ammonium 
persulfate (APS); 0.04 % (v/v) Tetramethylethylenediamine (TEMED) and H2O to a 
total volume of 10 ml. The resolving gel was poured to approximately 2 cm from the 
top between the two glass plates. Ethanol was applied to the top of the resolving gel to 
ensure a level gel. The ethanol was removed following polymerisation of the gel. The 
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stacking gel for SDS-PAGE contained the following: 5 % (v/v) acrylamide, 125 mM 
Tris-HCl pH6.8, 0.1 % (v/v) SDS, 0.1 % (v/v) APS, 0.1 % TEMED and H2O to a total 
volume of 6 ml. Prior to loading, protein samples were mixed with the appropriate 
volume of Laemmli sample buffer (Table 2.6. Buffers and Solutions) and boiled for 5 
min. Protein samples were run against 6 l of Precision Plus Protein All Blue standards 
marker (Biorad). The gels were run in 1x SDS-PAGE running buffer (Table 2.6) for 15 
min at 100 V, then for approximately 1 hour at 180 V. 
2.7.2 Coomassie staining of polyacrylamide gels 
Visualisation of proteins separated by electrophoresis through SDS-PAGE gels 
was achieved by staining with coomassie (Table 2.6. Buffers and Solutions.). Gels were 
incubated for 12 min with boiling coomassie and gentle shaking. To remove non-
specifically bound stain, the gels were washed twice briefly with boiling H2O and then 
washed overnight in H2O. 
 
2.7.3 Immunoblotting 
Immunoblotting was conducted in order to detect TssD in cellular and secreted 
supernatant fractions and to detect Ssp2 in secreted supernatant samples. TssD cellular 
and supernatant samples were prepared as follows: an overnight low salt LB culture of 
the strain of interest was grown at 30 
o
C with shaking at 200 rpm and the following 
morning was diluted 1 in 200 in 25 ml low salt LB. This culture was grown for 7 hours 
in low salt LB medium with shaking at 200 rpm at 30
o
C. The OD600 of the culture was 
then measured. Cellular samples were prepared by harvesting cells in 100 l culture by 
centrifugation at 13,500 rpm for 1 min. The resulting cell pellet was then re-suspended 
in 200 l Laemmli sample buffer and boiled for 10 min. Supernatant samples were 
prepared by centrifugation of a 1 ml sample of culture. 100 l cell free supernatant was 
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then mixed with 100 l Laemmli sample buffer and boiled for 10 min. To ensure equal 
volumes of protein were loaded, 6 l of sample were loaded per OD600 5. 
To prepare Ssp2 protein samples, an overnight low salt LB culture of the strain 
of interest was grown at 30 
o
C with shaking at 200 rpm and the following morning was 
diluted 1 in 200 in 25 ml low salt LB. This culture was grown for 7 hours in low salt LB 
medium with shaking at 200 rpm at 30 
o
C. 20 ml culture was centrifuged at 16,000 rpm 
for 20 min to harvest the cells. 15 ml of the resulting supernatant was then mixed with 
15 ml 1:1 (v/v) chloroform : methanol. This mix was centrifuged at 4,000 rpm for 5 min 
resulting in the secreted protein forming an interface between the aqueous layer at the 
top and the chloroform layer at the bottom. The liquid was removed from the 
precipitated protein and the protein pellet then washed in 1 ml methanol. The protein 
precipitate was again harvested by centrifugation at 13,500 rpm for 2 min and then re-
suspended in 200 l Laemmli sample buffer. 
Following SDS-PAGE, proteins were transferred onto polyvinylidene difluoride 
(PVDF) membrane (Millipore). Electroblotting was performed using the Mini Trans-
Blot Electrophoresis Transfer (Biorad) and transfer buffer (Table 2.6). The PVDF 
membrane was activated in 100 % methanol and rinsed in transfer buffer. The transfer 
cassette was then assembled as follows: transfer sponge-paper-gel-PVDF-paper-transfer 
sponge (cathode side up). Proteins were transferred at 4
o
C for 90 min at 250 mA. 
Following transfer of the proteins, the PVDF membrane was washed briefly in PBST 
(Table 2.6) and then incubated for 1 hour at room temperature in 5 % (w/v) milk 
powder in TBST. To detect Hcp or Ssp2, the PVDF membrane was then incubated with 
the primary antibiody (Table 2.7) in 5 % (w/v) milk powder in PBST for 1 hour at room 
temperature. The membrane was then washed briefly 3 times and then 4 times for 5 min 
in PBST. The PVDF membrane was then incubated with the secondary antibody (Table 
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2.7) in PBST for 1 hour at room temperature. The membrane was washed again, as 
before, in PBST prior to the detection of proteins using a chemiluminescent detection 
kit (Millipore) according to manufacturer’s instructions. The PVDF membrane was then 
exposed to X-ray film and developed using a Medical Film Processor SRX-101A 
(Konica Minolta). 
2.7.5 Mass spectrometry 
To identify protein bands in Coomassie gels, bands were excised from SDS-
PAGE gels and subjected to in-gel trypsin digestion followed by one-dimensional nLC-
ESI-MS/MS using a 4000 QTrap (Applied Biosystems) tandem mass spectrometry 
system by the FingerPrints Proteomics Facility at the College of Life Sciences, 
University of Dundee. The raw data was analysed using MASCOT software for protein 
identification. Proteins were identified using a combination of the highest MASCOT 
score and maximum peptide coverage. 
 
2.8 UHPLC-ESI-TOF-MS analysis to identify althiomycin 
5 ml of low salt LB was inoculated with 10 µl of overnight culture and the 
resulting culture was grown for 48 hours under the same conditions. Supernatant and 
methanol extracts of biomass were analysed by LC-MS on a Dionex 3000RS UHPLC 
coupled to a Bruker MaXis Q-TOF mass spectrometer. A Sigma Ascentis Express 
column (C18, 150 x 2.1 mm, 2.7 µm) was used. Mobile phases consisted of A (water 
containing 0.1% formic acid) and B (methanol containing 0.1% formic acid). A gradient 
of 20% B to 100% B in 15 minutes was employed with a flow rate of 0.2 ml/min. 
Absorbance at 270 nm was monitored. The mass spectrometer was operated in 
electrospray positive ion mode with a scan range of 50-2,000 m/z. Source conditions 
were: end plate offset at -500V; capillary at -4500V; nebulizer gas (N2) at 1.6 bar; dry 
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gas (N2) at 8 L/min; dry Temperature at 180 °C. Ion tranfer conditions: ion funnel RF at 
200 Vpp; multiple RF at 200 Vpp; quadruple low mass at 55 m/z; collision energy at 5.0 
ev; collision RF at 600 Vpp; ion cooler RF at 50-350 Vpp; transfer time at 121 µs; pre-
Pulse storage time at 1 µs. Calibration was performed with sodium formate (10 mM) 
through a loop injection of 20 µL of standard solution at the beginning of each run. 
 
2.9 Purification of althiomycin by HPLC for NMR 
Althiomycin was purified from the supernatant of a spent LB culture by semi-
preparative HPLC (Agilent Zorbax, RP-C18, 100 x 21 mm, 5 µm) on an Agilent 1100 
instrument. Mobile phases consisted of A: water containing 0.1% formic acid and B: 
methanol containing 0.1% formic acid. The flow rate was 5 ml/min and absorbance at 
270 nm was monitored. A gradient of 20% B (see above) to 100% B in 25 minutes was 
employed for the first purification. Fractions containing althiomycin were identified by 
MS and pooled. The pooled fractions were freeze-dried after solvent removal at reduced 
pressure; the dried material was then dissolved in a small volume of methanol and re-
purified on the same column with a gradient of 60% B to 100% B over 25 minutes. 
Fractions containing althiomycin were freeze-dried and dissolved in 200 µl of d6-
DMSO for NMR analysis 
2.10 Phenotypic assays 
 
2.10.1 Growth curves 
Growth curves were performed to determine whether novel strains carried a 
growth defect. An overnight low salt LB culture of the strain of interest was grown 
overnight and the following morning was diluted 1 in 200 in 180 l low salt LB in a 96 
well plate. A Synergy 2 plate reader (Biotek) was used to incubate the plate at 30 
o
C 
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with continuous shaking. OD600 readings were taken every 20 min for 16 hours and 
results were then plotted on a logarithmic scale. 
 
2.10.2 Antibacterial bioassay 
Antibacterial bioassays were performed to determine whether the S. marcescens 
strain of interest was capable of producing of antibacterial metabolites. Both the S. 
marcescens strain and the bacterial strain used as the indicator lawn (B. subtilis, M. 
luteus or S. aureus) were grown in the appropriate media for 7 hours at the appropriate 
temperature. 100 l of the indicator lawn was then spread onto an LB plate (B. subtilis 
and M. luteus) or a TSA plate (S. aureus), supplemented with antibiotics as required, 
and the plate allowed to dry. 10 l of the S. marcescens culture was then spotted on top 
of the indicator lawn and the spots allowed to dry. Plates were then incubated at 30 
o
C 
for 16 hours (B. subtilis and S. aureus) or 30 hours (M. luteus). Photographs of plates 
were acquired with a Nikon D600 camera. 
 
2.10.3 Competition assays 
S. marcescens Db10 attacker and S. marcescens Db10, P. fluorescens and S. 
marcescens 274 target strains were grown overnight (S. marcescens) or for 48 hours (P. 
fluorescens) on an LB plate at 30 
o
C. Cells on the plate were harvested and re-
suspended in LB, normalized to an OD600 of 0.5 and mixed at a ratio of 5:1 attacker : 
target. 25 l of the mixture was then spotted onto an LB plate and incubated for 4 hours 
at 30 
o
C (P. fluorescens and S. marcescens 274) or for 16 hours at 30 
o
C (S. 
marcescens). A control containing LB rather than the attacker strain was also included. 
Cells were recovered from the spot and re-suspended in 1 ml low salt LB. Dilutions 
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were made and cells were plated onto the LB Strep plates to enumerate surviving target 
bacteria. The recovery of surviving cells is reported as the total number of bacterial 
target cells recovered per co-culture spot. 
 
2.10.4 Chrome azurol S (CAS) assay   
S. marcescens strains being tested for siderophore biosynthesis were grown to 
stationary phase at 30
o
C and 10 µl of culture was spotted on to the CAS agar plate. The 
plates were incubated (15 h) at 30
o
C prior to photography. For the complementation 
analysis, plasmids were maintained by the addition of Kan to culture media and to the 
CAS agar plates. 
 
2.11 Microscopy 
Cells were prepared for microscopy in one of two ways. For initial imaging of 
the mCherry protein fusion strains (SAN157, SAN158, SAN159, SAN162, SAN163, 
SAN164, SAN166 and SAN186), cells were plated onto LB and incubated for 16 hours 
at 30 
o
C. The following morning, cells were harvested from the plate and re-suspended 
in 1 ml 1x PBS. These cells were then diluted 1 in 10 in 1x PBS. 2 ml of this diluted cell 
suspension was spotted onto a 1.5 % agarose pad prior to microscopy. To optimize 
microscopy conditions, the relevant bacterial strains were grown overnight in low salt 
LB. The following morning the cultures were diluted to an OD600 of 0.15 in 25ml 
minimal media glucose (Table 2.3). Cells were grown for approximately 4 hours at 
30
o
C with shaking at 200 rpm and 1.5 l of the cell suspension then was spotted onto a 
minimal media glucose pad solidified through the addition of 1.5 % agarose. SAN157, 
SAN159, SAN162, SAN163, SAN199, SAN207, SAN208, SAN209 and SAN210 were 
imaged under optimized microscopy conditions. Cells were grown for timelapse 
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fluorescence microscopy as for static imaging. Prior to imaging, the cell culture was 
diluted to an OD600 of 0.007. 1.5 l of the cell suspension then was spotted onto a 
minimal media glucose pad solidified through the addition of 1.5 % agarose. Cells were 
allowed to equilibriate on the slide for 1 hour prior to imaging. Images were acquired 
using a DeltaVision Core widefield microscope (Applied Precision) mounted on an 
Olympus IX71 inverted stand with an Olympus 100X 1.4 NA lens and Cascade2_512 
EMCCD camera (Photometrics), with Differential interference contrast (DIC) and 
fluorescence optics.   Datasets (512 × 512 pixels with 13  Z sections spaced by 0.2 µm 
were acquired.  GFP and mCherry were detected using a 100 W mercury lamp and an 
FITC (fluorescein isothiocyanate) filter set (excitation 490/20; emission 528/38) and a 
TRITC (Tetramethylrhodamine) filter set (excitation 555/28; emission 617/73), 
respectively. DIC images were acquired with an LED Transmitted light source (Applied 
precision) at 32 % intensity and exposure times between 25 and 100 ms. Post-
acquisition data sets were rendered and analysed using OMERO software 
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Althiomycin is a broad-spectrum antibiotic that was first identified as a product 
of Streptomyces althioticus in 1957. The X-ray crystal structure of the molecule was 
solved in 1974 (Sakakibara et al., 1974) and the total chemical synthesis of althiomycin 
and analogues has been achieved (albeit with low efficiency) (Inami & Shiba, 1985; 
Zarantonello et al., 2002). However, despite being identified more than 50 years ago, 
prior to the initiation of this project, the mechanism of althiomcyin biosynthesis was 
unknown. Difficulties encountered during the chemical synthesis of althiomycin and the 
lack of availability of a genetically tractable producing organism likely hampered 
further studies into the medical potential of this antibiotic. The work presented in this 
chapter delineates the biological pathway for althiomycin synthesis in S. marcescens 
Db10 and was performed in collaboration with Gregory Challis and Lijiang Song 
(University of Warwick). Additionally, we investigate the role of alb1 in althiomycin 
resistance and export. Whilst this project was underway, work was published describing 
the mechanism of althiomycin biosynthesis in the Gram-negative -proteobacteria, 
Myxococcus xanthus, and so a comparison of the proposed mechanism of althiomycin 
biosynthesis in both bacteria is discussed. Finally, the biotechnological potential for 
exploitation of the althiomycin NRPS/PKS biosynthetic proteins is considered. 
 
3.2 Identification of the althiomycin biosynthetic gene cluster 
3.2.1 S. marcescens Db10 is able to inhibit growth of Gram-positive bacteria 
It was serendipitously discovered that S. marcescens Db10 produced a diffusible 
molecule capable of inhibiting the growth of the Gram-positive soil bacterium Bacillus 
subtilis (Figure 3.13.A). To establish whether or not this effect was restricted to B. 
subtilis, the analysis was extended to include the Gram-positive human pathogen 
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Staphylococcus aureus and Gram-positive human commensal Micrococcus luteus, 
revealing that these organisms are indeed also susceptible (Figure 3.13.A). To establish 
the point in growth at which S. marcescens Db10 produced the molecule capable of 
inhibiting the growth of B. subtilis, the presence of this activity in the cell-free culture 
supernatant was assayed over 8 hours of growth. From this it was established that the 
activity was detectable in the stationary phase of growth, consistent with the diffusible 
compound being a secondary metabolite (Figure 3.13.B). On the basis of these 
experiments it was concluded that S. marcescens Db10 was capable of inhibiting the 
growth of Gram-positive bacteria by biosynthesis of a diffusible compound with 
antimicrobial activity. 
 
Figure 3.13 Serratia marcescens Db10 is able to inhibit growth of Gram-positive bacteria. 
A. Activity assays using Bacillus subtilis NCIB3610, Staphylococcus aureus 113 and 
Micrococcus luteus ATCC4698 as indicator strains, with S. marcescens Db10 or S. marcescens 
Db10 SMA2290::Tn5 (NRS2992) as the producer strains. B. Culture supernatant assays 
(described in experimental procedures) indicate the diffusible molecule is produced by S. 
marcescens Db10 in stationary phase. Clearance halo sizes (radius of cleared area) are averages 
of three replicates; error bars represent standard error of the mean. A representative growth 
curve is shown for reference.  
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3.2.2 Isolation of a mutant of S. marcescens Db10 unable to produce antimicrobial 
activity 
Based on the hypothesis that S. marcescens Db10 synthesized and secreted an 
antimicrobial compound, random transposon mutagenesis was used to screen for mutant 
isolates of S. marcescens Db10 that could no longer inhibit the growth of B. subtilis and 
S. aureus. Six mutants were isolated exhibiting reduced killing activity towards both B. 
subtilis NCIB3610 and S. aureus 113 (e.g. Figure 3.13.A). To ensure that disruption of 
the killing activity was associated with the transposon insertion, bacteriophage-
mediated transduction was used to introduce one of the Tn5 insertions back into wild 
type S. marcescens Db10. The resulting strain (SJC13) displayed an identical phenotype 
to the original Tn5 isolate (data not shown). Therefore we concluded that the lack of 
bioactivity was directly associated with the transposon insertion. The location of the 
transposon insertion in all six of the isolated transposon mutant strains was mapped, by 
interrogation of the publicly-available complete genome sequence of S. marcescens 
Db11 (Sanger Institute, UK). All of the insertions were located within the coding region 
of SMA2290 (Figure 3.14). In each case the site of insertion was identical, indicating 
that the strains were most likely clonal isolates. 
 
Figure 3.14. Map of the alb operon. Genes belonging to the alb operon are indicated as light 
grey arrows, genes that do not belong to the alb operon are indicated as dark grey arrows. Each 
gene is shown to scale. The transcription start site is shown as a black arrow. The site of the 
transposon (Tn) insertion (at nucleotide 2745) in alb4 is indicated with a grey triangle.  
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3.3 Characterisation of the althiomycin biosynthetic operon 
3.3.1 alb1-alb6 (SMA2293-2288) constitute an operon 
Examination of the genetic context of SMA2290 revealed it was the fifth of 
seven genes on the same strand (Figure 3.14), and thus likely part of a biosynthetic 
operon. To define the 5’ boundary of the operon responsible for the biosynthesis of the 
potential antimicrobial compound, RT-PCR analysis was used. This was performed 
using cDNA synthesized from mRNA isolated from S. marcescens Db10 and S. 
marcescens Db10 SMA2292::Tn5 (NRS2922). Primers designed to span the intergenic 
regions between 1) SMA2294 and SMA2293; and 2) SMA2293 and SMA2292 were used 
to assess co-transcription. In addition, primers designed to amplify internal coding 
regions of SMA2294, SMA2293, SMA2292, SMA2290, SMA2289 and SMA2288 were 
used to confirm that the gene in question was expressed. The evidence suggests that 
SMA2293-SMA2288 form a single operon since SMA2293-SMA2292 are co-transcribed 
(Figure 3.15), there is less than 5 bp between SMA2292-SMA2291 and SMA2290-
SMA2289, and translational coupling is observed between SMA2291-SMA2290 (see 
below). Furthermore while there is a 146 bp intergenic gap between SMA2289-
SMA2288, SMA2288 is clearly needed for maximal althiomycin biosynthesis (see 
below) and insertion of the transposon in SMA2290 disrupted transcription of both the 
downstream genes SMA2289 and SMA2288 (Figure 3.15). We renamed genes 
SMA2293-SMA2288 as alb1-alb6 for althiomycin biosynthetic cluster. Interestingly, the 
GC content of the althiomycin biosynthetic gene cluster was determined to be 55.1%, 
compared with the average GC content of the genome which is 59.5%. These data 
perhaps suggest that the alb1-6 genes have been horizontally acquired. 
  






Figure 3.15 RT-PCR analysis of the biosynthetic gene cluster. The template used in the PCR 
reaction is indicated above the gels as Db10 (wild type Serratia marcescens Db10 cDNA) or 
transposon (Tn5 mutant cDNA). Reactions were performed in the presence (+) and absence (-) 
of reverse transcriptase. Con. represents S. marcescens Db10 genomic DNA as a positive 
control (+) and water as a negative control (-). The region of the chromosome amplified is 
indicated to the left of each gel. Primers were designed to amplify a product internal to a single 
gene, or spanning the intergenic region between two genes. Twenty five cycles of PCR 
amplification were used with the exception of SMA2294 and SMA2294-alb1 where 30 cycles 
were used.  
 
3.3.2 A transcriptional start site is present upstream of alb1 
The above findings indicated that SMA2294 was not co-transcribed with alb1 
and that a promoter element should be present in the 305 bp gap between the stop codon 
of SMA2294 and start codon of alb1 to drive expression of alb1-alb6. To determine the 
location of the transcription start site, rapid amplification of cDNA 5’ ends (5’ RACE) 
was performed. The transcription start site was localised to -40 bp upstream and either -
41 bp or -42 bp upstream of the alb1 translation initiation codon (Figure 3.16). It is not 
possible to distinguish between the -41 bp or -42 bp sites because the anchor primer that 
is needed for the 5’ RACE contains a series of thymine residues, which cannot be 
distinguished from the thymine residue at position -42 bp in the promoter region by 
sequencing (Figure 3.16). Putative -10 and -35 binding sites for RNA polymerase were 
identified (Figure 3.16). The -10 region (TAGTTT) shows a three out of six base pair 
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match to the consensus sequence of TATAAT, whilst the -35 region (TTTACA) shows 
a five out of six base pair match to the consensus sequence of TTGACA. There is a 98 
bp gap between the stop codon of alb1 and the start codon of alb2 but when 5’ RACE 
was applied to the region upstream from the alb2 translation start site, no transcription 
initiation site could be identified (not shown). Taken together the data strongly indicate 
that alb1-alb6 are co-transcribed, with alb6 forming the final gene in the operon. 
 
 
Figure 3.16 5’ RACE analysis to identify the transcriptional start site of the alb operon. 
The region upstream of the alb1 gene highlighted with a broken box, the corresponding 
sequence is shown the methionine start codon is boxed. Asterisks indicate the number of times a 
particular base was identified as the transcriptional start site. Putative -10 and -35 regions are 
highlighted by a broken box. The -41 bp and -42 bp start sites are highlighted together as it is 
not possible to distinguish between these sites more specifically (see text).  
 
3.4 Predictive sequence analysis of alb gene products  
The likely functions for each of the gene products in the alb1-alb6 operon were 
deduced by sequence comparisons with proteins of known function. This analysis 
predicted that the operon encodes a three protein hybrid NRPS-PKS assembly line 
(alb4, alb5 and alb6), associated tailoring enzymes (alb2 and alb3) and an export and/or 
resistance protein (alb1). One of the genes encoding the hybrid NRPS-PKS 
multienzyme (alb4) was disrupted by the transposon insertion. The Alb4-5 NRPS-PKS 
multi-enzyme comprises six modules, the first two in Alb4 and the remainder in Alb5 
(Figure 3.17). The first five modules are typical NRPS modules predicted to 
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sequentially incorporate Gly, Cys, Ser, Cys and Gly residues (Challis et al., 2000; 
Stachelhaus et al., 1999), with heterocyclisation of the two cysteine residues and 
oxidation to the thiazole of the thiazoline resulting from the first. The final module is a 
PKS module and is predicted to incorporate a malonyl unit (Haydock et al., 1995). The 
thioesterase domain at the end of Alb5 is hypothesized to catalyse release of the fully 
assembled chain (see below). The products of the alb2 and alb3 genes are predicted to 
act as ‘tailoring’ enzymes which further modify the NRPS-PKS-generated intermediate. 
Alb3 is predicted to be a SAM-dependent methyltransferase, whereas Alb2 is predicted 
to be an N-oxygenase, exhibiting 41% sequence similarity to the aureothin biosynthetic 
enzyme AurF of Streptomyces althioluteus (Krebs et al., 2007). AurF is a diiron-
dependent oxygenase that catalyses the 6-electron oxidation of 4-aminobenzoic acid to 
4-nitrobenzoic acid. The product of alb6 is predicted to function as a Type II 
thioesterase which likely represents an external ‘editing’ thioesterase. The alb1 gene is 
predicted to encode a member of the major facilitator superfamily of membrane 
proteins, suggesting a possible role in self-resistance or efflux, as discussed further 
below. 
Database searches for known compounds with structural similarity to the 
intermediates predicted to be assembled on the module 6 ACP domain suggested 
althiomycin (or a closely related molecule) as the likely metabolic product of the alb 
gene cluster. The conversion of the intermediate attached to the ACP domain of module 
6 to althiomycin can be hypothesised to occur via Alb2-catalysed oxidation of the 
amino group in the intermediate to the corresponding oxime, followed by Alb3-
mediated O-methylation. Subsequent TE-catalysed cyclisation of the resulting 
intermediate would afford althiomycin (Figure 3.17). 




Figure 3.17. Proposed pathway for althiomycin biosynthesis in Serratia marcescens Db10. 
Alb4 and Alb5 form a hybrid NRPS-PKS assembly line, which consists of six modules as 
indicated. Domains within the NRPS-PKS are as follows. A: adenylation; PCP: peptidyl carrier 
protein; C: condensation; Cy: condensation/heterocyclisation; Ox: flavin-dependent oxidase; E: 
epimerisation; KS: ketosynthase; AT: acyl transferase; ACP: acyl carrier protein; TE: 
thioesterase. Alb6 (not shown) likely functions as an external ‘editing’ thioesterase. Alb3 is 
similar to known S-adenosylmethionine (SAM)-dependent methyltransferases and Alb2 is 
similar to known oxidases. The fact that no althiomycin-related compounds accumulate in 
alb2/alb3 mutants suggests that N-oxidation and O-methylation take place in trans during chain 
assembly on the hybrid NRPS-PKS. However, the precise timing of the N-oxidation reaction is 
currently unclear.  Analysis performed in collaboration with Greg Challis and Lijiang Song, 
University of Warwick.  




3.5 Identification of the antimicrobial metabolite as althiomycin  
To determine whether the metabolic product of the alb gene cluster is 
althiomycin, ultra high resolution UHPLC-ESI-TOF-MS analysis of the culture 
supernatant from the wild-type strain and the alb4 transposon mutant of S. marcescens 
Db10 was performed. This identified a compound present in the wild type, but lacking 
in the alb4 transposon mutant, that yields an ion with the same molecular formula as 
protonated althiomycin (calculated m/z for C16H18N5O6S2
+
: 440.0688, observed: 
440.0693 and Figure 3.18).  
 
Figure 3.18 Spectroscopic analysis of althiomycin produced by Serratia marcescens Db10. 
A. Extracted ion chromatograms at m/z=440.0600 for wild type and the alb4 transposon mutant 
strain (NRS2992) of S. marcescens Db10 B. Top panel: high resolution mass spectrum of 
althiomycin detected in culture supernatant of S. marcescens Db10. Bottom panel: simulated 
mass spectrum for the C16H18N5O6S2
+
 ion. Analysis performed in collaboration with Greg 
Challis and Lijiang Song, University of Warwick.  
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In order to unambiguously identify the metabolite as althiomycin, NMR 
spectroscopic analysis was performed on HPLC purified material (Figure 3.19). Due to 
the rich medium used for production, some impurities were present. Nevertheless, 
careful inspection of 
1
H, COSY, HBMC and HSQC spectra confirmed that the 
compound is althiomycin (Figure 3.19).  
 
Carbon  δH(ppm) δC (ppm)* HMBC Literature (Cortina et al., 
2011) 
δH(ppm) δC (ppm) 
1 8.37(s) 143.0 C2 8.37(s) 143.2 
2  162.6   162.6 
3 8.29 (s) 124.8 C2, C5 8.35(s) 125.3 
4  149.6   149.7 
5  160.4   159.8 
C5-NH-C6 8.39(br)  C5, C6 8.41(m)  
6 4.84(m) 53.5 C5, C7, C8 4.88(m) 53.9 
7 3.79(m) 61.8 C6, C8 3.80(m) 62.2 
8  173.5   173.4 
9 3.40/3.58(m) 34.9 C8, C10, 
C11 
3.40/3.58(m) 34.6 
10 6.14(t, 8.6) 77.8 C8, C9, C11 6.16(m) 78.0 
11  168.1   168.3 
12  169.5   169.6 
13 5.39(s) 94.3 C12, C15, 
C16 
5.43(m) 94.4 
14  177.2   177.2 
15 4.29(s) 47.9 C11, C12, 
C13, C14 
4.33(m) 48.0 
16 3.88(s) 58.9 C14 3.88(s) 59.2 
Figure 3.19 NMR assignment for althiomycin (DMSO-d6, 700MHz, 25°C). * Carbon shift 
obtained from HSQC and HMBC. Analysis performed in collaboration with Greg Challis and 
Lijiang Song, University of Warwick.  
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To further confirm that the lack of althiomycin production in the alb4 Tn5 
mutant was due solely to disruption of the althiomycin biosynthetic gene cluster, an in-
frame alb4-5 deletion strain (SAN5) was constructed. First, the ability of the alb4-5 
deletion strain to inhibit the growth of B. subtilis was assessed. It was observed that the 
alb4-5 strain was unable to inhibit the growth of B. subtilis either when directly 
spotted onto an indicator lawn (Figure 3.20.A) or when the culture supernatant was 
harvested and tested in the bioassay (data not shown). Second, ultra high resolution 
UHPLC-ESI-TOF-MS analysis showed that althiomycin was lacking from the culture 
supernatant of the alb4-5 mutant (Figure 3.20.A). These findings unequivocally 
demonstrate that production of althiomycin is dependent on the alb gene cluster. 
 
Figure 3.20. Alb4-5 are required for the biosynthesis of althiomycin. A. Assay to assess 
antimicrobial activity of Serratia marcescens Db10 and the alb4-5 mutant strain (SAN5) against 
Baccilus subtilis 3610. B. Extracted ion chromatograms at m/z=440.0600 for wild type and the 
alb4-5 mutant strain (SAN5) of S. marcescens Db10. Analysis performed in collaboration with 
Greg Challis and Lijiang Song, University of Warwick.  
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3.6 The tailoring enzymes Alb2, Alb3 and Alb6 are required for althiomycin 
biosynthesis 
Alb4 and Alb5, comprising the core NRPS-PKS machinery, are clearly required 
for althiomycin biosynthesis. To determine whether Alb2, Alb3 and Alb6 are also 
needed to produce althiomycin, in-frame deletions of alb2, alb3 and alb6 were 
constructed by allelic exchange. Similar to the alb4-5 mutant strain, the alb2 
andalb3 strains no longer exhibited antimicrobial activity towards B. subtilis (Figure 
3.21.A). The lack of althiomycin production was confirmed using ultra high resolution 
UHPLC-ESI-TOF-MS analyses (data not shown). Interestingly, no potential 
intermediates in althiomycin biosynthesis could be detected in the culture supernatant of 
either mutant, suggesting that the modification reactions may occur on intermediates 
that are covalently attached to the assembly line. It is also possible that non-oxidised or 
non-methylated intermediates are not detected in the culture supernatant because they 
are unstable. However, it is unlikely that retention within the cell is responsible for our 
inability to detect potential intermediates because they were not detectable in cellular 
extracts either (data not shown). In contrast with the S. marcescens Db10 alb2 and 
alb3 mutant analysis, bioassays indicated that in the alb6 mutant strain a small 
amount of antimicrobial activity was retained (Figure 3.21.A). Ultra high resolution 
UHPLC-ESI-TOF-MS analyses confirmed that althiomycin production in the alb6 
mutant strain was roughly 10% that of the wild type Db10 strain (Figure 3.21.B). These 
results indicate that alb2 and alb3 are essential for althiomycin production whereas 
Alb6 increases the efficiency of the process.  
 




Figure 3.21. Analysis of alb mutant strains of Serratia marcescens Db10. A. Assay to assess 
antimicrobial activity of S. marcescens Db10 and the alb1 (SAN2), alb2 (SAN3), alb3 (SAN4), 
alb4-5 (SAN5) and alb6 (SAN60) mutant strains against Bacillus subtilis 3610. B. Comparison 
of the extracted ion chromatogram at m/z 440.0600 for wild type S. marcescens Db10 (red line) 
and Db10 alb6 (SAN60) (blue line). Analysis performed in collaboration with Greg Challis 
and Lijiang Song, University of Warwick.  
 
To confirm that the loss of althiomycin production in each of the mutant strains 
directly resulted from the in-frame deletion constructed, genetic complementation 
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analysis was performed. To this end, medium-copy number plasmids carrying the 
complete alb2, alb3 and alb6 coding regions were introduced into the alb2, alb3 and 
alb6 strains, respectively, and the bioassay was performed. The growth inhibition 
activity in all cases was restored (Figure 3.22.B). Interestingly, in the case of alb3, on 
construction of an almost-complete in-frame deletion, alb3 (SAN4), in which only a 
fusion of the first three and final ten amino acids remained, the althiomycin defect could 
not be complemented by expression of alb3 in trans (not shown). Given that there is 
only a 21 bp gap between alb3 and alb4, we wondered if there might be translational 
coupling between these two genes. Supporting this idea, in the alb3 mutant, 
transcription of alb4 and alb5 was retained but SDS-PAGE analysis indicated that 
protein bands consistent with Alb4 (266.68 kDa) and Alb5 (597.17 kDa) were no longer 
easily detectable, compared with the wild type (Figure 3.22.A; the identity of Alb4 as 
the primary constituent of the ~250 kDa band in the wild type was confirmed by mass 
spectrometry; not shown). Generation of the alb351-262 mutant (SAN88), missing 211 
amino acids from the middle of the protein and thus preserving in-frame translation of 
the 3’ end of the gene, again abrogated althiomycin production, but this time the defect 
could be complemented be expressing alb3 in trans (Figure 3.22.B). Furthermore, 
consistent with translational coupling between alb3 and alb4, protein bands consistent 
with Alb4 and Alb5 were readily detected in the alb351-262 mutant (SAN88) strain 
(data not shown). This implies tight co-ordination between the production of Alb3 and 
Alb4-5, perhaps to ensure a 1:1:1 stoichiometry of Alb3:Alb4:Alb5 which would be 
consistent with O-methylation of a PKS-bound intermediate. 




Figure 3.22 The tailoring enzymes are required for althiomycin production. A. 
Visualisation of proteins corresponding to the predicted size of Alb4 and Alb5. Total cellular 
protein from Db10 (wild type Serratia marcescens Db10), alb3 (SAN4) or alb4-5 (SAN5) 
mutants was isolated from cultures grown to stationary phase and separated by SDS-PAGE, 
followed by staining with Coomassie blue. B. Activity assays were performed using Bacillus 
subtilis NRS1473 as the indicator lawn. The producer strains used are indicated above as: Db10 
+ VC (S. marcescens Db10 pSUPROM); Db10 + alb2 (S. marcescens Db10 pSAN2); alb2 + 
VC (SAN3 pSUPROM); alb2 + alb2 (SAN3 pSAN2); Db10 + alb3 (S. marcescens Db10 
pSAN3);alb351-262+ VC (SAN88 pSUPROM); alb351-262+ alb3 (SAN88 pSAN3); Db10 
+ alb6 (S. marcescens Db10 pSAN38); alb6 + VC (SAN60 pSUPROM); alb6 + alb6 
(SAN60 pSAN38). ‘VC’ represents the empty vector control.  
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3.7 The role of Alb1 in althiomycin biosynthesis 
3.7.1 Alb1 is not essential in S. marcescens Db10 and the alb1 deletion mutant is 
not sensitive to the effects of althiomycin 
Alb1 is predicted to be a member of the major facilitator superfamily (MFS) of 
membrane proteins. In many cases these proteins act as export or efflux pumps (Fluman 
& Bibi, 2009). In antibiotic producing organisms, resistance genes are commonly 
located within the antibiotic biosynthetic gene cluster (Hopwood, 2007). We therefore 
hypothesised that Alb1 was required for self-resistance to althiomycin and/or export of 
althiomycin from the cell into the surrounding environment. We predicted that if alb1 
was essential for self-resistance, it might not be possible to make an althiomycin-
producing alb1 mutant due to lethality. Of note, it was not possible to construct a alb1 
(almE) mutant in M. xanthus, the authors therefore propose a role for this protein in host 
self-resistance (Cortina et al., 2011). Surprisingly, an alb1 mutant was successfully 
constructed in S. marcescens Db10 and this mutant did not exhibit a growth defect (data 
not shown). To confirm whether alb1 was required for resistance to althiomycin in S. 
marcescens Db10, competition assays and plate bioassays were performed. Competition 
assays involve mixing wild type S. marcescens Db10 and a streptomycin resistant target 
bacterium, coculturing them on the surface of an agar plate and then recovering and 
enumerating the number of surviving target cells (Figure 3.23.A-C) . 




Figure 3.23. The alb1 mutant strain of Serratia marcescens Db10 (SAN2) is not sensitive to 
althiomycin produced by wild type S. marcescens Db10. A-C. Diagram of competition assay 





 and alb1 Strep
R
) are mixed and spotted onto an LB agar plate. B. 
After a period of incubation to allow time for the killer strain to have an effect on the target 
strain, cells from the culture spot are recovered. C. Recovered cells are plated onto selective 
media which allows for the enumeration of the surviving target cells. D. Activity assays were 
performed using alb1 as an indicator lawn and Db10 as the producer strain. E. Recovery of 
viable streptomycin resistant Db10, alb4-5 (SAN5) or alb1 (SAN2) cells after 16 h 
incubation with wild type S. marcescens Db10. Points show means + standard error of the mean 
(n=3).  
 
In contrast to the B. subtilis plate bioassays, when wild type S. marcescens Db10 
was spotted on top of a lawn of the alb1 mutant, no antibiosis halo could be observed 
(Figure 3.23.D). Furthermore, when a competition assay was performed with S. 
marcescens Db10 and streptomycin resistance derivatives of S. marcescens Db10, the 
alb4-5 mutant strain or the alb1 mutant strain, no significant difference in the number of 
cells recovered between  the three target strains could be observed (Figure 3.23.E). 
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Together, these data show that alb1 is not essential to confer resistance to althiomycin 
in S. marcescens Db10. 
 
3.7.2 Transcriptional analysis of alb2-6 in alb1 deletion mutants 
Plate bioassays revealed that upon the deletion of alb1, S. marcescens Db10 was 
no longer able to produce extracellular althiomycin (Figure 3.24.A). These results 
suggested that the alb1 mutant was either unable to biosynthesise althiomycin, or that 
althiomycin was not efficiently exported from the cell. To distinguish between these 
possibilities, we attempted to complement the alb1 mutant phenotype. The alb1 
coding region was expressed in trans using exactly the same vector system as was used 
to successfully complement the alb2, alb351-262 and alb6 mutant phenotypes. However, 
no complementation could be observed, suggesting that althiomycin was not 
biosynthesised in this mutant strain (Figure 3.24.A).  
To investigate why genetic complementation of the alb1 mutant was 
unsuccessful, the impact of deleting each of the alb genes on transcription within the alb 
operon was assessed by RT-PCR using the wild type S. marcescens Db10 and the alb1 
(SAN2), alb2 (SAN3), alb3 (SAN4), alb4-5 (SAN5) and alb6 (SAN60) deletion 
strains. We observed that deletion of alb2-6 had no effect on transcription of other 
genes in the alb gene cluster (Figure 3.24.B). However, in the alb1 strain, we could 
only detect a very low level of transcription from each of the remaining alb genes 
(Figure 3.24.B). Expression of alb1 in trans in the alb1 mutant was not sufficient to 
restore transcription of alb2-6 to wild type levels, thus explaining why it was not 
possible to genetically complement the alb1 mutant strain (Figure 3.24.C). 




Figure 3.24. The deletion of alb1 reduces transcript levels of alb2-6 and this phenotype 
cannot be complemented by expression of alb1 in trans. A. Activity assays using Bacillus 
subtilis NRS1473 as the indicator lawn for the producer strains: Db10 + VC (Serratia 
marcescens Db10 pSUPROM); Db10 + 1 (S. marcescens Db10 pSAN1); 1 +VC (SAN2 
pSUPROM); 1 + 1 (SAN2 pSAN1) B. RT-PCR analysis of alb1-alb6 transcript levels in each 
of the alb mutant strains. The template used in the PCR reaction is indicated above the gels as: 
Db10 (wild type S. marcescens Db10 cDNA); 1 (SAN2(alb1) cDNA); 2 (SAN2 (alb2) 
cDNA); 3 (SAN4 (alb3) cDNA); 4-5 (SAN5 (alb4-5) cDNA); 6 (SAN60 (alb6) 
cDNA). C. RT-PCR analysis of alb1-6 transcript levels in Db10 + VC (S. marcescens Db10 
pSUPROM), Db10 + 1 (S. marcescens Db10 pSAN1), 1 +VC (SAN2 pSUPROM) and 1 +1 
(SAN2 pSAN1). RT-PCR reactions were performed in the presence (+) or absence (-) of reverse 
transcriptase. Con. represents S. marcescens Db10 genomic DNA as a positive control (+) and 
water as a negative control (-). The primer pairs used to amplify a product internal to a 
particular gene are indicated to the right of each gel. Twenty five cycles of PCR amplification 
were used.  




3.7.3 Construction and characterisation of an alb1 mutant which can be 
complemented by expression of alb1 in trans 
The above data indicated that alb1 is not required for self-resistance to 
althiomycin in S. marcescens Db10. However, a region within the coding sequence of 
alb1 is required in cis for the transcription of downstream genes. Since it was not 
possible to conserve transcription of alb2-6 in the complete alb1 deletion mutant, we 
postulated that there may be a regulatory region at either the 5’ or 3’ end of the alb1 
coding region. Accordingly, we constructed two new alb1 mutant strains in which either 
the first (alb15-105 SAN89) or the final 100 amino acids were deleted (alb1295-395  
SAN177) thus retaining the majority of the alb1 coding sequence (Figure 3.25). 
Analysis of the alb15-105 mutant strain revealed it phenocopied the complete alb1 
mutant; extracellular althiomycin could not be detected by the B. subtilis bioassay, 
transcript levels of alb2-6 were reduced (Figure 3.24.A and B) and expression of alb1 in 
trans did not restore althiomycin biosynthesis (data not shown). However, as described 
below, the alb1295-395  mutant exhibited different phenotypic behaviours to the alb1 
and the alb15-105 mutant strains. Alb1 is 400 amino acids in length and thus in the 
alb1295-395 mutant 25% of the full length protein was deleted. This deletion included 
three of 11 predicted transmembrane domains (data not shown). It therefore seemed 
highly likely that deletion of this region of the protein would abolish the function of 
Alb1. To assess the impact of deletion of a functional Alb1 protein, plate bioassays 
were performed and transcript levels of alb2-6 were assessed by RT-PCR. When plate 
bioassays were performed, by comparison with the alb1 and alb15-105 strains, a small 
antibiosis halo could be observed to surround the alb1295-395 mutant. These findings 
indicate that either a small amount of althiomycin was biosynthesised or that export of 
althiomycin was impaired in the alb1295-395 mutant (Figure 3.26.A). Consistent with 
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this finding, RT-PCR analysis of the alb1295-395 mutant revealed that transcription of 
alb2-6 could be detected (Figure 3.26.B). Taking these results together with those 
indicating that S. marcescens Db10 is not sensitive to althiomycin in the absence of alb1 
(Figure 3.23), we predicted that it would be possible to complement the mutant 
phenotype by expression of alb1 in trans. Upon re-introduction of the alb1 coding 
region, extracellular althiomycin could be detected by the B. subtilis bioassay, 
indicating that the presence of Alb1 was sufficient to restore export of althiomycin 
(Figure 3.26.C). Together, these data demonstrate that a region within the 5’ end of alb1 
is required in cis for the transcription of alb2-6 and that Alb1 increases the efficiency of 
althiomycin export from the cell.  
 
Figure 3.25. Schematic representation of alb1 mutant strains constructed. A. Wild type 
alb1, which is 400 amino acids in length. B. The complete alb1 deletion mutant, in which only 
the first three, and the final five amino acids of alb1 are conserved. C. The alb15-105 mutant in 
which 300 nucleotides at the 5’ end of alb1 have been deleted. D. The alb1295-395 mutant in 
which 300 nucleotides at the 3’ end of alb1 have been deleted.  




Figure 3.26. Characterisation of the alb1 mutant strains. A. Activity assays using Bacillus 
subtilis 3610 as the indicator lawn for the producer strains: Db10 (Serratia marcescens Db10), 
1 (alb1 SAN2), 15-105 (alb15-105 SAN89) and 1295-395 (alb1295-395 SAN177). B. RT-PCR 
analysis of alb1-alb6 transcript levels in each of the alb1 mutant strains. The template used in 
the PCR reaction is indicated above the gels as: Db10 (S. marcescens Db10), 1 (alb1 SAN2), 
15-105 (alb15-105 SAN89) and 1295-395 (alb1295-395 SAN177). RT-PCR reactions were 
performed in the presence (+) or absence (-) of reverse transcriptase. Con. represents S. 
marcescens Db10 genomic DNA as a positive control (+) and water as a negative control (-). 
The primer pairs used to amplify a product internal to a particular gene are indicated to the right 
of each gel. Twenty five cycles of PCR amplification were used. C. Activity assays using B. 
subtilis NRS1473 as the indicator lawn for the producer strains: Db10 + VC (S. marcescens 
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Db10 pSUPROM); Db10 + 1 (S. marcescens Db10 pSAN1); 1295-395 +VC (SAN177 
pSUPROM); 1295-395 + 1 (SAN177 pSAN1)  
 
3.7.4 Alb1 is sufficient to confer resistance to extracellularly produced althiomycin 
The above data suggest that Alb1 greatly improves the efficiency of export of 
althiomycin in S. marcescens Db10. We predicted that if Alb1 was sufficient to export 
althiomycin then introduction of the alb1 coding region into a bacterial strain that was 
sensitive to althiomycin should improve resistance. Accordingly, we first tested whether 
S. marcescens ATCC274, a prodigiosin-producing environmental isolate of S. 
marcescens, produced althiomycin. This was assessed using two methods: firstly S. 
marcescens ATCC274 was found to be unable to produce a zone of inhibition in the B. 
subtilis bioassay (Figure 3.27.A). Secondly, PCR using primers specific to the S. 
marcescens Db10 alb gene cluster indicated the alb operon was most likely absent from 
S. marcescens ATCC274 (Figure 3.27.B). Consistent with S. marcescens ATCC274 not 
producing althiomycin, we also showed that it was sensitive to althiomycin produced by 
S. marcescens Db10 (Figure 3.27.C), providing an ideal heterologous background to test 
the role of Alb1. The coding region for Alb1 was expressed in S. marcescens ATCC274 
and resistance of the transformed strain to althiomycin was observed. Introduction of 
Alb1 into S. marcescens ATCC274 was indeed able to eliminate the antimicrobial effect 
of althiomycin, demonstrating that alb1 is sufficient to confer resistance to althiomycin 
in ATCC274 (Figure 3.27.C). Since the zone of growth inhibition surrounding the S. 
marcescens Db10 spot on the S. marcescens ATCC274 lawn was relatively small, we 
generated a strain of Db10 producing higher levels of althiomycin to further confirm 
these results.  The native althiomycin promoter was replaced with the constitutive T5 
promoter on the chromosome of S. marcescens Db10. This strain was found to produce 
increased levels of althiomycin (data not shown). Using this strain as the althiomycin 
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producer, we were able to clearly demonstrate that resistance to althiomycin was 
observed in the S. marcescens ATCC274 strain expressing Alb1 (Figure 3.27.C), most 
likely due to a decrease in the intracellular levels of althiomycin. To summarise, Alb1 is 
not essential to confer resistance to althiomycin in S. marcescens Db10 but increases the 
abundance of extracellular althiomycin. By comparison, S. marcescens ATCC274 is 
sensitive to the effects of althiomycin and the expression of Alb1 is sufficient to confer 
resistance to the presence of extracellularly produced althiomycin. Thus, secondary 
resistance mechanisms to althiomycin that are not present in ATCC274 must exist in S. 
marcescens Db10. 




Figure 3.27. Alb1 is sufficient to confer resistance to althiomycin in Serratia marcescens 
ATCC274. A. Activity assays in which S. marcescens ATCC274 has been grown on top of an 
indicator lawn of Bacillus subtilis 3610. B. PCR on gDNA extracted from S. marcescens Db10 
and ATCC274 using primers specific to the alb gene cluster. The template used in the PCR 
reaction is indicated above the gels as Db10 (S. marcescens Db10) or 274 (S. marcescens 
ATCC274). The primer pairs used to amplify a product internal to a particular gene are also 
indicated above the gel. Twenty five cycles of PCR amplification were used.  C. Activity assays 
using Db10 (S. marcescens Db10 pSUPROM), Db10 4-5 (SAN5 pSUPROM) and Db10 PT5-
alb1-6 (SAN100 pSUPROM) as the producer strain and using ATCC274 + VC (S. marcescens 
274 pSUPROM) and ATCC274 + alb1 (S. marcescens 274 pSAN1) as the indicator lawn. ‘VC’ 
represents the empty vector control.  
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 3.8 Discussion 
We have identified and characterised an NRPS-PKS biosynthetic gene cluster 
(alb1-6) which we demonstrate is required for the production and export of the 
antibiotic, althiomycin, in S. marcescens Db10. The production of althiomycin was 
initially detected as this antibiotic possesses antimicrobial activity against several 
species of Gram-positive bacteria. Although the antimicrobial activity of althiomycin 
was also tested against Gram-negative bacteria, including several strains of E. coli, 
Klebsiella aerogenes and Pseudomonas fluorescens, killing of these strains could not be 
detected (data not shown). These results may indicate that the outer membrane (OM) of 
Gram-negative bacteria, which is intrinsically resistant to many antibiotics, is also 
impermeable to althiomycin. Alternatively or additionally, Gram-negative bacteria are 
known to possess numerous multi-drug resistance (MDR) efflux pumps which may play 
a role in the export of althiomycin (Nikaido, 1994). The latter hypothesis seems 
plausible given that the MFS efflux pump, Alb1, is sufficient to confer resistance to 
althiomycin in S. marcescens 274 (Figure 3.27). 
In addition to delineating the biosynthetic pathway for althiomycin production, 
the role of MFS efflux pump, Alb1, was also defined. Initially, we hypothesised that 
Alb1 was essential for resistance to althiomycin in S. marcescens Db10, since resistance 
determinants are frequently encoded in the same gene cluster as the biosynthetic genes 
and since Alb1 was predicted to encode a member of the MFS family of efflux pumps. 
However, plate bioassays and competition assays revealed that the alb1 deletion mutant 
was not sensitive to extracellularly produced althiomycin (Figure 3.23). These results 
indicate that S. marcescens Db10 possesses alternative resistance mechanisms to 
althiomycin. Since althiomycin is thought to target the bacterial ribosome (Fujimoto et 
al., 1970), S. marcescens Db10 may modify its ribosomes to confer resistance to 
althiomycin, for example by methylation (Vester and Long, 2009). Our finding that the 
Chapter 3: The biosynthesis of althiomycin in Serratia marcescens Db10 
118 
 
deletion of alb1 dramatically reduced transcript levels of alb2-6 seemed to contradict 
the above results; we would otherwise have hypothesised that this phenotype was due to 
a “self-protection mechanism” against the toxic effects of althiomycin in the absence of 
the resistance protein. The function of Alb1 in althiomycin production, resistance and 
export was therefore unclear and further experiments were designed to characterise the 
mechanism behind the alb1 mutant phenotype and the role of Alb1 in althiomycin 
biosynthesis.  
Additional experiments revealed that it was not possible to complement the 
phenotype of the complete alb1 deletion mutant since the transcription of alb2-6 could 
not be restored upon expression of Alb1 in trans. These results indicated that the 
presence of the Alb1 protein alone was not sufficient for transcription of alb2-6 and that 
a region of the alb1 coding region was required in cis for the transcription of 
downstream genes. In light of these results, we attempted to construct an alb1 mutant 
that would no longer synthesise a functional Alb1 protein, but that was competent for 
the transcription of alb2-6. This was achieved by the construction of a strain lacking 
100 amino acids at the C-terminal end of Alb1 (alb1295-395 SAN177). We observed that 
the  alb1295-395 strain produced lower amounts of extracellular althiomycin but that this 
phenotype could be complemented by the expression of alb1 in trans (Figure 3.26). We 
note the difference in the size of the antibiosis halos between the alb1 mutant strains 
(Figure 3.26.A) and the complemented alb1295-395 mutant strain (Figure 3.26.C). To 
maintain the alb1 plasmid in the complementation activity assays, kanamycin was 
added to the media and the B. subtilis indicator strain used was therefore kanamycin 
resistant. In B. subtilis, kanamycin resistance is conferred by the expression of an 
aminoglycoside 3'-phosphotransferase which catalyses phosphorylation of a hydroxyl 
group of kanamycin (Middleton & Hofmeister, 2004; Mingeot-Leclercq et al., 1999). 
The kanamycin resistance cassette is therefore unlikely to additionally confer resistance 
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to althiomycin. However, under conditions of stress, e.g. in the presence of antibiotics, 
bacteria are known to become generally more resilient to the effects of antibiotics 
(Poole, 2012). This may explain why the althiomycin antibiosis halo appears reduced 
when B. subtilis is grown in the presence of kanamycin. Further experiments into the 
role of alb1 revealed that expression in S. marcescens 274 was sufficient to confer 
resistance to extracellularly produced althiomycin, again implicating Alb1 in the export 
of althiomycin. S. marcescens Db10 therefore does not produce althiomycin in the 
absence of the region encoding the protein required for export; this is not due to self-
protection mechanisms but perhaps to avoid the energetically expensive biosynthesis of 
antibiotic that cannot be exported to fulfil its function.  
Our results indicated that a region within the first 300 nucleotides of alb1 were 
required for transcription of alb2-6 (Figure 3.26). Interestingly, experiments conducted 
simultaneously by S. Murdoch (SJC lab, unpublished) suggested a role for the RNA 
binding protein, Hfq, in the regulation of althiomycin production; it was observed that 
the Hfq mutant was unable to kill B. subtilis in the antimicrobial bioassay (data not 
shown). Further analysis of the Hfq mutant revealed that the transcript levels of alb1-6 
were dramatically reduced, similar to the complete alb1 deletion mutant (data not 
shown). Hfq is a global post-transcriptional regulator that facilitates the interaction 
between small regulatory RNA (sRNA) and messenger RNA (mRNA) (Vogel & Luisi, 
2011). It is possible that Hfq is a positive regulator of althiomycin biosynthesis; the 5’ 
region of alb1 may serve as a binding site for Hfq and the deletion of either Hfq or the 
binding site encoded by alb1 might abolish transcription of alb2-6. Our understanding 
of the role of Hfq and the potential overlap with the requirement for the 5’ end of alb1 
is incomplete and further experiments would be required to confirm this hypothesis. 
However, to date, experiments to identify direct interactions between Hfq and the alb 
mRNA have been unsuccessful (SJC lab, unpublished). 
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Concurrent with our independent, de novo identification, analysis and characterisation 
of the althiomycin biosynthetic gene cluster of S. marcescens Db10, a similar cluster 
directing althiomycin production was identified in the Gram-negative, soil dwelling 
bacterium, Myxococcus xanthus strain DK897 (Cortina et al., 2011), following earlier 
reports of althiomycin production by this organism (Kunze et al., 1982). S. marcescens 
Db10 and M. xanthus are only distantly related, being members of the Gamma and 
Delta Proteobacteria, respectively. Therefore to determine the level of similarity 
between the two althiomycin biosynthetic gene clusters, a comparative bioinformatic 
analysis was performed (Table 3.14 Comparative analysis of the althiomycin 
biosynthetic proteins). The althiomycin biosynthetic gene clusters of M. xanthus and S. 
marcescens Db10 both contain six genes: almA-F and alb1-6, respectively. Five of the 
six gene products are clearly equivalent and the gene order is conserved, suggesting that 
the clusters are related. The Alb1-5 proteins share reasonable identity with the 
corresponding proteins in M. xanthus at the primary amino acid sequence level (Table 
3.14). Our predictions for the role played by each of these proteins in althiomycin 
biosynthesis by S. marcescens Db10 are similar to those made for the corresponding 
proteins in M. xanthus (Cortina et al., 2011). Although similar at the protein level, Alb1 
and AlmE likely fulfil different functions in S. marcescens Db10 and M. xanthus, 
respectively. As discussed in detail above, we propose that Alb1 is not essential in S. 
marcescens to confer resistance to althiomycin but is rather required for export of the 
antibiotic. Contrastingly, in M. xanthus, it was not possible to make an almE deletion 
mutant and this led the authors to speculate that AlmE was required for self-resistance 
in this strain in addition to being required for export of the antibiotic. Surprisingly, Alb6 
and AlmF show no detectable identity with each other at the primary amino acid 
sequence level. Alb6 is predicted to be a type II thioesterase, with an ‘editing’ or 
‘proofreading’ function, required for the removal of incorrect intermediates from the 
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NRPS/PKS machinery or acetyl moieties from incorrectly primed ACP or PCP domains 
(Fischbach & Walsh, 2006). This finding is corroborated by the finding that althiomycin 
production is reduced to ~ 10% of wild type levels in the alb6 mutant. By contrast, 
AlmF of M. xanthus is predicted to be a proline iminopeptidase (TIGR01250) and 
Cortina et al. (2011) prefer a model where AlmF catalyses the formation of the 
methyoxypyrrolinone ring of althiomycin following release from the NRPS-PKS 
enzyme. These authors do note, however, that this step could also be performed by the 
integrated (Type I) thioesterase domain at the end of AlmB (equivalent to that of Alb5). 
Alb6 and AlmF are both members of the α/β hydrolase superfamily of proteins (Pfam 
12697) and consistent with this, similarities in the predicted protein secondary 
structures of these proteins can be seen (data not shown). Additionally, minor 
differences exist in the organisation of the biosynthetic operons between the two 
organisms. In M. xanthus, almB and almF (equivalent to alb5 and alb6) are predicted to 
be translationally coupled. In the S. marcescens Db10 alb gene cluster, alb5 and alb6 
are separated by a 146 bp gap suggesting that translational coupling is unlikely. 
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Table 3.14 Comparative analysis of the althiomycin biosynthetic proteins from 
Serratia marcescens Db10 and Myxococcus xanthus 
S. marcescens  Length a M. 
xanthus 
Length a % identity / 
similarity b 
Proposed Function 
Alb1 393 AlmE 446 56 / 72 Resistance/export 
Alb2 318 AlmD 317 55 / 70 Fe/Mn-dependent 
N-oxygenase 
Alb3 303 AlmC 302 55 / 69 O-
Methyltransferase 
Alb4 2376 AlmA 2396 44 / 59 NRPS 
Alb5 5347 AlmB 5428 46 / 61 NRPS/PKS 
Alb6 244 AlmF 322 None Thioesterase 
a
 The length of the protein is given as the number of amino acids. 
b
 The percentage similarity and identity was obtained using pairwise protein-protein BLAST 
analysis across the entire length of the protein (Altschul et al., 1997). 
 
Althiomycin has attracted pharmaceutical interest as a potentially useful 
antibiotic, but progress has been curtailed by the lack of efficient chemical syntheses 
and availability of the biosynthetic genes/enzymes. Furthermore, of broader interest is 
the 4-methoxy-3-pyrrolin-2-one moiety of althiomycin (Figure 3.28). This is a key 
structural feature of numerous other bioactive natural products that are mostly of marine 
origin, including sintokamide A, malyngamide A, mirabimide E and the extremely 
potent anticancer agent dolastatin 15 (Figure 3.28). Nothing is known about the 
biosynthesis of these remarkable natural products (Bai et al., 1992; Cardellina, 1979; 
Paik, 1994; Sadar et al., 2008). We hypothesise that they, like althiomycin, are the 
products of hybrid NRPS-PKS assembly lines and that the 4-methoxy-3-pyrrolin-2-one 
unit in these molecules is assembled by analogous enzymatic logic to that employed in 
the assembly of althiomycin (Figure 3.17). Thus, NRPS-mediated chain extension with 
glycine (in the case of malyngamide) or L-phenyalanine (in the case of dolastatin-15) 
followed by PKS-mediated chain extension with malonyl-CoA, O-methylation of the 
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resulting beta-ketothioester and thioesterase-mediated cyclisation, equivalent to the 
action of Alb3 and the final two modules of Alb5, would yield the corresponding 4-
methoxy-3-pyrrolin-2-ones.  
 
Figure 3.28. The 4-methoxy-3-pyrrolin-2-one moiety of althiomycin is shared by other 
bioactive natural products. The position of the 4-methoxy-3-pyrrolin-2-one moiety in 
althiomycin is highlighted by a broken box and this moiety is depicted in grey within the other 
molecules. Analysis performed in collaboration with Greg Challis and Lijiang Song, University 
of Warwick.  
 
3.9 Conclusions 
We identify alb1-6 as being required for the biosynthesis and export of the broad 
spectrum antibiotic, althiomycin, in S. marcescens Db10 and we propose a function for 
each of the identified biosynthetic proteins. Reassuringly, our predictions for the 
function of alb2-5 overlap with those presented by Cortina et al. 2011. We demonstrate 
that Alb1 is required for efficient export of althiomycin but that it is not required for 
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resistance in S. marcescens Db10. Additionally, the identification and characterisation 
of the althiomycin biosynthetic gene cluster in S. marcescens, which is a fast-growing 
and highly genetically tractable organism, offers an exciting “tool box” for the potential 
future exploitation of Alb proteins as a starting point for the generation and synthesis of 
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Phosphopantetheinyl transferase (PPTase) enzymes catalyse the transfer of a 
phosphopantetheinyl (PPT) group from coenzyme A to a conserved serine residue 
within the carrier protein domains of fatty acid synthases, non-ribosomal peptide 
synthases (NRPSs) and polyketide synthetases (PKSs) and this modification is essential 
for the activity of the enzymes (Figure 1.7) (Beld et al., 2014). Given that PPTase 
enzymes are essential for NRPS and PKS dependent biosynthesis, we reasoned that S. 
marcescens Db10 must encode at least one PPTase enzyme required for althiomycin 
biosynthesis. We describe the identification of a PPTase enzyme, PswP, that is required 
for althiomycin biosynthesis. Upon further characterisation of PswP, it was determined 
that this enzyme is additionally required for the biosynthesis at least two other NRPS 
products in S. marcescens Db10, namely serrawettin W2 and an enterobactin-like 
molecule. All three metabolites identified as being dependent on PswP for biosynthesis 
possess antimicrobial activity, illustrating the essential nature of this PPTase enzyme in 
secondary metabolite production in S. marcescens Db10. 
  
4.2 Identification of the phosphopantetheinyl transferase enzyme, SMA2452 
(PswP) 
Prior results indicated that the genome of S. marcescens Db10 encoded at least 
one functional NRPS-PKS enzyme; Alb4-5, which is required for the biosynthesis of 
the antibiotic, althiomycin. It known that functional NRPS and PKS enzymes must be 
activated by PPTase enzymes, which catalyse the addition of a PPT group (Figure 1.7) 
(Lambalot et al., 1996). We therefore hypothesised that the genome of S. marcescens 
Db10 encoded a PPTase enzyme and we sought to identify the encoding gene. The gene 
encoding the PPTase required for activation of an NRPS or PKS enzyme may or may 
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not be encoded in the same region of the genome as the NRPS or PKS biosynthetic gene 
cluster (Beld et al., 2014). The alb1-alb6 gene cluster does not encode a PPTase 
enzyme; therefore we extended our search for the PPTase needed for althiomycin 
biosynthesis to the entire genome of S. marcescens Db10.  
As described above, the Sfp family of PPTases are generally required for the 
activation of PKS and NRPS enzymes of secondary metabolism. We therefore 
hypothesised that the PPTase required for althiomycin biosynthesis would belong to this 
family. Two well characterised PPTases belonging to the Sfp family were thus used to 
identify Sfp type PPTases in S. marcescens Db10 by searching for homologous 
proteins; Sfp of B. subtilis (which is required for surfactin biosynthesis) and EntD of E. 
coli (which is required for the biosynthesis of a siderophore called enterobactin). Two 
PPTases were identified based on their similarity to Sfp and EntD; SMA4147 and 
SMA2452, respectively (Figure 4.29).  




Figure 4.29. Sequence alignments of S. marcescens PPTase enzymes with the characterised 
PPTases used to identify them. Sequence alignments performed using Clustal 2.1 A. 
SMA2452 and EntD of Escherichia coli H730. Percentage identity and similarity between the 
corresponding proteins was calculated as 37% and 54%, respectively. B. SMA4147 and Sfp of 
Bacillus subtilis subsp. subtilis RO-NN-1. Percentage identity and similarity between the 
corresponding proteins was calculated as 26% and 43%, respectively. Asterisk indicates 
positions which have a single, fully conserved residue. Colon indicates conservation between 
groups of strongly similar properties. Full stop indicates conservation between groups of weakly 
similar properties.  
  
As the SMA2452 and SMA4147 genes represented likely candidates for the 
PPTase needed for althiomycin biosynthesis, deletion strains were constructed. 
Althiomycin production was assessed using the B. subtilis bioassay and by UHPLC-
ESI-TOF-MS analysis. Deletion of SMA4147 did not affect althiomycin production; in 
contrast, mutation of SMA2452 abolished althiomycin production (Figure 4.30.A and 
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B). To confirm that the loss of althiomycin production in the SMA2452 mutant strain 
was specific to this gene, complementation analysis was performed. To this end, a 
plasmid carrying the complete SMA2452 coding region was introduced into the 
SMA2452 mutant strain, and the bioassay was performed. The growth inhibition activity 
was restored (Figure 4.30.C). It is therefore reasonable to conclude that SMA2452 
functions to phosphopantetheinylate the Alb4-5 multi-enzyme during althiomycin 
biosynthesis. 
 
Figure 4.30. The PPTase encoded by SMA2452 is required for althiomycin biosynthesis. A. 
Assay to assess the antimicrobial activity of S. marcescens Db10, the alb4-5 mutant strain 
(SAN5), the 4147 mutant strain (SAN96) and the 2452::Cml mutant strain (SAN112) against 
B. subtilis 3610. B. Extracted ion chromatograms at m/z=440.0600 for S. marcescens Db10 and 
SMA2452 (SAN112). C. Activity assays were performed using Bacillus subtilis NRS1473 as 
the indicator lawn. The producer strains are indicated above as: Db10 + VC (S. marcescens 
Db10 pSUPROM); Db10 + 2452 (S. marcescens Db10 pSAN46); 2452::Cml +VC (SAN112 
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pSUPROM); 2452::Cml + 2452 (SAN112 pSAN46). ‘VC’ represents the empty vector 
control. Analysis performed in collaboration with Greg Challis and Lijiang Song, University of 
Warwick.  
 
4.3 Bioinformatic analysis of SMA2452 
Having identified SMA2452 as the PPTase enzyme required for althiomycin 
biosynthesis, the protein sequence was compared with the sequences of proteins of 
known function. Further inspection of SMA2452 revealed that it is 96% identical to 
PswP of S. marcescens 274. In S. marcescens 274, PswP is the PPTase required for 
prodigiosin and serrawettin W1 production (Sunaga et al., 2004). Since SMA2452 and 
PswP are highly similar, SMA2452 will henceforth be referred to as PswP. 
As described above, PswP is one of two Sfp type PPTases encoded by S. 
marcescens Db11. Based on the presence of the conserved residues within motifs 1A, 1, 
2 and 3, we assigned PswP to the F/KES subfamily of Sfp type PPTases (Figure 4.31).  
 
 
Figure 4.31. Identification of conserved motifs of the F/KES subfamily of Sfp type PPTases 
within PswP of Serratia marcescens Db10. Conserved PPT motifs 1A, 1, 2 and 3 are boxed. 
Residues previously identified as being highly conserved across the F/KES subfamily are 
indicated below the sequence; those residues of PswP matching this consensus are shaded black. 
Analysis based on motif alignment analysis perfomed by Copp and Neilan (Copp & Neilan, 
2006).  




4.4 The PswP PPTase is required for the biosynthesis of more than one metabolite 
with antimicrobial activity in S. marcescens Db10 
The above data demonstrate that when B. subtilis is used as an indicator lawn, 
the deletion of alb4-5 is sufficient to negate the antimicrobial effect of S. marcescens 
Db10. However, we noted that while S. aureus was sensitive to althiomycin, disruption 
of althiomycin biosynthesis did not completely abolish the antimicrobial effect of S. 
marcescens Db10 against S. aureus (Figure 4.32).  
 
Figure 4.32. The althiomycin mutant strain of Serratia marcescens Db10 possesses 
antimicrobial activity against Staphylococcus aureus. Antimicrobial activity assays using S. 
aureus as the indicator lawn for the producer strains: Db10 (S. marcescens Db10), alb4-5 
(SAN5) and pswP (SAN112).  
 
We proceeded to demonstrate that deletion of the PswP PPTase enzyme required 
for althiomycin biosynthesis is sufficient to negate the antimicrobial activity of S. 
marcescens Db10 against S. aureus (Figure 4.32). PPTase enzymes are known to 
modify the carrier protein domain of FAS, PKS and NRPS enzymes (Lambalot et al., 
1996). We thus hypothesised that, in addition to being required for althiomycin 
biosynthesis, PswP was required for the biosynthesis of one or more FAS, PKS or 
NRPS product(s) with antimicrobial activity against S. aureus. Following this initial 
observation, we aimed to determine the identity of this metabolite(s).  




4.5 Identification of candidate targets of PswP 
In S. marcescens Db10, the pswP coding region is not embedded within or 
adjacent to an NRPS or PKS biosynthetic gene cluster. We were therefore unable to 
predict additional PKS or NRPS biosynthetic pathways that might require that activity 
of PswP based on its genomic context. The bioinformatics tool, antiSMASH, allows 
identification and preliminary analysis of secondary metabolite gene clusters in bacterial 
and fungal genomes in an unbiased manner (Blin et al., 2013). Therefore, antiSMASH 
was employed to identify all genomic regions containing putative PKS, NRPS and 
NRPS-PKS gene clusters in the S. marcescens Db10 genome, on the basis that one or 
more of these might direct the biosynthesis of the secondary metabolite(s) active against 
S. aureus. The results of this search are summarised in Table 4.15. Five genomic 
regions containing NRPS or NRPS-PKS gene clusters, whose products could potentially 
be modified by the action of PswP, were identified. Upon closer inspection of the NRPS 
and NRPS-PKS gene clusters, the althiomycin biosynthetic machinery and the 
machinery required for the biosynthesis of the surfactant, serrawettin W2, were 
identified in clusters three and four (Gerc et al. 2012, Pradel et al., 2007). Published 
data for the three remaining gene clusters was not available and so a bioinformatic 
approach was adopted. In an attempt to deduce the likely product of the three remaining 
NRPS biosynthetic gene clusters, the protein sequences encoded by the NRPS genes(s) 
identified by antiSMASH, together with the products of the flanking genes, were 
subjected to database searching using BlastP (Altschul et al., 1997). Analysis of the 
NRPSs in gene cluster one revealed that this locus likely encodes proteins involved in 
the biosynthesis of a microcin (Table 4.15). SMA1574A shows 41% identity with 
microcin N of E. coli 2424 (Corsini et al., 2010) and the NRPS proteins, SMA1572 and 
SMA1571, are likely involved in biosynthesis of a modifying group added to the 
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microcin peptide encoded by this gene cluster (Rebuffat, 2012).  In contrast, gene 
clusters two and five appear to direct the synthesis of multiple siderophores (Table 
4.15). The NRPS encoded within gene cluster two shares homology with chrysobactin 
synthetase component F (Persmark et al., 1989) and within gene cluster five is a locus 
containing an NRPS and associated genes conserved with the enterobactin biosynthesis 
and utilisation genes from E. coli (see below) (Raymond et al., 2003). 
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Putative product Comments 
1 SMA1552-1589 NRPS SMA1571-1572 - Unknown Predicted NRPS encoded within a cluster of genes 
(SMA1575-1568) showing similarity with genes involved 
in biosynthesis and secretion of microcins; may synthesize 
a modifying group added to the microcin. 
2 SMA1705-1744 NRPS SMA1729 - Siderophore Predicted NRPS similar to chrysobactin synthetase (64% 
identity over the whole length) and flanked by genes 
encoding proteins with similarity to proteins mediating 
siderophore export, uptake and iron release. 
3 SMA2274-1309 NRPS-PKS SMA2289-2290 Althiomycin  n/a Althiomycin is a broad-spectrum antibiotic.  NRPS-PKS is 
encoded within the six-gene alb operon (SMA2288-2293) 
which also encodes tailoring and export functions. 
4 SMA3659-3702 NRPS SMA3680 Serrawettin W2  n/a Serrawettin W2 is a biosurfactant  (Pradel et al., 2007). 
5 SMA4386-4438 NRPS SMA4411 - Siderophore Predicted NRPS is similar to enterobactin synthetase EntF 
and within cluster of genes (SMA4408-4415) similar to the 
enterobactin biosynthesis, export and uptake cluster of E. 
coli (Figure 4.35). 
SMA4402-4404, 
SMA4406 
- Unknown Encoded NRPS proteins share similarity with siderophore 
synthetase enzymes from other organisms but number and 
nature of product(s) unclear. 
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4.6 The PswP-dependent surfactant serrawettin W2 has antimicrobial activity 
against S. aureus 
Biosurfactants are amphipathic molecules whose primary function is to reduce 
surface tension to allow bacterial spreading across surfaces (Matsuyama, 2011). 
Biosurfactants have been shown to possess several properties, including antimicrobial 
activity (Singh & Cameotra, 2004). Of particular note, Serrawettin W1 produced by S. 
marcescens ATCC274 has been shown to have antimicrobial properties against 
methicillin resistant Staphylococcus aureus (MRSA) (Kadouri & Shanks, 2013). In S. 
marcescens Db10, PswP had previously been shown to be required for the biosynthesis 
of serrawettin W2 (Pradel et al., 2007). Therefore, to determine whether serrawettin W2 
also possessed antimicrobial activity against S. aureus, a serrawettin W2 single mutant 
was obtained (Pradel et al., 2007) and used to construct a double mutant (swrA::Tn5 
alb4-5) unable to produce althiomycin or serrawettin W2. Both mutant strains were 
tested for antimicrobial activity against S. aureus (Figure 4.33). Compared with S. 
marcescens Db10, the swrA::Tn5 mutant showed a slight reduction in antimicrobial 
activity against S. aureus. The reduction in antibiosis halo observed with the double 
swrA::Tn5 alb4-5 mutant was much more pronounced than with either single mutant, 
however, a small antibiosis halo could still be observed (Figure 4.33). We therefore 
concluded that serrawettin W2 does indeed possess antimicrobial activity against S. 
aureus, but that S. marcescens Db10 must produce another antimicrobial, in addition to 
serrawettin W2 and althiomycin, which is dependent on the presence of PswP for 
biosynthesis. 




Figure 4.33. The PPTase PswP is required for the biosynthesis of at least three secondary 
metabolites with antimicrobial activity against Staphylococcus aureus. Antimicrobial 
activity assays using S. aureus as the indicator lawn for the producer strains: Db10 (S. 
marcescens Db10), swrA::Tn5 (JESM267) and swrA::Tn5 alb4-5 (SAN124).  
 
 The SMA4408-4415 gene cluster encodes a siderophore which is dependent on 
PswP for biosynthesis and has antimicrobial activity against S. aureus 
In light of the results presented above, we reasoned that one or more of the three 
remaining NRPS gene clusters identified by antiSMASH should be responsible for the 
antimicrobial effect against S. aureus in the absence of althiomycin and serrawettin W2. 
Two of the three remaining NRPS gene clusters identified by antiSMASH encoded 
proteins with similarity to siderophore biosynthetic proteins (Table 4.15 and Figure 
4.35). We therefore hypothesised that either a siderophore produced by S. marcescens 
Db10 was directly toxic toward S. aureus, or that siderophore dependent removal of 
iron from the environment prevented growth of S. aureus. In order to distinguish 
between these possibilities, FeCl3 was added to the growth media and the antimicrobial 
bioassay repeated. The small antibiosis halo which could be observed with the double 
swrA::Tn5 alb4-5 mutant in the absence of additional iron disappeared upon the 
addition of FeCl3 (Figure 4.34).  




Figure 4.34. An althiomycin and serrawettin W2 mutant of Serratia marcescens Db10 is 
unable to kill Staphylococcus aureus in the presence of additional iron. Antimicrobial 
activity assays in the absence (a) or presence (b) of 50 mM FeCl3, using S. aureus as the 
indicator lawn, with a schematic of the location of each producer strain shown (c). The 
producing strains were: 1. S. marcescens Db10 (wild type) 2. SAN5 (alb4-5) 3. JESM267 
(swrA::Tn5) 4. SAN112 (pswP) 5. SAN124 (alb4-5, DswrA::Tn5).  
 
From these results two scenarios are possible: 1) Addition of excess iron negates 
the iron depletion effect of a siderophore(s) or 2) The addition of iron negatively affects 
the production of siderophores by S. marcescens Db10, as observed in E. coli and many 
other Gram-negative bacteria (Crosa & Walsh, 2002). In either case, these findings 
indicated that siderophore production by S. marcescens Db10 was likely to inhibit S. 
aureus growth.  
As mentioned above, a set of genes (SMA4408-4415) within cluster five show 
homology and synteny with the enterobactin gene cluster of E. coli (Figure 4.35). It 
therefore seemed likely that these genes are involved in the synthesis of enterobactin or 
a closely related molecule. It should be noted, however, that the only close homologue 
of entA, which is located immediately upstream of entB in E. coli, was identified as 
SMA2450 in S. marcescens Db11. In contrast with E. coli, the SMA2450 gene is located 
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at a distant locus from the other enterobactin genes, however it is closely genetically 
linked with pswP (SMA2452) in S. marcescens. Given both the linkage between entA 
and pswP in S. marcescens and that the SMA4408-4415 genomic region showed the 
most convincing similarity with a well-characterised cluster of genes involved in 
siderophore biosynthesis and utilisation, we tested whether the product of these genes 
was responsible for the PswP- and iron-dependent growth inhibition observed in the 
swrA::Tn5 alb4-5 double mutant. The product of SMA4415 shares significant 
homology with entB of the enterobactin biosynthetic gene cluster (Figure 4.35).   





Figure 4.35 Comparison of the SMA2450-2452 and SMA4408-4415 gene clusters of Serratia marcescens Db10 with the enterobactin biosynthetic gene 
cluster of Escherichia coli CFT073 (c0668-c0683). Genes are drawn approximately to scale and protein length is indicated below the encoding gene (as the number 
of amino acids). Homologous genes are indicated by the same colour and the level of identity between homologous proteins is shown below the corresponding gene. 
The extent to which two (nucleotide or amino acid) sequences have the same residues at the same positions is indicated as an absolute value or as a percentage.  
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Since EntB is essential for enterobactin biosynthesis in Escherichia coli (Crosa 
& Walsh, 2002), we reasoned that SMA4415 would be essential for biosynthesis of this 
siderophore in S. marcescens Db10. An in-frame deletion in entB was therefore 
constructed in the althiomycin and serrawettin W2 deficient strain to give a triple 
althiomycin, serrawettin W2 and enterobactin mutant (swrA::Tn5, alb4-5, entB). 
and also in the althiomycin and serrawettin W2 mutant background to give a triple 
althiomycin, serrawettin W2 and entB mutant (swrA::Tn5 alb4-5 entB). To 
compare siderophore production by wild type S. marcescens Db10 with that of the 
single entB mutant, the triple swrA::Tn5 alb4-5 entB mutant and the pswP mutant, 
the relevant strains were  grown on chrome azurol S (CAS) indicator plates. The 
CAS/hexadecyltrimethylammonium bromide/ferric iron complexes present in these 
plates serve as an indicator of siderophore biosynthesis; in the presence of an iron 
chelator this indicator turns from a blue to an orange colour (Schwyn & Neilands, 
1987). In wild type S. marcescens Db10, production of a diffusible siderophore was 
clearly observed (Figure 4.36). In contrast, no siderophore production was observed in 
the entB single mutant, in the althiomycin, serrawettin W2 and entB triple mutant 
(swrA::Tn5 alb4-5 entB), or in the PswP PPTase mutant (pswP) (Figure 4.36). The 
loss of siderophore production was specific to the deletion of entB or pswP, with 
siderophore production being unaffected  in strains unable to produce althiomycin 
and/or serrawettin (Figure 4.36). These results clearly show that both entB and pswP are 
essential for the biosynthesis of a siderophore in S. marcescens Db10.  




Figure 4.36. The PPTase PswP and SMA4415 (EntB) are required for the biosynthesis of a 
siderophore in S. marcescens Db10. Chrome azurol S (CAS) assay for the detection of 
siderophore biosynthesis, as indicated by the presence of an orange halo. (a) The producer 
strains are indicated above as: Db10 (wild type S. marcescens Db10), alb4-5 (SAN5), 
swrA::Tn5 (JESM267), alb4-5 swrA::Tn5 (SAN124), entB (SAN176), pswP (SAN112) and 
alb4-5swrA::Tn5 entB (SAN181).  
 
Additionally, the CAS assay allowed us to confirm that construction of the pswP 
(SMA2452) PPTase mutant did not affect siderophore biosynthesis through downstream 
polar effects on the expression of SMA2450, predicted to encode an EntA homologue 
(Figure 4.35), since the loss of siderophore biosynthesis observed with the pswP mutant 
could be complemented by the expression of pswP in trans (Figure 4.37). 




Figure 4.37. The expression of sma2450 (entA) is unaffected in the pswP mutant. 
Complementation of the pswP deletion by expression of pswP in trans. The producer strains are 
indicated above as: Db10 + VC (S. marcescens Db10 pSUPROM, vector control), Db10 + pswP 
(S. marcescens Db10 pSAN46), pswP + VC (SAN112 pSUPROM) and ), pswP + pswP 
(SAN112 pSAN46).  
 
Having shown that entB was required for biosynthesis of a siderophore in S. 
marcescens Db10, the triple althiomycin, serrawettin W2 and siderophore mutant was 
tested for antimicrobial activity against S. aureus. No antibiosis halo was observed with 
the swrA::Tn5 alb4-5 entB triple mutant (Figure 4.38), thus providing a phenocopy 
of the PswP PPTase mutant and indicating that the entB-dependent siderophore is the 
third PswP-dependent antimicrobial secondary metabolite produced by S. marcescens 
Db10.  
  




Figure 4.38. The PPTase PswP is required for the biosynthesis of three secondary 
metabolites with antimicrobial activity against Staphylococcus aureus. Antimicrobial 
activity assays using S. aureus as the indicator lawn for the producer strains: Db10 (S. 
marcescens Db10), pswP (SAN112) and entB, swrA::Tn5, alb4-5 (SAN181)  
 
 4.7 Discussion  
Our data highlights how an individual bacterial PPTase enzyme can play an 
essential role in the biosynthesis of multiple secondary metabolites with disparate 
physiological roles and additionally demonstrates how several distinct secondary 
metabolites can contribute to the inhibition of growth of competitor bacteria. PPTase 
enzymes may therefore be essential for survival in multispecies environments. 
PswP was one of three PPTases identified in S. marcescens Db10. SMA3052 
was identified based on homology to AcpS of E. coli and likely the sole PPTase 
involved in primary metabolism (data not shown). Both PswP and SMA4147 belong to 
the Sfp family of PPTases and, as mentioned above, were identified based on homology 
to EntD of E. coli and Sfp of B. subtilis, respectively (Figure 4.29). In contrast to pswP, 
deletion of SMA4147 did not influence the antimicrobial effect of S. marcescens Db10 
on S. aureus growth (data not shown). Since no phenotypic effects could be observed 
upon the deletion of SMA4147, the role of this enzyme in secondary metabolite 
biosynthesis in S. marcescens Db10 could not be defined. It appears that the targets of 
PswP and SMA4147 do not overlap, however, since deletion of PswP alone was 
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sufficient to abolish althiomycin, serrawettin W2 and enterobactin(-like) biosynthesis. It 
is possible that SMA4147 is required for the biosynthesis of the additional NRPS 
products whose encoding genes were identified by antiSMASH.   
Given that a single PPTase enzyme may be essential for several metabolic 
pathways, the potential for PPTase enzymes to serve as targets for the development of 
antimicrobials seems an obvious step forwards, however, this may not be feasible. In 
humans, there exists a single PPTase (AASDHPPT) which, surprisingly, was identified 
through homology to Sfp of B. subtilis (Joshi et al., 2003); as described above, Sfp 
family PPTases are generally associated with NRPS and PKS enzymes of secondary 
metabolism in micro-organisms (Mootz et al., 2001; Quadri et al., 1998). To date, three 
metabolic pathways requiring AASDHPPT have been described (Joshi et al., 2003; 
Strickland et al., 2010), perhaps explaining why a typically promiscuous Sfp family 
PPTase exists in humans. The overlap in sequence and structural homology between 
bacterial PPTases and the human AASDHPPT may render the development of bacterial 
specific PPTase antimicrobials impossible. Further, AASDHPPT has been suggested to 
be essential, since AASDHPPT silencing by small interfering RNA induces a strong G1 
cell cycle arrest (Joshi et al., 2003). 
Work presented in this study is the first to implicate the SMA4408-4415 gene 
cluster in the biosynthesis of an enterobactin-like siderophore in S. marcescens Db10. In 
the Serratia strain sp. V4, a siderophore called serratiochelin was identified as a product 
of an operon which appeared to share characteristics with the enterobactin gene cluster 
of E. coli and the vibriobactin gene cluster of Vibrio cholera. Unfortunately, the 
genome sequence of the serratiochelin gene cluster has not been published and so it was 
not possible to directly compare this gene cluster with the enterobactin-like gene cluster 
that we identified in S. marcescens Db10. Within the vibriobactin-like gene cluster of 
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Serratia sp. V4, schH shows a similar level of identity to the corresponding vibriobactin 
protein as SMA4402. The organisation of the SMA4402-2206 gene cluster also appears 
to be similar to that of the serratiochelin gene cluster, although not identical; in the S. 
marcescens Db10 gene cluster entA is associated with pswP, whereas in Serratia sp. 
V4, the equivalent gene is located within the enterobactin-like gene cluster 
(Seyedsayamdost et al., 2012).  
The presence of more than one iron uptake system is common in bacteria, for 
example, some strains of E. coli possess up to eight of these systems (Adler et al., 
2012). The SMA4408-4415 gene cluster was one of two siderophore biosynthetic gene 
clusters identified in S. marcescens Db10. The NRPS SMA1729 was also identified and 
predicted to encode a chrysobactin-like molecule. Noteably, the chrysobactin like 
siderophore was either not produced or not active under CAS assay conditions, since 
deletion of entB was sufficient to negate siderophore production. 
 The antimicrobial effects of siderophores have previously been investigated 
(Adler et al., 2012; Braun et al., 2009; Wang et al., 2009). For example, pyochelin 
produced by Pseudomonas aeruginosa displays antimicrobial activity against several 
Xanthomonas strains and S. aureus. Perhaps surprisingly, the antimicrobial effects were 
attributed to the generation of reactive oxygen species rather than iron depletion  (Adler 
et al., 2012). In the case of  S. marcescens Db10, the antimicrobial effects of the 
enterobactin like siderophore were not defined. The addition of iron to the antimicrobial 
assay plates abolished the antimicrobial effects of S. marcescens Db10 against S. 
aureus. However, the addition of iron may have either turned off expression of the 
enterobactin like siderophore encoding genes, or it may have negated the iron limiting 
antimicrobial effects of the siderophore. A distinction between these possibilities was 
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not made. It is entirely possible that the inhibition of S. aureus growth by the 
enterobactin like siderophore occurs independently of the available iron. 
4.8 Conclusions 
We demonstrate that the function of the PswP PPTase is essential in several 
secondary metabolite biosynthesis pathways in S. marcescens Db10. We were able to 
identify althiomycin, serrawettin W2 and an enterobactin (-like) molecule as being 
dependent on PswP for biosynthesis, since all three metabolites possess anti-microbial 
activity against S. aureus. Our data suggests that a single PPTase can play important 
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Insights into the assembly and function of the Type 
VI Secretion System of Serratia marcescens Db10 





 The Type VI secretion system (T6SS) is the most recently discovered of the 
Gram-negative bacterial secretion systems. This system comprises a minimum of 13 
core components and functions to target proteins directly from the producing cell into a 
bacterial or eukaryotic cell (Boyer et al., 2009). S. marcescens Db10 possesses a single 
T6SS gene cluster (sma2244-2281) which encodes the essential core components TssA-
TssM. This 38 gene operon additionally encodes effector proteins that are secreted by 
the system and proteins that are involved in post-translational regulation (Figure 5.39) 
(English et al., 2012; Fritsch et al., 2013; Murdoch et al., 2011). However, the roles of 
several proteins encoded by the gene cluster have yet to be defined. In the case of S. 
marcescens Db10, the T6SS is a potent anti-bacterial system (Murdoch et al., 2011). 
The aim of this work was to gain new insight into the mechanism of the T6SS using S. 
marcescens Db10, specifically by constructing strains encoding translational fusions of 
components of the T6SS with fluorescent proteins. Analysis of these strains, using 
several fluorescence microscopy based approaches, should permit aspects of T6SS 
assembly and function to be investigated. Here, we describe the construction and 
functional characterisation of eight such fusion strains and the visualisation of the 
corresponding T6SS components using fluorescence microscopy. Additionally, we 
further characterise the frequency with which the T6SS assembles by using the strain 
expressing the TssB-mCherry fusion protein to indicate the site of assembly of an active 
T6SS. 
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5.2 Construction and characterisation of strains expressing tss-mCherry fusion 
proteins 
As described above, the T6SS is composed of 13 essential conserved 
components. Seven of these universally conserved components, together with one 
widely conserved component, were chosen for construction of chromosomally encoded, 
C-terminal, translational fusions with the fluorescent protein, mCherry. The T6SS 
components selected were; TssJ, TssK, TssH, TssL, TssB, TssE, VgrG-2 (a TssI family 
protein) and Fha. As described in detail in the Introduction, these components are 
believed to occupy distinct locations within the machinery, including the basal 
cytoplasmic complex (TssK, TssE, Fha), the contractile cytoplasmic sheath (TssB, 
TssH), the membrane subcomplex (TssL, TssJ) and the expelled puncturing structure 
(VgrG-2) (Figure 5.39). 




Figure 5.39. Schematic representation of the genomic context and predicted cellular 
localisation of selected components of the Type VI Secretion System. Components in 
Serratia marcescens Db10 selected to construct chromosomal translational fusions with 
mCherry are indicated in red. A. Schematic representation of the T6SS gene cluster. Genes 
encoding conserved T6SS components are shown by letter, indicating their Tss name. Of note, 
two TssI family proteins are encoded by the T6SS in S. marcescens Db10, VgrG-1 and VgrG-2 
B. Schematic representation of the structure of the T6SS. VgrG2 forms a spike-like structure 
that is thought to puncture the membrane of target cells and may also associate with a subset of 
effector proteins to mediate translocation. TssJ is a lipoprotein found in the outer membrane. 
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TssL is anchored in the inner membrane, and possesses a periplasmic peptidoglycan binding 
domain and a cytoplasmic domain. TssB forms part of the sheath which surrounds the TssD 
tube in the cytoplasm. Contraction of this sheath is thought to propel the TssD tube forwards 
and out of the host cell. TssE and TssK are likely components of the cytoplasmic baseplate 
structure, however, their precise role remains unclear. TssH is a cytoplasmic ATPase that is 
required for disassembly of the TssBC sheath following contraction. Finally, Fha, when present, 
is an essential component of the system; it can be a target of post-translational regulation and 
may be involved in promoting an active conformation of the machinery.  
 
Having constructed strains encoding translational fusions of each of the above 
T6SS components with mCherry, at the normal chromosomal location, we determined 
the functionality of the T6SS in each case. To achieve this, three different assays were 
employed. These were the TssD secretion assay, the Ssp2 secretion assay and bacterial 
competition assays, schematically depicted in Figure 5.40. Since TssD is an essential 
component of the T6SS and is secreted when the system fires, detection of this 
component in the extracellular milieu is used as an indicator of the assembly of an 
active T6SS (Pukatzki et al., 2009). Ssp2 has been identified as a T6SS dependent 
bacterial effector, however, it is not an essential component of the system. Detection of 
Ssp2 in the extracellular milieu indicates that the T6SS is competent for the secretion of 
“true” effector proteins (English et al., 2012). Finally, the efficiency with which the 
T6SS kills neighbouring target cells can be assessed by conducting competition assays 






Figure 5.40. Schematic representation of assays used to determine the functionality of the T6SS in each strain expressing a tss-mCherry fusion protein. TssD 
and Ssp2 secretion assays involved the immunoblot detection of these proteins in the culture supernatant of the relevant strain. To assess T6SS functionality by 





5.2.1 Functionality of the T6SS in strains expressing tss-mCherry fusion proteins as 
determined by a TssD secretion assay 
TssD secretion was compared between the following strains: wild type S. 
marcescens Db10, S. marcescens Db10 tssH, S. marcescens Db10 tssJ-mCherry, S. 
marcescens Db10 tssK-mCherry, S. marcescens Db10 tssH-mCherry, S. marcescens 
Db10 tssL-mCherry, S. marcescens Db10 tssB-mCherry, S. marcescens Db10 tssE-
mCherry (SAN164) and S. marcescens Db10 fha-mCherry. Since TssH is an essential, 
conserved component of the T6SS, a strain lacking this gene was used as a negative 
control. Secretion of TssD in the S. marcescens Db10 vgrG-2-mCherry strain was 
assessed separately, since VgrG-2 is not essential in the presence of VgrG-1 in S. 
marcescens Db10 (SJC lab, unpublished). Results revealed that all the fusion strains 
constructed were competent for the secretion of TssD, with the exception of the strain 
encoding TssK-mCherry (Figure 5.41). In the case of the strain encoding VgrG-2-
mCherry, we observed that VgrG-2-mCherry was able to support secretion of TssD in 
the absence of VgrG-1, indicating its functionality in this assay (Figure 5.41). 




Figure 5.41. TssD secretion assay to assess functionality of the T6SS-mCherry fusion 
proteins. Immunoblot detection of TssD in the cellular and secreted fractions from: A. Serratia 
marcescens Db10, SJC3 (S. marcescens Db10 tssH), SAN157 (S. marcescens Db10 tssJ-
mCherry), SAN159 (S. marcescens Db10 tssH-mCherry) B. S. marcescens Db10, SJC3 (S. 
marcescens Db10 tssH), SAN158 (S. marcescens Db10 tssK-mCherry), SAN162 (S. 
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marcescens Db10 tssL-mCherry), SAN163 (S. marcescens Db10 tssB-mCherry), SAN166 (S. 
marcescens Db10 tssE-mCherry) and SAN164 (S. marcescens Db10 fha-mCherry) C. S. 
marcescens Db10, SJC3 (S. marcescens Db10 tssH), FRA01 (S. marcescens Db10 vgrG-2), 
FRA02 (S. marcescens Db10 vgrG-1), FRA03 (S. marcescens Db10 vgrG-1 vgrG-2), 
SAN186 (S. marcescens Db10 vgrG-2-mCherry) and SAN202 (S. marcescens Db10 vgrG-1 
vgrG-2-mCherry)  
 
5.2.2 Functionality of the T6SS in strains expressing tss-mCherry fusion proteins as 
determined by an Ssp2 secretion assay 
Ssp2 secretion assays were then performed on the strains, described above, 
encoding Tss-mCherry fusion proteins. TssE and TssH are essential conserved 
components of the T6SS and so strains lacking these components were used as negative 
controls for Ssp2 secretion. Similar to results obtained from the TssD secretion assay, 
the strain encoding the TssK-mCherry fusion protein was the only strain which 
harboured a non-functional T6SS (Figure 5.42). Again, in agreement with results 
obtained from the TssD secretion assay, VgrG-2-mCherry was sufficient for export of 
TssD in the absence of VgrG-1 (Figure 5.42). 




Figure 5.42. Ssp2 secretion assay to assess functionality of the T6SS-mCherry fusion 
proteins. Immunoblot detection of Ssp2 in secreted fractions from: A. Serratia marcescens 
Db10, SJC1 (S. marcescens Db10 tssE), SAN157 (S. marcescens Db10 tssJ-mCherry), 
SAN158 (S. marcescens Db10 tssK-mCherry), SAN159 (S. marcescens Db10 tssH-mCherry), 
SAN162 (S. marcescens Db10 tssL-mCherry), SAN163 (S. marcescens Db10 tssB-mCherry), 
SAN164 (S. marcescens Db10 fha-mCherry) and SAN166 (S. marcescens Db10 tssE-mCherry) 
B. S. marcescens Db10, SJC3 (S. marcescens Db10 tssH), FRA01 (S. marcescens Db10 
vgrG-2), FRA02 (S. marcescens Db10 vgrG-1), FRA03 (S. marcescens Db10 vgrG-1 
vgrG-2), SAN186 (S. marcescens Db10 vgrG-2-mCherry) and SAN202 (S. marcescens Db10 
vgrG-1 vgrG-2-mCherry)  
 
5.2.3 Functionality of the T6SS in strains expressing tss-mCherry fusion proteins as 
determined by a competition assay 
Finally, competition assays were performed using strains encoding Tss-mCherry 
fusion proteins in order to monitor their T6SS-mediated bacterial killing ability. 
Competition assays were performed as described in Figure 3.23, using Pseudomonas 
fluorescens as the target organism. Results from these assays revealed that, consistent 
with results from the TssD and Ssp2 secretion assays, the TssK-mCherry strain was the 
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only strain in which the T6SS was completely inactive, with target cell recovery 
indistinguishable from that observed with the tssH mutant (Figure 5.5). The TssJ-
mCherry strain showed some reduction in ability to kill P. fluorescens when compared 
with wild type S. marcescens Db10, however, it retained significant killing ability, 
causing a drop of >100x in the number of viable P. fluorescens cells recovered when 
compared with a T6SS-inactive mutant (Figure 5.5).  
  
Figure 5.43. Competition assay to determine the number of viable Pseudomonas 
fluorescens cells recovered following co-culture with the Serratia marcescens strains 
indicated. Recovery of viable P. fluorescens cells after 4 h co-culture with the S. marcescens 
strain indicated, at 30°C, with an initial ratio of 5:1 S. marcescens : P. fluorescens (see 
Materials and Methods for full details). Points and bars show mean +/- standard error of the 
mean (n=3).  
 
To further investigate the reason behind the reduced killing phenotype of the 
TssJ-mCherry protein fusion strain, an -TssJ western blot was performed on samples 
prepared from wild type S. marcescens Db10, a tssJ mutant and the tssJ-mCherry 
fusion strain (Figure 5.44). The total amount of protein loaded was normalised 
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according to the OD600 of the culture, however, less TssJ was detected in the strain 
expressing tssJ-mCherry when compared with wild type TssJ in S. marcescens Db10 
(Figure 5.44). A decrease in the amount of TssJ present in the cell might limit the 
number of T6SSs that could be assembled, explaining why killing of competitor 
bacteria is not as efficient as S. marcescens Db10 in this strain. 
  
Figure 5.44. Immunoblot detection of TssJ in total cellular fractions of Serratia marcescens 
Db10, SAN157 (S. marcescens Db10 tssJ-mCherry) and SJC10 (S. marcescens Db10 tssJ). 
Asterisk indicates non-specific band.  
 
In the case of the strain encoding the VgrG-2-mCherry fusion protein, S. 
marcescens 274 was used as the target strain since with this strain, unlike many other 
target strains, a strong phenotype can be observed when the vgrG-2 mutant is used as 
the killer (SJC lab, unpublished). The VgrG-2-mCherry strain showed some killing 
activity when compared with the vgrG-2 mutant strain, however, the fusion strain was 
clearly much less efficient than wildtype S. marcescens Db10 at killing S. marcescens 
274 (Figure 5.45).  




Figure 5.45. Competition assay to determine the number of viable Serratia marcescens 274 
cells recovered following co-culture with the S. marcescens Db10 strains indicated. 
Recovery of viable S. marcescens 274 cells after 4 h co-culture with the S. marcescens Db10 
strain indicated, at 30°C, with an initial ratio of 5:1 S. marcescens Db10 : S. marcescens 274 
cell (see Materials and Methods for full details). Points show mean +/- standard error of the 
mean (n=3). For a diagram of the competition assay set up, see Figure 3.11.  
 
From the above results we concluded that all of the strains encoding the 
mCherry fusion proteins harboured a T6SS that was functional on some level, with the 
exception of the TssK-mCherry strain. Immunoblot analysis of TssK expression in the 
TssK-mCherry strain revealed that the TssK-mCherry protein was present at a similar 
level to wild type S. marcescens Db10 (data not shown). In S. marcescens Db10, TssK 
has been shown to interact with the conserved T6SS components, TssF and TssG. 
Additionally, TssK has been shown to exist in several oligomeric states (English et al., 
2014). It is likely that addition of mCherry to the C terminus of this protein interferes 
with self-self interactions or with its interaction with TssFG.  
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5.2.4 Analysis of the integrity of the mCherry fusion proteins 
To confirm whether the each mCherry fusion protein was full length (in other 
words that the mCherry was not being cleaved off), an -mCherry immunoblot was 
performed on total cellular protein from each strain. For the VgrG-2-mCherry strain, 
secreted fractions were also probed for mCherry, since VgrG proteins are expelled from 
the cell when the T6SS fires, similar to TssD. 
 
Figure 5.46. -mCherry immunoblot analysis of cellular fractions isolated from strains 
encoding the mCherry fusion protein indicated. Immunoblot detection of mCherry in cellular 
fractions from: Serratia marcescens Db10 pSC1008 (in which mCherry is under the control of 
an inducible promoter), S. marcescens Db10, SAN157 (S. marcescens Db10 tssJ-mCherry), 
SAN158 (S. marcescens Db10 tssK-mCherry), SAN159 (S. marcescens Db10 tssH-mCherry), 
SAN162 (S. marcescens Db10 tssL-mCherry), SAN163 (S. marcescens Db10 tssB-mCherry), 
SAN164 (S. marcescens Db10 fha-mCherry) and SAN166 (S. marcescens Db10 tssE-mCherry)  
 
Full length mCherry fusion proteins were detected for TssJ-, TssH-, TssL-, 
TssB- and Fha-mCherry (Figure 5.46). In contrast, mCherry could not be detected for 
the strains expressing TssK, TssE (Figure 5.46) or VgrG-2-mCherry (data not shown). It 
is likely that these proteins are simply not expressed to a level high enough for detection 
with the -mCherry antibody, particularly since full length TssK-mCherry had 
previously been detected by TssK immunoblot analysis (data not shown).  
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5.2.5 Visualisation of the strains expressing Tss-mCherry fusion proteins by 
fluorescence microscopy 
To further characterise the fluorescent fusion strains, the fusion proteins were 
visualised by fluorescence microscopy (Figure 5.47). Initial observations revealed no 
fluorescence could be observed for the TssE- and VgrG-2-mCherry fusion strains. 
These data agree with the data obtained from the -mCherry immunoblot experiments, 
whereby TssE- and VgrG-2-mCherry could not be detected, presumably due to low 
expression levels (Figure 5.47.A). For the remaining strains expressing Tss-mCherry 
fusion proteins, fluorescence could be detected by microscopy. Initial observations 
suggested that the localisation of TssJ-mCherry and TssL-mCherry was distinct from 
the localisation of TssK-mCherry, TssH-mCherry, TssB-mCherry and Fha-mCherry 
(Figure 5.47.A).  
We selected for further analysis the TssJ-, TssH-, TssL- and TssB-mCherry 
fusions, since these were functional, readily detectable and their localisation was of 
particular interest (see below). Upon optimisation of microscopy conditions, the 
localisation of the fluorescent proteins could be seen more clearly (Figure 5.47.B). For 
TssJ-mCherry and TssL-mCherry, the fluorescent proteins could be visualised around 
the cell periphery in the majority of cells. Additionally, for TssL-mCherry, foci could be 
observed in a sub-population of these cells. For the TssH-, and TssB-mCherry fusions, 
either diffuse cytoplasmic fluorescence or fluorescent foci could be observed. In line 
with previously published data, we assume that focus formation by TssB represents the 
assembly of an active T6SS (Basler & Mekalanos, 2012). 
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Figure 5.47. Representative examples of fluorescence microscopy images acquired from 
strains encoding Tss-mCherry fusion proteins. The strains imaged were SAN157 (S. 
marcescens Db10 tssJ-mCherry), SAN158 (S. marcescens Db10 tssK-mCherry), SAN159 (S. 
marcescens Db10 tssH-mCherry), SAN162 (S. marcescens Db10 tssL-mCherry), SAN163 (S. 
marcescens Db10 tssB-mCherry), SAN164 (S. marcescens Db10 fha-mCherry), SAN166 (S. 
marcescens Db10 tssE-mCherry) and SAN186 (S. marcescens Db10 vgrG-2-mCherry); the 
fusion protein imaged is indicated at the top left of each main panel. In each case, the broken 
box indicates the area of the main image that has been magnified in the two right hand panels. 
The channels in which images were acquired are labelled: POL (differential interference 
contrast) and TRITC (detection of mCherry). The scale bar is 1 M. A. Initial fluorescence 
microscopy observations with all mCherry fusion strains. To prepare cells for microscopy, the 
relevant strains were grown overnight on plates. The following day, cells were collected and re-
suspended in phosphate buffered saline. The cell suspension was diluted 10-fold and cells were 
immobilised on an agarose slide prior to imaging. B. Observations with selected mCherry fusion 
strains following optimisation of microscopy conditions.  To prepare cells for microscopy, the 
relevant strains were grown overnight in liquid LB. The following day, these cultures were used 
to inoculate minimal media glucose to an OD600 of 0.15. Cells were grown for four hours and 
then were immobilised on minimal media glucose solidified through the addition of agarose 
prior to imaging.  




5.2.6 Co-localisation analysis of TssB with TssH, TssJ and TssL 
It was of great interest to determine how the foci observed for the individual 
TssH, TssL and TssJ fusion proteins spatially corresponded with those observed for 
TssB, since this might provide insight into the spatial and dynamic assembly of 
different subcomplexes within the machinery. TssH has been shown previously to 
interact with the contracted TssBC sheath to catalyse disassembly of the structure and, 
in Vibrio cholerae, to co-localise with TssB by microscopy (Basler & Mekalanos, 2012; 
Kapitein et al., 2013). It might be expected that components of the T6SS should come 
together either before or upon firing of the system, however, the localisation of TssB in 
relation to the outer membrane (OM) lipoprotein, TssJ, and the inner membrane (IM) 
protein, TssL has not been reported. We therefore aimed to visualise the co-localisation 
of TssB with the cytoplasmic protein, TssH, the IM protein, TssL and the OM 
lipoprotein, TssJ. In order to achieve this, strains were constructed in which TssB was 
translationally fused to Gfpmut2 and, simultaneously, TssH, TssL or TssJ were 
translationally fused to mCherry. To demonstrate that these strains harboured a 
functional T6SS, TssD secretion assays were performed as described above. 
Additionally, an -Gfp immunoblot of total cellular fractions was performed to confirm 
that the TssB-Gfpmut2 fusion was full length. These data confirmed that the T6SS was 
functional for the secretion of TssD and that the TssB-Gfpmut2 protein fusion was full 
length in each case (Figure 5.48). 




Figure 5.48. -Gfp and -TssD immunoblot analysis of cellular fractions or cellular and 
secreted fractions isolated from strains encoding the TssB-Gfpmut2 protein 
simultaneously with TssH-, TssL- or TssJ-mCherry. Immunoblot detection of TssD and 
TssB-Gfpmut2 from: SAN207 (S. marcescens Db10 tssB-gfpmut2), SAN208 (S. marcescens 
Db10 tssB-gfpmut2, tssJ-mCherry), SAN209 (S. marcescens Db10 tssB-gfpmut2, tssH-
mCherry) and SAN210 (S. marcescens Db10 tssB-gfpmut2, tssL-mCherry). A. Detection of 
TssD in the cellular and secreted fractions of the strains indicated. B. Immunoblot detection of 
TssB-Gfpmut2, which would be expected to be 49 kDa in size.  
 Each dual fusion strain was imaged by fluorescence microscopy in an attempt to 
visualise co-localisation of the fluorescently labelled proteins (Figure 5.49). The TssB-
Gfpmut2, TssH-mCherry strain served as a reference, as it has already been 
demonstrated that TssH co-localises with the contracted TssBC sheath in V. cholerae 
(Kapitein et al., 2013).  





Figure 5.49. Representative examples of co-localisation images from strains encoding 
TssB-Gfpmut2 alone or with TssH-, TssL- or TssJ-mCherry. Fluorescence microscope 
images acquired with SAN207 (S. marcescens Db10 tssB-gfpmut2), SAN209 (S. marcescens 
Db10 tssB-gfpmut2, tssH-mCherry), SAN210 (S. marcescens Db10 tssB-gfpmut2, tssL-
mCherry) and SAN208 (S. marcescens Db10 tssB-gfpmut2, tssJ-mCherry). The channels in 
which images were acquired are labelled:  POL (differential interference contrast), FITC 
(detection of Gfp) and TRITC (detection of mCherry). The scale bar is 1 M. To prepare cells 
for microscopy, the relevant strains were grown overnight in liquid LB. The following day, 
these cultures were used to inoculate minimal media glucose to an OD600 of 0.15. Cells were 
grown for four hours and then were immobilised on minimal media glucose solidified through 
the addition of agarose prior to imaging.  
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Visual inspection of our images revealed that, in agreement with previously 
published data, TssH-mCherry foci always co-occur with TssB-gfpmut2 foci (Basler & 
Mekalanos, 2012; Kapitein et al., 2013). However, TssB-gfpmut2 foci do not always 
co-localise with TssH-mCherry foci. Given that TssH is required for the disassembly of 
the contracted TssBC sheath but is not required for its assembly, these data agree with 
the biological function of TssH. In the case of TssL-mCherry and TssB-gfpmut2, there 
appeared to be more TssL-mCherry foci than TssB-gfpmut2 foci. Only a subset of 
TssB-Gfpmut2 and TssL-mCherry foci appeared to co-localise. In these instances TssB-
Gfpmut2 did not always completely overlay TssL-mCherry, rather the fusion proteins 
appeared adjacent to one another. With the TssJ-mCherry and TssB-gfpmut2 fusion 
strain, co-localisation of the fluorescent proteins was not as apparent given that TssJ-
mCherry tended not to form foci as distinct as TssH- or TssL-mCherry. Nevertheless, 
some cells did appear to harbour foci and in some instances we could observe an 
overlap of TssJ-mCherry and TssB-Gfpmut2. However, given that TssJ-mCherry was 
distributed abundantly around the periphery of many cells, this might be expected. 
 
5.2.7 Further analysis of the TssB-mCherry fusion strain 
The strain expressing the TssB-mCherry fusion protein was chosen for some 
further analysis as foci appeared brightest in this strain. Visualisation of a TssB-
mCherry focus was used as a read out for the assembly of an active T6SS, as has been 
described in previous studies (Basler & Mekalanos, 2012; Basler et al., 2012). 
Timelapse fluorescence microscopy using this strain allowed us to follow the dynamics 
of the T6SS in S. marcescens Db10 over a period of hours. Timelapse fluorescence 
microscopy with the TssB-mCherry fusion strain showed that the T6SS was active 
throughout growth under the conditions that we tested. Assembly of an active T6SS was 
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not a rare event, with many cells within the growing microcolony assembling a T6SS 
(Figure 5.50). Dynamic T6SS assembly and disassembly was readily observed, with 
foci frequently appearing and disappearing between images taken every 10 min (Figure 
5.50 and data not shown). 
 
Figure 5.50. Timelapse fluorescence microscopic analysis of the TssB-mCherry fusion 
strain (SAN163). The channels in which images were acquired are labelled: POL (differential 
interference contrast) or TRITC (to detect mCherry). The scale bar is 1 M. To prepare cells for 
microscopy, the relevant strains were grown overnight in liquid LB. The following day, 25l 
was used to inoculate 5ml minimal media glucose (MM glucose). Cells were grown in MM 
glucose for 18 hours. This culture was then diluted to an OD600 of 0.02 and cells were 
immobilised on MM glucose solidified through the addition of agarose prior to imaging. Cells 
were imaged over a period of 360 mins. The time of image acquisition is indicated at the top 
right of each image.  
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In the longer term, we hope to apply automated spot detection and tracking 
software to quantify spatial and temporal distribution and dynamics of T6SS foci. To 
facilitate this, it is desirable to have strains in which the cell boundary is clearly 
distinguishable. Therefore we constructed a strain in which gfp was expressed 
constitutively from the chromosome using an inducible bacteriophage T5 promoter and 
Gfp protein was evenly distributed throughout the cytoplasm (SAN195), data not 
shown. We then introduced this cytoplasmic GFP cassette into the TssB-mCherry 
background (generating strain SAN199). This strain was then imaged by fluorescence 
microscopy and preliminary analysis performed by visual inspection of the resulting 
images. The following conclusions were derived from analysis of a single field of view 
(Figure 5.51). 




Figure 5.51. Representative example of a fluorescence image acquired from S. marcescens 
Db10 tssB-mCherry, lacZ::PT5-gfpmut2-kan (SAN199). The channels in which images were 
acquired are labelled: POL (differential interference contrast), FITC (to detect GFP) and TRITC 
(to detect mCherry). The scale bar is 1 M. To prepare cells for microscopy, SAN199 was 
grown overnight in liquid LB. The following day, these cultures were used to inoculate minimal 
media glucose to an OD600 of 0.15. Cells were grown for four hours and then were immobilised 
on minimal media glucose solidified through the addition of agarose prior to imaging.  
 
In this field of view, 123 cells were present. Of these, 32 cells harboured at least 
one TssB-mCherry focus, meaning that approximately 26% of the population assembles 
an active T6SS at a single point in time under the conditions that we tested. Several 
cells within the field of view harboured two TssB-mCherry fluorescent foci, indicating 
that a cell can assemble more than one T6SS at one time. Interestingly, foci were also 
Chapter 5: Insights into the T6SS of Serratia marcescens Db10 
171 
 
observed in single cells which were not surrounded by neighbouring cells. These results 
indicate that in S. marcescens Db10, the presence of neighbours is not required to 
stimulate assembly of the T6SS. 
 
5.3 Discussion 
 Analysis of strains expressing Tss-mCherry or -Gfpmut2 fusion proteins by 
fluorescence microscopy has allowed visualisation of the localisation of several 
components of the T6SS in S. marcescens Db10 (Figure 5.47 and Figure 5.49). The 
visualisation of cytoplasmic fluorescence or fluorescent foci for the TssH-, TssB- and 
Fha-mCherry fusion strains agrees with previous microscopic analysis of these proteins 
in other organisms (Basler & Mekalanos, 2012; Brunet et al., 2013; Hsu et al., 2009; 
Kapitein et al., 2013). Foci comprised of fluorescent TssB have previously been 
proposed to represent the contracted form of the TssBC sheath and the site of assembly 
of the focus is thought to mark the location for T6SS assembly (Basler et al., 2012). 
TssB could not be visualised in the extended form under the conditions that we tested. 
This may be due to the fact that the extended form of the TssBC sheath is thought to 
exist only transiently prior to contraction, which occurs in approximately 5 ms. 
Contrastingly, the contracted sheath takes tens of seconds to be disassembled (Basler et 
al., 2012). Visualisation of the extended TssBC sheath may also be beyond the 
resolving power of the microscope used in these studes. TssH is known to be required 
for the disassembly of the contracted TssBC sheath and so its co-localisation with 
TssBC would be expected and has been demonstrated in V. cholera (Basler & 
Mekalanos, 2012; Basler et al., 2012; Bonemann et al., 2009). Whilst the precise role of 
Fha remains unclear, evidence is consistent with Fha localising to a partially or 
completely assembled T6SS (Hsu et al., 2009). To our knowledge, this is the first time 
that TssJ, TssL and TssK have been visualised by fluorescence microscopy. The 
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localisation patterns observed with the TssJ-mCherry fusion protein and the TssL-
mCherry fusion protein are consistent with biochemical data showing that that TssJ is 
an lipoprotein anchored in the OM (Aschtgen et al., 2008) and that TssL is an integral 
IM protein (Aschtgen et al., 2012), however their precise localisation within the cell 
envelope cannot be accurately determined within the limits of resolution of light 
microscopy. Whilst TssK also appeared to form foci similar to other cytoplasmic 
components of the T6SS, we cannot make confident conclusions based on this data 
since the addition of mCherry to the protein rendered the T6SS non-functional.  
 Parallel studies performed by a collaborating group have attempted to shed light 
on the dynamics of components of the T6SS by following fluorescent fusion proteins 
over different time ranges by fluorescence microscopy. These studies were performed 
on the same S. marcescens Db10 strains expressing the TssJ-, TssH-, TssL- and TssB-
mCherry fusion proteins that were constructed in this study. The fusion proteins were 
imaged over milliseconds, seconds or tens of seconds (A. Diepold, University of 
Oxford). Of the proteins analysed, TssJ appeared the most motile and some motility 
could be observed over milliseconds. These data agree with our observation that little 
TssJ specifically localises upon T6SS assembly. Foci representative of TssH and TssL 
were more stable than TssJ, suggesting these proteins come together to form a sub-
complex upon firing of the system. Foci representative of TssB were most stable and 
could be observed to disappear and re-appear at different locations in the cell when 
imaged over tens of seconds (A. Diepold, University of Oxford). It has previously been 
reported that the TssBC sheath is assembled and disassembled over tens of seconds and 
that TssH only associates with the contracted version of the sheath (Basler & 
Mekalanos, 2012; Basler et al., 2012). These data offer an explanation as to why foci 
representative of TssH appear and disappear more quickly than foci representative of 
TssB. In our studies, timelapse fluorescence microscopy was performed with the strain 
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expressing the TssB-mCherry fusion protein. When imaged every 10 mins, foci 
representative of TssB were observed to appear and disappear at different locations in 
the cell for the duration of the timelapse (Figure 5.50). These data agree with the 
microscopic analysis performed by A. Diepold (University of Oxford). 
We then proceeded to consider the extent to which TssJ, TssL and TssH were 
co-localised with TssB. TssH served as a reference as it has previously been shown that 
TssH co-localises with a subset of TssB foci (Basler & Mekalanos, 2012). Indeed, we 
also observed the co-occurrence of TssH-mCherry foci with a subset of TssB-Gfpmut2 
foci (Figure 5.49). Since TssH only localises with the contracted TssBC sheath, the 
extended form of the sheath would not be expected to co-localise with TssH (Kapitein 
et al., 2013). Co-visualisation of TssJ or TssL with TssB has not yet been reported. In S. 
marcescens Db10, little specific co-localisation of TssJ with TssB was observed. 
Conversely, a subset of TssL foci appeared to co-localise with TssB, however in many 
instances the fluorescent foci appeared adjacent or overlapping with one another rather 
than completely co-localised (Figure 5.49). Given that TssL is anchored in the IM 
whereas TssB is entirely cytoplasmic, these data may reflect the difference in the 
cellular localisation of TssB versus TssL. Our data suggest that TssJ is distributed 
throughout the cell envelope and that only a small proportion is specifically recruited 
upon assembly of the T6SS. In comparison, TssL does appear to aggregate upon 
assembly of the T6SS. A future quantitative analysis of the co-localisation of the 
fluorescent proteins will permit more solid conclusions about the extent of co-
localisation of TssB with each of the other components, TssJ, TssL or TssH, to be made. 
 Further analysis of TssB-mCherry allowed us to make some initial, tentative 
conclusions and comparisons with the T6SS in other organisms. In V. cholerae, upon 
labelling of VipA (TssB) with sfGfp, between zero and five foci per cell were observed 
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in the wild-type background (Basler et al., 2012). In S. marcescens Db10 we observed a 
maximum of two foci within each cell, implying that the T6SS is not assembled as 
frequently as in V. cholerae under the conditions that we tested (Figure 5.51).  In P. 
aeruginosa, it has been reported that T6SS foci are present in 15% of cells at any given 
time (LeRoux et al., 2012). However it should be noted that in this organism, a fusion 
of ClpV1 (TssH) with Gfp, rather than TssB, was used to determine the frequency with 
which an active T6SS assembles and our data have indicated that, at a given instant, 
there are more detectable TssB than TssH foci. Additionally, in the above study a P. 
aeruginosa retS regulatory mutant, in which the transcription of the T6SS is 
upregulated, is frequently used in studies concerning the T6SS. These factors mean that 
the frequency with which the T6SS assembles in P. aeruginosa cannot currently be 
directly compared with S. marcescens Db10, although non-quantitative observation 
suggests that frequency of focus formation is more similar between P. aeruginosa and 
S. marcescens  Db10 than between P. aeruginosa and V. cholerae. Future development 
of an automated analysis tool capable of recognising cells based on cytoplasmic Gfp 
and recognising fluorescent TssB foci would allow the analysis of many more fields of 
view and quantification of various parameters including number of foci per cell, 
distribution of foci along the length of the cell and dependence of focus formation on 
the presence of a neighbouring cell (see below).  
In P. aeruginosa, efficient targeting of recipient cells requires that the recipient 
cells possess a functional T6SS. This phenomenon has been termed “duelling” and can 
be visualised by microscopy since foci in neighbouring cells appeared to be paired 
(Basler et al., 2013; LeRoux et al., 2012). Perturbation of the membrane of the recipient 
cell has recently been reported as the trigger which activates the T6SS in P. aeruginosa 
(Ho et al., 2013). Our analysis of microscopy data obtained with the TssB-mCherry 
protein fusion in S. marcescens Db10 suggests that this system does not require 
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activation by sensing of an incoming T6SS attack (Figure 5.51). We could readily 
observe TssB-mCherry foci within single S. marcescens Db10 cells that were not in 
contact with neighbouring cells and we did not see evidence for the ‘paired’ foci 
characteristic of duelling. Additionally, it has been demonstrated that S. marcescens 
Db10 can kill a strain of Serratia marcescens 274 in which the T6SS has been 
inactivated as efficiently as it can kill the T6-active wild type strain (SJC lab, 
unpublished). This is in contrast with P. aeruginosa, which cannot efficiently kill E. coli 
cells which are devoid of a functional T6SS (Basler et al., 2013).  
In P. aeruginosa, the threonine phosphorylation pathway (TPP) has been 
implicated in response to an incoming T6SS attack (Basler et al., 2013). The TPP 
includes the cell envelope associated TagQRST system, the threonine kinase PpkA and 
the cognate phosphatase PppA. TagQRST somehow sense the incoming attack, 
probably via detecting a membrane breach, and activate PpkA, which then 
phosphorylates Fha. Phosphorylation of Fha is essential for T6SS activity (for more 
detail, see section 1.4.4) and appears to trigger assembly of a T6SS at the site of the 
exogenous attack, allowing the Pseudomonas cell to to counter-attack The genes 
encoding PpkA, PppA and Fha also exist in S. marcescens Db10, and phosphorylation 
of Fha by PpkA is also essential for T6SS activity in this organism (Fritsch et al., 2013). 
However, in S. marcescens Db10, the TagQRST system is not present, meaning that 
PpkA must be regulated by some other mechanism. These data fit with our microscopy 
data which suggests that the T6SS of S. marcescens Db10 is not activated by the T6SS 
of a neighbouring cell (Figure 5.51). Additionally, the deletion of PppA in P. 
aeruginosa results in a de-repression of T6 dependent secretion in liquid culture 
(normally no T6 secretion occurs in liquid culture in this organism since productive 
cell-cell interactions require close contact on a solid surface), whereas in S. marcescens 
Db10 deletion of PppA does not have any observable effect in liquid culture since the 
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system is already active in liquid in this organism (Fritsch et al., 2013). Together, the 
existing data and the single cell microscopy analysis reported here, strongly indicate 
that signal required to activate the T6SS in S. marcescens Db10 is distinct from that in 
P. aeruginosa. 
 In P. aeruginosa, the T6SS has been described as “defensive”, since it fires in 
response to attack from neighbouring cells (Basler et al., 2013). Conversely, in V. 
cholera the T6SS is not activated upon sensing of a T6SS attack from a neighbouring 
cell (Basler et al., 2012). The T6SS of Enteroaggregative E. coli (EAEC) bears some 
similarities to that of both P. aeruginosa and V. cholera. In EAEC, E. coli target cells 
devoid of a T6SS are efficiently killed, however, T6SS dynamics are also increased if 
neighbouring cells possess an active T6SS (Brunet et al., 2013). These data highlight 
the diversity in T6SS regulation. Our data suggest that the T6SS of S. marcescens Db10 
is more similar to that of V. cholera, which fires constantly and does not exhibit 
“duelling” behaviour (Basler et al., 2012). The T6SS of S. marcescens Db10 therefore 
appears to be “offensive” rather than “defensive”.  
5.4 Conclusions  
 
 Work conducted in this study has set the stage for further investigation into the 
mechanism and structure of the T6SS in S. marcescens Db10 via fluorescence 
microscopy. We have shown that strains of S. marcescens Db10 carrying fusions of key 
components of the T6SS with fluorescent proteins may be used as a tool for 
visualisation of components of the system. In the future, high resolution fluorescence 
microscopy, for example Fluorescence Activated Photobleaching (FRAP), could be 
employed to elucidate the dynamics and rate of turnover of T6SS components. 
Additionally, the strain expressing the TssB-mCherry fusion protein may be used to 
visualise the subcellular localisation of T6SS assembly and firing and the subsequent 
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killing of target bacteria. Initial analysis conducted in this study allowed tentative 
conclusions to be drawn about the frequency with which the T6SS assembles and about 
the co-localisation of certain components. We have demonstrated that approximately 
one third of cells harbour an active T6SS. We observed co-localisation of TssB with 
TssH and TssL and, to a lesser extent, with TssJ. In the future, quantitative and perhaps 
also automated analysis of larger data sets would strengthen these conclusions. Finally, 
in contrast with the well-studied T6SS of P. aeruginosa, analysis of TssB-mCherry by 
fluorescence microscopy has provided further evidence that the activating signal for the 
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Work conducted in this study has provided important insights into the 
mechanisms by which Serratia marcescens Db10 kills or inhibits the growth of 
competing bacteria. In this work, two very different strategies of antibacterial activity 
were investigated, namely the biosynthesis of NRPS/PKS products and the assembly of 
the Type VI Secretion System (T6SS). NRPS/PKS products biosynthesised by S. 
marcescens Db10 were shown to possess antibacterial activity against several species of 
Gram-positive bacteria. Conversely, the T6SS has, to date, only been demonstrated to 
possess antibacterial activity against Gram-negative bacteria (Schwarz et al., 2010). S. 
marcescens Db10 therefore has the capacity to kill a diverse range of bacteria. This is 
highly likely to give it a competitive advantage in a polymicrobial community. 
 
6.1 Identification and characterisation of althiomycin and its encoding gene cluster 
 Work on the biosynthesis of althiomycin was initiated upon the serendipitous 
discovery that S. marcescens Db10 was capable of killing or inhibiting the growth of 
several Gram-positive bacteria through the production of a diffusible substance. This 
was observable through the production of an antibiosis halo when S. marcescens Db10 
was grown on a lawn of the susceptible bacterium. The convenient nature of this 
antibacterial bioassay allowed us to conduct a high throughput transposon mutagenesis 
screen for the identification of S. marcescens Db10 mutants no longer able to kill the 
target bacterium. A 27 kb antibacterial gene cluster was subsequently identified. 
Analysis of the operon structure revealed that the antibacterial gene cluster comprised 
six genes, alb1-6, transcribed from a single promoter at the start of the operon. 
Bioinformatics analysis predicted that the gene cluster encoded NRPS/PKS biosynthetic 
enzymes, tailoring enzymes associated with modification of the NRPS/PKS product 
(Figure 3.17) and a protein involved in export of, or resistance to, the antibacterial 
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product. Experimental data identified the antibacterial product as the ribosome 
inhibiting antibiotic, althiomycin, and confirmed the essential role of alb2-6 in its 
biosynthesis (Figure 3.19 and Figure 3.21). Other strains of Serratia have been 
demonstrated to synthesise the -lactam antibiotic, carbapenem, and the pigmented 
antimicrobial, prodigiosin (Thomson et al., 2000). However, this is the first report of 
althiomycin biosynthesis by the genus Serratia, or indeed by any organism outside of 
Streptomyces or Myxococcus.  
Alb1 was demonstrated to have a role in the export of althiomycin, but, whilst 
capable of conferring resistance to a heterologous organism, was shown not to play an 
essential role in conferring resistance in S. marcescens Db10 (Figure 3.23 and Figure 
3.27). It is not uncommon for bacteria to encode more than one resistance determinant to 
the antibiotic they produce (Mak et al., 2014). Therefore, whilst not being the sole 
resistance determinant, Alb1 appears to provide one layer of self-protection against 
althiomycin (Mak et al., 2014). One or more althiomycin resistance determinants in S. 
marcescens Db10 therefore remain unidentified. Bacteria mediate self-resistance to 
antibiotics by an array of mechanisms. For example, they may encode export proteins, 
modify antibiotic intermediates or the final product, synthesise resistant versions of the 
target or modify the target of the antibiotic (Mak et al., 2014). Given that such a 
resistance determinant is not encoded within the alb1-6 gene cluster, identification of 
the main althiomycin resistance determinant may not be straightforward. However, as S. 
marcescens strain 274 was shown to be sensitive to the effects of althiomycin, 
comparison of the genomes of these bacteria may give some clues as to how S. 
marcescens Db10 avoids the toxic effects of althiomycin. For example, since 
althiomycin targets the bacterial ribosome (Fujimoto et al., 1970), S. marcescens Db10 
may encode alternative ribosomal RNA or proteins. Alternatively, since antibiotic 
resistance determinants must be expressed prior to or concomitantly with biosynthesis, 
Chapter 6: Conclusions and outlook 
181 
 
if specific regulators of althiomycin biosynthesis can be identified then these may in 
turn offer clues to the identities of the outstanding resistance determinant(s). 
S. marcescens Db10 is a fast growing and genetically tractable organism and so 
identification of the althiomycin biosynthetic gene cluster in this bacterium paves the 
way for future studies on the pharmaceutical potential of althiomycin, and also towards 
engineering compounds containing the bioactive 4-methoxy-3-pyrrolin-2-one moiety. 
 
6.2 Characterisation of the phosphopantetheinyl transferase enzyme, PswP 
Phosphopantetheinyl transferase enzymes are known to be essential for the 
function of NRPS/PKS enzymes (Figure 1.7). Since such an enzyme was not encoded 
within the althiomycin NRPS/PKS gene cluster, a bioinformatics approach was taken to 
identify candidate althiomycin PPTase enzymes elsewhere in the genome. Two 
candidate PPTase enzymes were identified. The deletion of PswP was demonstrated to 
be sufficient to abolish althiomycin biosynthesis whilst the deletion of the second 
PPTase enzyme had no observable effect (Figure 4.30). Upon testing of the PswP 
mutant for antimicrobial activity, it was realised that Staphylococcus aureus remained 
sensitive to diffusible products produced by S. marcescens Db10 in an althiomycin 
mutant but not in the PswP PPTase mutant. These data indicated that PswP was required 
for the biosynthesis of more than one NRPS/PKS metabolite in S. marcescens Db10 and 
that these metabolites possessed antimicrobial activity against S. aureus. Candidate 
NRPS gene clusters were identified by bioinformatics. Experimental evidence 
confirmed that two of these NRPS gene clusters, namely the serrawettin W2 gene 
cluster and a siderophore encoding gene cluster, were responsible for production of 
these metabolites. Several genes within the siderophore biosynthetic gene cluster were 
shown to be homologous to genes encoded within the enterobactin biosynthetic gene 
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cluster. The gene cluster also showed similarities to the serratiochelin gene cluster of 
Serratia sp. V4. Purification and determination of the structure of the enterobactin-like 
siderophore produced by S. marcescens Db10 will be required to unambiguously 
identify this product. This would require isolation by HPLC and analysis by NMR 
 Two additional NRPS containing gene clusters were identified by 
bioinformatics. The SMA1571-1572 NRPS containing gene cluster was predicted to 
biosynthesise a microcin, whilst the SMA1729 containing gene cluster was predicted to 
be required for the biosynthesis of second siderophore. Since production of these 
metabolites could not be detected, the necessity for PswP in their biosynthesis could not 
be assessed. For Bacillus subtilis, Micrococcus luteus and S. aureus, deletion of 
althiomycin or PswP was sufficient to negate the antimicrobial activity of S. marcescens 
Db10. These data suggest that either the putative bacteriocin is not synthesised under 
these conditions or that the bacteria we tested are not sensitive to the effects of the 
bacteriocin. Isolation and inducible expression of the bacteriocin encoding gene cluster 
in a heterologous host would determine whether the relevant genes synthesise a toxic 
molecule. Under the conditions that we tested, the enterobactin-like siderophore was the 
only detectable siderophore produced by S. marcescens Db10 (Figure 4.36). Analysis of 
different growth conditions may lead to the identification of conditions conducive to the 
production of the putative siderophore encoded by SMA1729, perhaps allowing 
characterisation of the molecule. If biosynthesis of the microcin or the putative 
siderophore could be detected under different conditions then the role of PswP in their 
biosynthesis could also be determined. 
Overall, work conducted here has highlighted the importance of a single PPTase 
enzyme in the production of multiple important secondary metabolites with varying 
biological functions, namely killing competitors, iron acquisition and motility. 




6.3 Insights into the assembly and function of the T6SS of S. marcescens Db10 
 Work conducted in this study involved the construction of S. marcescens Db10 
strains carrying translational fusions of components of the T6SS to fluorescent proteins. 
Analysis of these strains revealed that the majority harboured a functional T6SS and the 
fluorescent proteins could be visualised by fluorescence microscopy. Localisation 
patterns were distinct between particular T6SS components (Figure 5.47). Differences 
in the localisation of the T6SS components were further assessed in strains which 
harboured fusions of TssB to Gfp and TssJ, TssH or TssL to mCherry. The co-
localisation of these fluorescent proteins was assessed visually, allowing us tentatively 
conclude that components of different subcomplexes of the T6SS localise differently 
during T6SS assembly. Automated analysis of multiple fields of view will strengthen 
these tentative conclusions. Timelapse fluorescence microscopy over a period of hours 
with the strain expressing the TssB-mCherry fusion protein confirmed that cells grew 
well under the conditions that we used and that the T6SS was active in many cells 
throughout the experiment. Analysis of a strain expressing cytoplasmic Gfpmut2 and 
the TssB-mCherry fusion protein revealed that approximately a quarter of the 
population had an active T6SS under the conditions of our study. Development of an 
analysis tool capable of recognising cells based on the presence of cytoplasmic Gfp and 
fluorescent foci representative of the T6SS would enable the analysis of many more 
fields of view. Assembly of the T6SS was shown not to be dependent on the presence of 
neighbouring cells, indicating that the trigger which activates the T6SS in S. marcescens 
Db10 is distinct from that in Enteroaggregative E. coli (EAEC) and Pseudomonas 
aeruginosa. These data agree with previous data demonstrating that the T6SS is 
constitutively active in S. marcescens Db10 (Fritsch et al., 2013; Murdoch et al., 2011). 
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The strains constructed in this study will comprise a toolbox for further 
investigations into the mechanisms of assembly and the dynamics of the T6SS. Indeed, 
further analysis by microscopy may offer several insights into the T6SS of S. 
marcescens Db10. The dynamics and turnover of individual T6SS components could 
potentially be assessed by Fluorescence Activated Photobleaching (FRAP). This would 
allow us to determine whether individual T6SS components within the entire machinery 
or within particular subcomplexes are exchanged or whether they are fixed. The number 
of molecules of a particular T6SS component within one system may be assessed by 
stochastic optical reconstruction microscopy (STORM). Analysis of the images 
obtained with a widefield microscope gave first insight into the co-localisation of TssB 
with TssJ, TssH or TssL. Fluorescence Resonance Energy Transfer (FRET) microscopy 
may allow us to further probe the physical proximity of fluorescent proteins. The above 
analyses have been performed on components or homologues of other bacterial 
secretion systems, for example, the Type III Secretion System (T3SS) (Delalez et al., 
2010; Dickenson & Picking, 2012). 
Previous studies have made use of fusions of TssB to fluorescent proteins to 
mark the site of T6SS assembly (Basler et al., 2012). Further analysis of such fusion 
proteins in different mutant backgrounds may help in trying to decipher the role of 
particular T6SS proteins. For example, analysis of T6SS assembly in the PpkA or PppA 
mutant background may give some clues as to how this kinase and phosphatase spatially 
or temporally regulate the T6SS. Using the TssB-mCherry fusion protein as a marker 
for T6SS assembly, it may also be possible to directly visualise the secretion and 
subsequent toxic effects of T6SS effectors on target cells in S. marcescens Db10, as has 
previously been performed with EAEC (Brunet et al., 2013). 
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Finally, it will be important to analyse the strains expressing fusions of single 
T6SS components with fluorescent proteins in different mutant backgrounds. If the 
localisation of these components changes upon the deletion of certain T6SS proteins 
then it may be possible to determine when the recruitment of particular T6SS 
components is dependent on the presence of other components. Additionally the order 
of assembly of the T6SS may be deduced from this type of analysis, as has previously 
been performed for the T3SS (Diepold et al., 2010). 
 
6.4 Additional remarks 
 Interestingly, recent experimental evidence has suggested a link between the 
althiomycin biosynthetic operon and the T6SS operon. Both gene clusters have been 
shown to be regulated by the small RNA binding protein, Hfq (SJC lab, unpublished), 
perhaps indicating that antibacterial strategies in S. marcescens Db10 are co-ordinately 
regulated. The althiomycin and T6SS gene clusters are also located relatively closely on 
the S. marcescens Db10 genome, with only 6 genes separating the two gene clusters.  
 
6.5 Conclusion 
 Work conducted in this study has significantly contributed to our understanding 
of the mechanisms by which S. marcescens Db10 kills competing bacteria (Figure 
6.52). 




Figure 6.52. Schematic representation of work conducted in this study to elucidate the 
antibacterial strategies employed by Serratia marcescens Db10. The mechanism of 
biosynthesis and the mode of export of the antibiotic, althiomycin, was elucidated. The 
phosphopantetheinyl transferase enzyme, PswP, was shown to play an essential role in the 
biosynthesis of althiomycin, serrawettin W2 and an enterobactin-like siderophore, all of which 
were shown to possess antibacterial activity against Staphylococcus aureus. Lastly, the Type VI 
Secretion System (T6SS) was visualised through the construction of strains carrying 
translational fusions of T6SS components to fluorescent proteins. 
 
The mechanism of althiomycin biosynthesis and export was de-lineated and the 
role of the PPTase enzyme, PswP, in the biosynthesis of secondary metabolites was 
defined. Strains were constructed which harboured translational fusions of components 
of the T6SS to fluorescent proteins and these proteins were visualised by fluorescence 
microscopy. Further analysis of these strains by fluorescence microscopy will contribute 
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